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It is estimated that approximately 30% of individuals worldwide are affected by mental health problems during 
their lifetime. Currently, Major Depressive Disorder (MDD) is one of the most prevalent psychiatric disorders 
and a leading cause of non-lethal disability worldwide. However, despite exposure to known risk factors for 
MDD, human responses to it vary widely. Whilst some individuals develop MDD, others develop only mild and 
transient symptoms or no depressive symptomology at all. This ability to ‗bounce back' from or ‗escape‘ the 
development of psychiatric illness is referred to as psychological resilience (Chapter 1). Scientific and clinical 
interest in resilience has grown exponentially over recent decades, but wide discrepancies are still found in both 
its definition and measurement. As such, resilience is rarely measured directly, but inferred from the 
measurement of two specific points of convergence; adversity (its antecedents) and positive adaptation (its 
consequences). Whilst the study of adversity and positive adaptation has informed our knowledge of resilience it 
often fails to consider other putative risk factors for MDD (such as genetics), or potential protective factors that 
may foster resilience despite risk. More recently, examining protective factors have become a focus of research 
in relation to resilience. This research suggests that numerous protective factors coalesce to contribute to 
resilient outcomes which give rise to a dynamic resilience process that varies contextually and temporally. 
Although investigating resilience may be expected to reveal similar findings to studying MDD itself, it does 
represent a new facet to scientific and clinical research. Specifically, resilience focuses on intervention long 
before the development of MDD when effects on subsequent suffering may be ameliorated. For this reason, it is 
imperative to address the concept of resilience, concentrating on the core components of adversity, positive 
adaptation and protective factors, to move beyond description towards an understanding of individual 
differences in resilience (Chapter 2). In this thesis, three studies will be presented which aim to examine 
psychological resilience from multiple perspectives to further delineate the concept.  
 
In Chapter 3, the associations and interactions between neuroticism and general intelligence (g) on MDD, and 
psychological distress were examined in GS:SFHS (Generation Scotland: Scottish Family Health Study) to 
investigate whether g mitigates the detrimental effects of neuroticism on mental health, as such an association 
has previously been identified for physical health and mortality. A larger replication was also performed in UK 
Biobank using a self-reported measure of depression. Across two large samples it was found that intelligence 
provides protection against psychological distress and self-reported depression in individuals high in 
neuroticism, but intelligence confers no such protection against clinical MDD in those high in neuroticism. In 
Chapter 4, a new dataset is presented which was designed to investigate psychological resilience and mental 
health. Specifically, the STRADL (Stratifying Resilience and Depression Longitudinally) dataset aimed to re-
contact existing GS:SFHS participants to obtain repeat measures of MDD and psychological distress in addition 
to obtaining data on resilience, coping style and adverse life experiences. This dataset has the potential to 
identify mechanisms and pathways to resilience but also elucidate causal mechanisms and pathways of 
depression sub-types. Chapter 5 investigated whether neuroticism and resilience are downstream mediators of 
genetic risk for depression, and whether they contribute independently to such risk. Specifically, the moderating 
and mediating relationships between polygenic risk scores (PRS) for depression, neuroticism, resilience, and 
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both clinical and self-reported MDD were examined in STRADL. Regression analyses indicated that 
neuroticism and PRS for depression independently associated with increased risk for both clinical and self-
reported MDD, whereas resilience associated with reduced risk. Structural equation modelling suggested that 
polygenic risk for depression associates with vulnerability for both clinical and self-reported MDD through two 
partially independent mediating mechanisms in which neuroticism increases vulnerability and resilience reduces 
it. In Chapter 6, the proportion of phenotypic variance that is attributable to genetic and shared-familial 
environment was estimated for resilience and three main coping styles; task-, emotion-, and avoidance-oriented 
coping. Bivariate analyses were conducted to estimate the genetic correlations between these traits and 
neuroticism. Our results indicate that common genetics affect both resilience and coping style. However, in 
addition, early shared-environmental effects from the nuclear family influence resilience whereas recent shared-
environment effects from a spouse influence coping style. Furthermore, strong genetic overlap between 
resilience, emotion-oriented coping, and neuroticism suggests a relationship whereby genetic factors that 
increase negative emotionality lead to decreased resilience. These studies highlight the necessity for 
complementary multivariate techniques in resilience research to elucidate tractable methodologies to potentially 






































Major Depressive Disorder (MDD) is a leading cause of disease burden worldwide. However, despite exposure 
to numerous risk factors for depression, not all individuals become unwell. This ability to ‗bounce back‘ from or 
‗escape‘ MDD is known as psychological resilience (Chapter 1). Despite growing scientific interest in 
resilience, agreement has not been reached as to how best to define and measure it. Instead, resilience has often 
been inferred from investigating negative life experiences (adversity) and how individuals cope with these 
events (positive adaptation). Whilst much has been learned from this research, it fails to consider other 
important facets of resilience such as unobservable risk for depression (e.g., genetic liability), and protective 
factors which may help an individual overcome the disorder. More recently, research has focused on the 
protective roles of personality, coping style and genetics to inform our knowledge of resilience. It suggests that 
multiple factors work together to ‗produce‘ resilience, which varies throughout the life course, and from 
situation to situation (Chapter 2). 
 
This thesis presents three studies which aim to investigate resilience from different perspectives to inform a 
better understanding of the concept. Chapter 3 shows that higher intelligence provides protection against 
unpleasant emotions and feelings (psychological distress) in individuals that score highly on the personality trait 
neuroticism. However, intelligence does not provide protection from clinical depression in individuals high in 
neuroticism. In Chapter 4, a new dataset that was specifically created to investigate psychological resilience is 
described. Chapter 5 shows that both genetic liability to depression and neuroticism independently increase risk 
for the disorder, whereas resilience reduces this risk. Furthermore, Chapter 5 demonstrates that the association 
between genetic liability for depression and the disorder itself is underlain by two partially separate pathways: 
one in which neuroticism increases risk for depression and one in which resilience reduces such risk, even in 
individuals genetically susceptible to depression. Chapter 6 shows that in addition to genetic effects, the early 
environment shared by families contributes to resilience whereas the more recent environment shared between 
couples‘ influences coping style. Additionally, Chapter 6 suggests that the genes which lead to unpleasant and 
negative feelings also reduce psychological resilience. Together, these findings highlight factors that may 
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Epidemiological research findings estimate that approximately 30% of the world‘s population are affected by a 
psychiatric disorder during their lifetime (Kalisch et al., 2015). Major Depressive Disorder (MDD) is among 
one of the oldest psychiatric disorders to be historically identified (Hippocrates, 1923-1931, Jackson, 1986), and 
is currently a leading cause of non-lethal disability worldwide (Ferrari et al., 2013). MDD is a highly pervasive 
and debilitating disorder, with a complex multifactorial interaction of genetic, neurobiological, and 
environmental components likely contributing to the individual differences seen in clinical liability and 
depressive symptomology (Otte et al., 2016). However, despite exposure to known risks for MDD, human 
responses to it vary widely. Indeed, despite significant risk for MDD, many individuals exhibit better than 
expected adjustment. This ability to ‗bounce back' and ‗escape‘ the development of MDD is widely referred to 
as psychological resilience. Research into resilience is currently in its infancy and a primary aim of this thesis is 
to better elucidate the underlying causes and mechanisms of the construct which will be addressed empirically 
in subsequent chapters. The findings from this thesis may have important implications not only for researchers, 
but for clinicians and policy makers by providing evidence for who is most and least likely to develop MDD, in 
addition to furthering scientific knowledge for the development of preventative strategies in mental health which 
may circumvent the need for curative treatments.   
 
Before researchers can begin to investigate protective factors (Chapter 3), protective pathways (Chapter 5), or 
the genetic and environmental components (Chapter 6) which enable an individual to demonstrate resilience to 
MDD, a comprehensive knowledge of the disorder itself is needed. This chapter aims to present a brief overview 
of MDD to familiarise the reader with the disorder, its prevalence and potential causes, as following chapters 
will employ MDD status as a study variable in order to better illuminate resilience mechanisms. Firstly, a brief 
historical context of MDD will be outlined before an overview of current diagnostic criteria is detailed. 
Additionally, current therapeutic techniques for the treatment of MDD will be discussed as a better 
understanding of psychological resilience may change how current treatments are administered and lead to the 
development of more efficacious interventions focussing on prevention. Secondly, epidemiological research 
findings will be discussed in relation to the prevalence of MDD and its impacts at individual and societal levels. 
An understanding of the impact MDD has on individual suffering and economic burden will likely demonstrate 
the importance of resilience and how it may alleviate such burden in the future. Finally, the aetiology of MDD 
will be discussed. Specifically, an overview of putative genetic, neurological, psychological and environmental 
causes of depression will be presented. A comprehensive understanding of factors which may cause depression 
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1.2. Diagnostic criteria and treatment for MDD 
The symptoms of depression have been described for millennia, and represent one of the first clear descriptions 
of neuropsychiatric syndromes in historical texts (Jackson, 1986). Indeed, the history of depression stems as far 
back as the earliest writings of Hippocrates and Galen in which the symptomatic descriptions of melancholia 
mimic contemporary features of MDD with surprising accuracy (Hippocrates, 1923-1931, Jackson, 1986). 
Whilst the historic causes of MDD ranged from demonic possession to an imbalance of bodily ‗humors‘, all 
descriptions differentiate periods of sadness or bereavement from MDD - a chronic and incapacitating illness. 
The first serious attempt to categorise and explain melancholic/depressive illness came from the publication of 
The Anatomy of Melancholy by Robert Burton during the seventeenth century (Burton, 1621/2001). In this 
seminal work, Burton described three key components of melancholia — mood, cognition, and physical 
symptoms — all of which are distinguishing features in contemporary descriptions of MDD. However, despite 
the comprehensive descriptions given by Burton, it was the work of diagnosticians such as Kraepelin who 
identified that modern symptoms of depression likely had the same underlying pathophysiology despite 
divergent clinical presentations (Kraepelin, 1921/1976). Kraepelin‘s approach to psychiatric diagnosis has 
subsequently been credited as the inspiration for the comprehensive manuals used by clinicians today such as 
the Diagnostic and Statistical Manual of Mental Disorders (DSM; American Psychiatric Association, 2013) and 
the International Classification of Diseases (ICD; World Health Organization., 1992).  
 
Table 1.1. DSM-IV Major Depressive Disorder criteria 
 
To meet criteria for MDD, five (or more) of the following symptoms must be present for a minimum of two 
weeks (sequentially), lasting nearly all day, every day, and represent a change from previous functioning. At 
least one symptom must be either depressed mood (1) and/or loss of interest/pleasure in daily activities (2) 
1. Depressed mooda 
2. Decreased interest or pleasure is most activities (anhedonia)b 
3. Fatigue or loss of energy 
4. Diminished concentration or indecisivenessb 
5. Significant (5%) weight change or change in appetitec 
6. Feelings of worthlessness or excessive/inappropriate guiltd,e 
7. Hypersomnia/insomnia (changes in sleep) 
8. Psychomotor retardation/agitation (changes in activity)f 
9. Suicidality or recurrent thoughts of deathg 
a In children and adolescents this can be irritable mood 
b As indicated by either subjective account or observation made by others 
c In children, consider failure to make expected weight gains 
d Which may be delusional 
e Not merely self-reproach or guilt about being sick 
f Observable by others, not merely subjective feelings of restlessness or being slowed down 
g With or without intent/plan 
Abbreviations: DSM, Diagnostic and Statistical Manual of Mental Disorders; MDD, Major Depressive Disorder 
N.B. Symptoms must not meet criteria for a Mixed Episode. Symptoms must cause clinically significant distress 
or impairment in social, occupational, or other important areas of functioning. Symptoms must not be due to the 
direct physiological effects of a substance or general medical condition. Symptoms must not be better accounted 
for by bereavement (which must persist > two months) 
 
Currently, MDD is characterised by one or more depressive episodes lasting a minimum of two weeks that 
involve an impairment in normal functioning. A minimum of five symptoms including low mood and/or 
anhedonia must be present, lasting nearly all day, every day, for a minimum of two weeks. The current 
diagnostic criteria for MDD as specified in the DSM-5 (5th edition; American Psychiatric Association, 2013) is 
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presented in Table 1.1. Although it is possible for clinicians to diagnose MDD on the basis of a single 
depressive episode, the disorder is highly recurrent (American Psychiatric Association, 2013). To illustrate, it 
has been reported that at least 50% of individuals who recover from a first episode of MDD will have one or 
more additional episodes in their lifetime, and approximately 80% of individuals with a history of two 
depressive episodes will experience further recurrence of the disorder (American Psychiatric Association, 2003). 
A better understanding of psychological resilience may lead to patient interventions which could drastically 
reduce recurrence rates. A total of nine depressive symptoms are given in the DSM-5 and as such, multiple 
symptom combinations can each result in an MDD diagnosis, leading to substantial heterogeneity. This 
heterogeneity has led to the hypothesis that MDD may in fact act as an umbrella term which groups together 
several causally distinct but symptomatically related syndromes (Kessing, 2007) and as a result, efforts are now 
being made to stratify the disorder, which could potentially transform current therapeutic outcomes. For 
example, a large research programme has recently been developed which was specifically designed to 
investigate the stratification of depression and psychological resilience (STRADL; Navrady et al., 2017a), from 
which findings from this thesis belong.    
 
Table 1.2. Common psychological treatments used in the treatment of Major Depressive Disorder 
 
Cognitive-behavioural therapy (CBT): CBT is a talking therapy which teaches patients to change negative, 
distortive thinking patterns which contribute to depression, and teaches skills to manage these thoughts and 
behaviours in the future 
 
Psychodynamic therapy: This method encourages patients to think about how earlier life experiences have 
contributed to their current emotions and problems, and aids patients in recognising how these patterns can be 
changed to facilitate more effective coping strategies. 
 
Problem-solving therapy: This therapy teaches patients the skills needed to identify, address and overcome 
problems and potential barriers in order to make more effacious decisions in the future. 
 
Interpersonal therapy: This technique focuses on resolving interpersonal conflicts and impoverished 
relationships 
 
Mindfulness-based therapy: Mindfulness is a contemplative practice commonly involving meditation which 
encourages patients to pay specific attention to their thoughts, feelings, and experiences to learn acceptance 
 
In managing MDD, two main initial treatment options are utilised: psychological intervention and 
pharmacotherapy. Psychological treatments include; cognitive–behavioural therapy (CBT), mindfulness-based 
therapy, and psychodynamic therapy. These interventions broadly focus on changing negative cognitive biases 
in depressed patients, strengthening effective coping strategies, and illuminating potential sources of stress 
and/or sadness (Wender and Klein, 2005). A list of common psychological treatments and a brief description of 
their aims is given in Table 1.2. At present, no consistent clinically meaningful differences have been found 
between the different types of psychological therapy, although they are each more effective than no treatment at 
all (Cuijpers et al., 2013, Cuijpers et al., 2008, Linde et al., 2015). Despite psychological treatments clearly 
being effective, patients often experience several barriers to access including cost, time constraints and lack of 
available services (Mohr et al., 2006, Mohr et al., 2010). To overcome such issues, delivering psychological 
services over the telephone or through technology-supported mediums have shown to be equally as effective 
(Mohr et al., 2012). Alternatively, pharmacological treatments have been demonstrated to produce equivalent 
effects to psychological treatments. For example, the beneficial effects of CBT have been shown to persist for at 
least 12 months post-treatment, which is similar to the effects seen in individuals who remain on antidepressants 
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(Hollon et al., 2005). However, effect sizes from psychological and pharmacological treatments cannot be easily 
compared due to methodological issues (Amick et al., 2015, Weitz et al., 2015).  
 
Antidepressants act to acutely increase levels of monoamine neurotransmitters such as serotonin and 
noradrenaline. Whilst they have been shown to significantly improve mood and positive affect, and reduce the 
risk of relapse, how they accomplish these changes is not fully understood (Otte et al., 2016). There are several 
types of antidepressant medication which are grouped on the basis of their known pharmacological actions, 
including: selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs), 
noradrenaline and specific serotonergic antidepressants (NASSAs), and tricyclic antidepressants (TCAs). SSRIs 
such as Citalopram and Fluoxetine are the most widely prescribed MDD medications as they cause fewer side 
effects than other forms of antidepressant, and are less likely to result in a fatal overdose (López-Muñoz and 
Alamo, 2009, Zimmerman et al., 2004). Whilst both psychological and pharmacological treatments are effective 
in the treatment of MDD, it is estimated that 30% of patients do not remit from the disorder, even after several 
treatment attempts (Rush et al., 2006, Thase et al., 2007). In extreme cases in which treatment resistant patients 
are severely depressed and/or highly suicidal, electroconvulsive therapy (ECT) is the most widely used and 
effective non-pharmacological, biological treatment (UK ECT Review Group, 2003). It is likely that our limited 
knowledge of the biological basis of MDD impedes the development of more efficient treatments for individuals 
with severe and treatment resistant MDD. However, advancements in resilience research may enable clinicians 
to develop more efficacious treatments for MDD which could reduce both the recurrence and severity of the 
disorder. For example, with a better understanding of psychological resilience we may be able to ‗teach‘ 
resilience and foster it from childhood across the lifespan and such techniques could be fortified as part of 
existing therapeutic techniques.  
 
1.3. Epidemiology 
In 2011, a multi-national study estimated the 12-month prevalence of MDD to be 6%, based on approximately 
90,000 individuals from 18 countries across the globe (Bromet et al., 2011). Whilst the 12-month prevalence for 
MDD was found to vary between countries (e.g., 2% in Japan and 10% in Brazil), prevalence rates were largely 
similar across high- and low-income countries. Furthermore, median age of onset, symptomology, disorder 
severity, and sociodemographic profiles were mostly comparable between countries and cultures (Kendler et al., 
2015, Kessler and Bromet, 2013). However, cross-cultural differences are found between high- and low-income 
countries whereby approximately 60% of individuals with MDD in high-income countries receive treatment for 
the disorder in comparison to 10% of patients in low-income countries (Wang et al., 2007). The lifetime 
prevalence of the disorder is estimated to be three times greater than the 12-month prevalence estimates, 
suggesting that one in six adults will suffer from MDD throughout their lifetime (Bromet et al., 2011). Reports 
suggest a two-fold increase in MDD risk in women compared to men in adulthood (Seedat et al., 2009). Across 
genders, the median age of onset for MDD is estimated to be 25 years, with increased risk for MDD onset 
typically ranging from mid-to-late adolescence to early 40s (Bromet et al., 2011), although generally, MDD 
prevalence decreases moderately after adulthood, especially in high-income countries (Kessler et al., 2003). 
However, prevalence rates are often an unreliable metric as they are subject to substantial underestimation and 
issues surrounding recall bias (Moffitt et al., 2010, Patten, 2009).  
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MDD is currently the second leading cause of disease burden worldwide (Vos et al., 2015), with significant 
consequences at individual and societal levels. In 2010, the economic burden associated with MDD was 
estimated to be $2.5 trillion (Bloom et al., 2011), with this number expected to increase exponentially in coming 
years. At an individual level, MDD patients are 20-times more likely to die by suicide in comparison to the 
general population (Chesney et al., 2014), with estimates suggesting that 50% of suicides worldwide (annually) 
are attributable to the disorder (Otte et al., 2016). Moreover, not only does MDD increase mortality risk in the 
general population by 60-80% (Cuijpers et al., 2014, Walker et al., 2015), but also has consequences that extend 
to physical health. Specifically, longitudinal research suggests that MDD increases risk for heart disease, stroke, 
obesity, diabetes, cancer, cognitive impairment and dementia (Penninx et al., 2013). At present, the mechanisms 
underlying these comorbidities remain largely unknown, although numerous biological and environmental 
factors have been suggested (Kessler, 1997, Ripke et al., 2013, Schmaal et al., 2016). The economic burden and 
individual suffering associated with MDD could potentially be alleviated with the employment of resilience 
strategies. For example, if individuals can develop resilience before MDD onset, the healthcare system may not 
need to spend as much money on antidepressant medication or primary care. Furthermore, providing individuals 
with the tools needed to ‗bounce back‘ could potentially result in fewer deaths from suicide, or from co-morbid 
health complications such as heart disease.   
 
1.4. Aetiology 
The aetiology of MDD is likely complex and at present nascent mechanisms in MDD remain largely elusive. 
However, methodological advancements in molecular genetics, neuroimaging and population-based approaches 
are enabling researchers to learn more about the underpinnings of MDD (Otte et al., 2016). Below, a selection 
of contemporary methodological approaches to MDD research are reviewed, and relevant gaps in our current 
knowledge are highlighted. 
 
1.4.1. Genetics  
For centuries, it has been observed that MDD clusters within families (Mullins and Lewis, 2017). This familial 
aggregation hypothesis has been supported by the finding that first-degree relatives of depressed patients are 
three times more likely to receive an MDD diagnosis than the general population (Geschwind and Flint, 2015), 
with twin studies reporting narrow-sense heritability estimates of 37% (Geschwind and Flint, 2015, Sullivan et 
al., 2000). Heritability estimates from family and twin-based studies are generally higher than single-nucleotide 
polymorphism-derived (SNP) estimates which have been calculated at 21% (Ripke et al., 2013). Estimates of 
SNP heritability have been found to vary across populations and samples (0.21 ~ 0.32) (Lee et al., 2013, Lubke 
et al., 2012). Such findings suggest that heritability estimates may be over-estimated which could potentially be 
due to shared environmental effects, or from unaccounted variance from rare genetic variants, gene interactions 
or poorly tagged SNPs (Flint and Kendler, 2014, Wray and Maier, 2014). These findings do, however, illustrate 
the genetic complexity of MDD, and as such make it amenable to many powerful methodologies designed for 
complex diseases and quantitative traits.  
 
In recent years, genome-wide association studies (GWAS) have been utilised to find specific genetic variants 
associated with MDD. However, thus far, the search for main genetic effects in MDD have failed to find 
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consistent or replicable findings (Bosker et al., 2011), as indicated by GWAS meta-analysis (Ripke et al., 2013). 
This is likely due to the excessive heterogeneity of the disorder and so attempts have now been made to identify 
genetic loci with a homogeneous phenotypic approach. In 2015, the CONVERGE Consortium published the 
first GWAS to identify genome-wide significant variants for MDD in a non-European population, in which two 
replicated loci were associated with recurrent MDD (CONVERGE Consortium, 2015). The subsequent year, a 
joint analysis of three European samples (n > 75,000),  identified 15 genetic loci associated with self-reported 
clinical MDD (Hyde et al., 2016). One replicated genome-wide significant locus has also been associated with 
adult-onset MDD (> 27 years) (Power et al., 2017). Furthermore, recent studies have identified several genome-
wide significant loci for neuroticism, a personality trait strongly associated with MDD (Okbay et al., 2016, 
Smith et al., 2016). Whilst significant progress has been made in genetic research, these studies suggest that 
MDD may be highly polygenic, involving many genes whose cumulative effects may have stronger associations 
than any one individual locus (Hyman, 2014). Alternatively, the lack of consistent findings may be resultant 
from complex gene-environment (GxE) interactions whereby genetic variants only confer risk in the presence of 
specific environmental stressors (Klengel and Binder, 2013, Otte et al., 2016). 
 
1.4.2. The brain 
In recent decades, researchers have sought to determine the role of the brain in association with MDD. In 
particular, the neurological basis of emotion and cognition has received much attention as deficits in these areas 
are widely implicated in MDD (Bradley et al., 2011, Trivedi, 2006), and are known to be predominately 
controlled by cortical and subcortical brain regions (Heatherton and Wagner, 2011, Wager et al., 2008). Indeed, 
numerous studies have identified both morphological and functional abnormalities in association with MDD 
pathology, most of which focus on the hippocampus (Arnone et al., 2012). For example, structural magnetic 
resonance imaging (MRI) studies have reported consistent evidence to suggest that hippocampal volume is 
reduced in MDD patients (Goodkind et al., 2015, Kempton et al., 2011, Schmaal et al., 2016). Specifically, a 
meta-analysis of 143 imaging studies found MDD patients have smaller hippocampal volumes than healthy 
controls, in addition to reductions in the thalamus, basal ganglia and several frontal regions (Kempton et al., 
2011). Another meta-analysis also found significantly lower hippocampal volumes in MDD patients (Schmaal et 
al., 2016), although no differences between depressed and non-depressed individuals were found in other 
subcortical areas. Furthermore, a more recent study also failed to detect significant differences in subcortical 
volumes between depressed individuals and healthy controls, although the small sample size was recognised as 
a limiting factor (Shen et al., 2017). At present, contradictory evidence has prevented researchers from 
determining if small hippocampal volumes are causal in MDD pathology, or if the disorder itself causes 
morphological changes (Cole et al., 2011, Schmaal et al., 2016). Additionally, findings suggest that significant 
differences of cortical thinning in the temporal lobes, orbitofrontal cortex, anterior and posterior cingulate, and 
the insula between MDD patients in comparison to never-depressed controls (Schmaal et al., 2016). It has been 
proposed that a complex interaction of molecular and cellular mechanisms ultimately contribute to the structural 
changes found in MDD patients (Otte et al., 2016), but further investigation is needed to confirm this.  
 
Neuroimaging studies have also identified functional abnormalities in MDD, with specific reference to 
activation and connectivity perturbances within the medial prefrontal–medial parietal default mode network, the 
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frontoparietal cognitive control circuit, and the affective– salience circuit in MDD patients (Maier et al., 2015, 
Nusslock and Miller, 2016). The Default Mode Network (DMN) is charactersied by greater neurological activity 
during ‗resting‘ states, and has been found to be hyperconnected in MDD (Dutta et al., 2014), which is 
purported to underlie the symptoms of rumination typical of the disorder (Cooney et al., 2010, Hamilton et al., 
2012, Sheline et al., 2009). Conversely, the dynamic coupling between the DMN deactivation and frontoparietal 
activation is disturbed in MDD (Hamilton et al., 2011, Whitfield-Gabrieli and Ford, 2012), which is 
hypothesized to underlie (in part) the cognitive deficits seen in MDD. This is unsurprising given the 
frontoparietal cognitive control circuit is primarily responsible for cognitive tasks (Cole et al., 2013). It has been 
suggested that the goal-directed attention deficits seen in MDD are due to frontoparietal hypoconnectivity 
(Kaiser et al., 2015), whereas decreased frontoparietal connectivity has been associated with negative cognitive 
appraisals (Hamilton et al., 2013, Pizzagalli et al., 2009). One of the most frequently reported findings of 
functional brain abnormalities in MDD pertain to the heightened activation and increased connectivity of the 
amygdala (Hamilton et al., 2012), a central component of the affective–salience circuit which is responsible for 
guiding behaviour. Moreover, hyperactivities have also been found in the anterior insula and anterior cingulate 
in MDD patients, which potentially explain the increased salience of negative biases typical of the disorder 
(Hamilton et al., 2012). It is purported that these functional aberrations are due to stress-associated changes in 
inflammatory and glucocorticoid signalling (Otte et al., 2016) which demonstrate that MDD aetiology is the 
result of a complex interaction between molecular, neurological and environmental factors. 
 
1.4.3. Psychological and cognitive factors 
There is evidence to suggest that personality traits may predispose individuals to MDD (Dunbar, 1943). To 
illustrate, a recent study has shown that negative affect significantly predicts depressive symptoms 
longitudinally (Elovainio et al., 2015). Negative affect represents a personality trait characterised by the 
elevated experience of negative emotions, and as such, it is purported to be highly similar to the personality trait 
neuroticism (Braithwaite et al., 1984). Neuroticism is a stable personality trait characterised by negative 
emotional response and stress sensitivity, and has been shown to associate with MDD both cross-sectionally 
(Chan et al., 2007, Hakulinen et al., 2015, Roelofs et al., 2008), and prospectively (Farmer et al., 2008, Kendler 
et al., 2006). Further support for the role of neuroticism in depressive illness comes from two large meta-
analyses which have demonstrated strong positive associations between neuroticism and mood disorders such as 
MDD (Kotov et al., 2010, Malouff et al., 2005). However, whilst Malouff and colleagues (2005) found strong 
associations between neuroticism and mood disorders generally, Kotov et al. (2010) found stronger effects for 
the association between neuroticism and dysthymia - a more chronic form of MDD. This suggests that MDD 
severity and chronicity may be associated with exceptionally high levels of neuroticism. The majority of 
research linking neuroticism and MDD has been cross-sectional, making it difficult to discriminate associative 
relationships from causal ones. A further difficulty in disentangling the relationship between personality and 
MDD comes from research which suggests that neuroticism may act as a possible mediator between adversity 
and indices of mental health (Lardinois et al., 2011). For example, childhood adversity has been found to affect 
personality development, whereby negative experiences in childhood have been found to promote neuroticism 
which in turn increases risk for MDD (Roy, 2002). Neuroticism is unlikely to influence developmental 
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trajectories that lead to MDD in isolation and so it is important to understand the role of potential genetic factors 
that may influence the association between personality and MDD.  
 
Neuroticism is a partially heritable trait, with numerous family-based and adoption studies reporting estimates of 
approximately 40% (Birley et al., 2006, Hahn et al., 2013, Vukasović and Bratko, 2015, Wray et al., 2007). 
Thus far, no evidence for differential heritability has been found when using different measures of neuroticism, 
or when investigating sex differences (Vukasović and Bratko, 2015, Wray et al., 2007), although phenotypically 
neuroticism scores are generally higher in women than men (Costa et al., 2001, Soto et al., 2011). It has been 
suggested that half the genetic variance in neuroticism is attributable to non-additive effects (Hahn et al., 2013, 
Keller et al., 2005) and so phenotypic differences in neuroticism between sexes is likely resultant from 
environmental factors, gene-environment interactions, or rare genetic variants (Smith et al., 2016). At a 
molecular level, research suggests that there may be genetic loci associated with both neuroticism and MDD. 
For example, a GWAS meta-analysis from the Genetic of Personality Consortium (PGC) identified one genome-
wide significant gene - MAGI1 (de Moor et al., 2015) which has been previously associated with MDD (Etain et 
al., 2006, Ferentinos et al., 2014, Karlsson et al., 2012). A subsequent GWAS for neuroticism found nine 
genome-wide significant loci, two of which have been associated with stress response pathways in MDD (Gray 
et al., 2015, Lee et al., 2012, Weber et al., 2016). The largest neuroticism GWAS to date identified 11 genome-
wide significant loci of which four were nominally significant in a GWAS of MDD (Okbay et al., 2016). 
Further evidence of a shared genetic aetiology between neuroticism and MDD comes from twin studies which 
report genetic correlations between neuroticism and MDD of between 0.43 and 0.69 (Hettema et al., 2006, 
Kendler et al., 2006, Kendler and Myers, 2010). These findings suggest an overlapping genetic architecture in 
which genes responsible for negative emotions (neuroticism) also increase the risk for MDD. 
 
1.4.4. The environment 
Whilst genetic and neuroimaging research has thus far found inconsistent evidence to suggest a definitive 
preclinical marker for MDD, a number of putative environmental risk factors have been consistently shown to 
associate with the disorder. For example, marital difficulties, major health issues, job loss, and interpersonal 
conflicts have been found to substantially associate with an increased risk for MDD onset (Kessler, 1997). 
These factors occur most often in adulthood and demonstrate that environmental exposures/insults may be 
closely related to MDD in time, usually in the 12-months preceding onset of the disorder (Kessler, 1997). More 
recent evidence, however, suggests that difficulties in childhood may be an antecedent of later MDD. 
Experiences such as physical or sexual abuse, neglect, parental separation or bereavement, and exposure to 
domestic violence in childhood demonstrate a dose-response relationship whereby the number and severity of 
early negative life events directly associate with MDD risk, chronicity, and severity (Li et al., 2016). 
Furthermore, stress in utero has also been found to associate with increased MDD risk in later life (Entringer et 
al., 2015), demonstrating that early life experiences can have profound and long-lasting effects on an 
individual‘s mental health (Stein et al., 2014), potentially involving epigenetic regulation (Klengel and Binder, 
2015). It is likely that - although not definitively proven - genetic liability for MDD may increase an 
individual‘s propensity for stressful life events which result in the neurological abnormalities described above.  
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1.5.  Chapter conclusions 
MDD is a pervasive psychiatric condition characterised, in part, by low mood, anhedonia, cognitive deficits and 
vegetative symptoms such as disturbed appetite or sleep. Currently, management of depressive symptomology 
comprises both psychological and pharmacological treatments, the latter of which are used most commonly. 
However, whilst current treatments for MDD prove effective for some, it is estimated that 30% of patients do 
not remit from the disorder, even after several treatment attempts (Rush et al., 2006, Thase et al., 2007). Whilst 
current treatments for MDD are effective for the majority of patients, our limited knowledge of the specific 
causes of MDD hinder the development of more efficacious treatments, especially for individuals with severe 
and chronic depression. Current research indicates that the aetiology of MDD likely encompasses a complex 
interaction of genetic, neurological and environmental factors, although the correlational nature of much of this 
research means we are unable to infer causality. At present, no underlying mechanism for MDD has been 
robustly identified which not only limits research for new treatment opportunities, but also ultimately 
contributes to further disability and suffering. The observation that not all individuals are risk for MDD go on to 
develop the disorder represents an important area for scientific research. Specifically, the investigation of 
psychological resilience has the potential not only to alleviate individual suffering but also reduce the economic 
burden associated with MDD by focussing on prevention rather than cure. Identifying potential factors and 
mechanisms that may enable individuals to ‗bounce back‘ and ‗escape‘ the development of MDD will be the 



























The concept of psychological resilience 
 
 
2.1. History and overview 
Negative life events are ubiquitous, and, as outlined in Chapter 1 are potential risk factors for the onset of Major 
Depressive Disorder (MDD). For example, researchers such as Paykel and colleagues (1969) have long 
demonstrated the importance of life stress and adversity on the genesis of MDD. However, despite the 
frequency with which stressful/negative events occur, only a small subset of individuals go on to develop 
psychopathology (Kalisch et al., 2015). Indeed, it is widely observed that despite exposure to known risks for 
MDD, most individuals are able to successfully overcome such risk with little or no disruption to their normal 
functioning (Bonanno, 2004). Specifically, whilst some individuals develop depression in response to MDD 
risk, others develop only mild and transient symptoms or no depressive symptomology at all. This ability to 
‗bounce back‘ and maintain or regain mental health and ‗escape‘ the development of MDD is widely referred to 
as psychological resilience (Bonanno and Mancini, 2011, Feder et al., 2011, Luthar et al., 2000, Masten et al., 
1990, Sapienza and Masten, 2011).  
 
The origins of resilience can be traced back to the natural sciences whereby researchers noticed that objects – 
such as a spring - will return to their baseline form despite being previously misshapen (Geller et al., 2003, 
Lazarus, 1993). Our knowledge of psychological resilience, however, emerged from the clinical observation of 
individuals who were able to effectively negotiate, adapt to, or manage high-risk situations with little or no 
detriment to their mental health (Richardson, 2002). While initially proposed by psychologists and clinicians 
(Werner, 1993), interest in psychological resilience has grown substantially over recent decades, motivating a 
wealth of research across disciplines (Leipold and Greve, 2009, Russo et al., 2012, Southwick and Charney, 
2012, Werner, 1982). Although investigations of resilience may be expected to reveal similar risk factors and 
causality as studying MDD itself, it does represent a new facet to scientific and clinical research. Specifically, 
resilience focuses on intervention long before the development of MDD when effects on subsequent suffering 
and its consequences – including its economic burden - may be ameliorated (Sapienza and Masten, 2011). 
Unlike ‗deficit‘ models of MDD (Fergus and Zimmerman, 2005), resilience research focuses on understanding 
healthy functioning despite risk, and on strengths rather than weaknesses (Fergus and Zimmerman, 2005).  
 
The complexities of defining the concept of resilience are widely recognized (Haskett et al., 2006, Luthar et al., 
2000, Masten, 2007), leading to wide discrepancies in both its definition and measurement (Bonanno et al., 
2015). For this reason, resilience is rarely directly measured (Luthar et al., 2006, Masten and Obradovic, 2006), 
but inferred from the direct measurement of two specific points of convergence; adversity (its antecedents) and 
positive adaptation (its consequences) (Windle, 2011). Researchers have also investigated protective factors 
which could serve as potential moderators and mediators between adversity and positive adaptation (Connor and 
Davidson, 2003, Wagnild and Young, 1993). Thus far, protective factors in MDD have been assessed from 
developmental (Garmezy, 1985), dispositional (Bonanno, 2004, Campbell-Sills et al., 2006), genetic (Amstadter 
et al., 2016, Luthar et al., 2000) and neurobiological (Chan et al., 2016, Russo et al., 2012) viewpoints. This 
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concept-based perspective indicates that the measurement of resilience needs to consider three fundamental 
components — adversity, positive adaptation, and protective factors simultaneously (as illustrated in Figure 
2.1). However, inconsistencies in the specific delineation of these concepts have resulted in confusion over their 
meaning, and the scientific validity of resilience being questioned (Bodin and Winman, 2004). As the 
fundamental concepts in resilience are distinct, it is important to address them separately to depict an accurate 
representation of resilience to MDD. In this chapter, the core components of resilience will be outlined and 
critically discussed in order to elucidate more effective strategies to examine the aetiology and mechanisms of 







Figure 2.1. The three core components of psychological resilience 
 
2.2 Adversity 
It is estimated that 50-60% of individuals will experience a severe trauma during their lifetime, with all 
individuals experiencing at least one potentially traumatic event (Bonanno and Mancini, 2008, Kessler et al., 
1995). The term ‗potentially‘ is a vital distinction as it draws attention to the individual differences in how 
people react to negative events. Indeed, despite the frequency with which individuals experience traumatic and 
distressing events, it is estimated that only 7.8% of psychopathology is resultant from them (Kessler et al., 
1995), indicating that resilience is ubiquitous. Luthar and Cicchetti (2000) assert that ‗adversity‘ incorporates 
negative life events which are associated with poor functioning. For example, a dose response relationship has 
been found in which incremental adversity in childhood confers increased risk for depression and suicidality in 
later life (Cabrera et al., 2007, Felitti et al., 1998). Furthermore, numerous studies report that the number of 
negative life events experienced greatly increases the risk for MDD across adulthood (Dolan et al., 1985, 
Ezquiaga et al., 1987, Perris, 1984, Paykel et al., 1969). This threshold-dependent definition of adversity is 
closely associated with the concept of risk and the statistical probability that an event (or condition) only 
becomes an indicator of vulnerability when it is strongly associated with maladjustment (Luthar et al., 2000, 
Masten, 2001). However, the literature pertaining to putative risk factors for MDD is extensive and is not 
limited only to isolated and highly disruptive events. A constellation of risk factors for depression have been 
found across biological, psychological, environmental and social domains (for a comprehensive review, see 
Dobson and Dozois, 2011) and for this reason it is essential to examine adversity in regards to any known risk 
factor.  
 
The narrow definition of adversity as a negative event/condition which predicts MDD fails to account for the 
cumulative stress resultant from daily hassles or positive (but stressful) events. Indeed, as suggested in the 
seminal work of Brown and Harris (1978), environmental risk factors found in daily life often produce cognitive 
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adversity encompasses any hardship or suffering linked to struggle, misfortune or trauma (Jackson et al., 2007), 
including everyday disruptions and highly stressful, yet still common, events (Davis et al., 2009, Sameroff and 
Rosenblum, 2006, Paykel et al., 1969). For example, epidemiological research has long examined the depressive 
effects of chronic work stress (Karasek and Theorell, 1990, Kasl, 1978) and marital difficulties (Beach et al., 
1990, Gotlib and McCabe, 1990) with their depressive effects (Kessler et al., 1987, Umberson et al., 1992). 
Although the connotations associated with ‗adversity‘ are often negative, positive life events also play a role. 
For instance, a job promotion will nonetheless necessitate resilience to positively adapt to the new role. 
Similarly, the birth of new child, which again is unlikely to be considered an adversity, requires a range of 
resources to navigate a number of novel demands (Neff and Broady, 2011) which could otherwise increase the 
risk for depressive illness. Hence, resilience mechanisms may differ in regards to their contextual severity 
(Davydov et al., 2010) and so when examining adversity, we must include not only negative life events, but also 
everyday stressors and stable, endogenous factors to sufficiently reflect individual differences in resilient 
outcomes. 
 
Resilience research employs three general approaches to quantify adversity: (1) specific life stressors, (2) 
multiple-item checklists of negative life events, and (3) the concurrent risk from multiple sources to form an 
overall adversity estimate (Luthar and Cushing, 1999). Initially, research into adversity focused on specific 
single life occurrences such as war, death of a loved one or job loss. A psychometric problem in examining 
distal risk factors for depression is that individuals who demonstrate positive adaptation may not be facing high 
proximal risk (Richters and Weintraub, 1990). Single risk events (such as witnessing a terror attack) usually 
precede a negative psychological response (e.g., MDD or post-traumatic stress disorder) but are typically distal 
in nature. Research suggests that whilst single event adversity confers immediate risk, it can be influenced (and 
reduced) by proximal variables (Fletcher and Sarkar, 2013). To illustrate, prospective studies investigating 
children in high-risk environments have found that social support and close interpersonal relationships can 
ameliorate the detrimental relationship between MDD and adversity (Collishaw et al., 2007, DuMont et al., 
2007, Luthar, 2006, Masten et al., 1990, Parker, 1983, Werner and Johnson, 2004). This intimates that resilience 
is likely the result of protective mechanisms mitigating the negative effects of adversity and so whilst 
investigating distal risks can illuminate successful outcome in times of adversity, it is equally important to 
explain their proximal processes (Fletcher and Sarkar, 2013). Furthermore, in studying the time elapsed since 
the occurrence of an event, the variation in initial impact and length of risk period can be examined. Kessler and 
Magee (1993, 1994) found that severe adversity in childhood significantly effects early-onset depression, but 
not late-onset depression, indicating that there is a risk period for adversity after which its depressogenic effects 
are diminished.  
 
A second approach to investigating adversity focuses on multiple-item inventories such as the Life Events 
Checklist (Work et al., 1990) and the List of Threatening Experiences (LTE: Brugha et al., 1985) which assess 
the events in an individual‘s life which confer adversity such as natural disasters, financial difficulties and 
marital problems. Although the LTE examines the subjective emotional experiences associated with adverse 
events, the majority of checklists fail to capture the meaningful variability in adversity which may prevent 
accurate comparisons between both events and individuals (Seery et al., 2010). Such issues are also relevant 
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when examining less severe stressors with greater chronicity (e.g., The Daily Hassles Scale; Kanner et al., 
1981), and, although studies demonstrate little difference in weighted and unweighted scores according to an 
individual‘s impact rating (Swearingen and Cohen, 1985) of negative events, it is important to take account of 
the heterogeneity of the events in a multiple item inventory (Luthar and Cushing, 1999, Masten et al., 1994). 
Checklist methodologies also fail to consider the issue of accuracy; depressed individuals consistently 
demonstrate a negative recall bias (Blaney, 1986). Not adjusting for recall bias may elicit spurious associations 
between adversity and depression. Indeed, research has found that the experimental induction of depressed 
mood leads to significantly more reports of past stressful events (Cohen et al., 1988). It is also important to 
consider measurement confounds such as ‗controllability‘ of items within the checklist. Whilst it is relevant to 
evaluate both ‗uncontrollable‘ events (eg., serious injury or sexual assault) and ‗controllable‘ events (e.g., 
detrimental health behaviours such as excessive alcohol consumption or divorce), the inclusion of controllable 
events may inflate adversity-depression associations (Luthar and Cushing, 1999, Masten et al., 1988) insofar 
that some events might be attributable to MDD rather than independent of the illness. A differentiation also 
needs to be made between the characteristics of stressors such as duration (chronic vs. acute), frequency (rare 
vs. common occurrence), and intensity (high vs. low demand).   
 
Adversity can also be measured by combining specific, distinct risk factors to produce a cumulative 
approximation of adversity. This approach typically involves computing a total adversity score across a number 
of high-risk domains, including; genetic liability, low parental income and membership to a minority group 
(Chang et al., 2014, Gutman et al., 2003, Sameroff et al., 2003, Sameroff and Rosenblum, 2006) to which a 
count of one or zero is assigned to each index. This methodological approach is gaining increasing popularity as 
it recognised that adversity rarely occurs in isolation (Fletcher and Sarkar, 2013, Heller et al., 1999, Luthar et 
al., 2006). Moreover, a summed risk methodology can account for a multitude of known biological and 
environmental risk factors simultaneously. For example, whilst socioeconomic deprivation is an important risk 
factor to consider in MDD due to its chronicity and diffuse impact, behavioural genetics research demonstrates 
that low socioeconomic status has substantive genetic influence (Plomin and Bergeman, 1991, Plomin et al., 
1994). Specifically, studies suggest that parents yielding increased genetic risks for their children are more 
likely to provide sub-optimal environments and upbringing (Clark et al., 2000, Hashima and Amato, 1994, 
Runyan et al., 1998), decreasing the likelihood of resilient outcomes. Conversely, several studies have reported 
that children of emotionally warm and nurturant care-givers are found to be more resilient to stressful life events 
(Egeland et al., 1993, Kim-Cohen et al., 2004, Werner, 1982), even in genetically high-risk, low-income 
families (Wyman et al., 1999). Together, these studies suggest that some of the risks which are thought to 
represent environmental adversity actually involve genetic mediation (Plomin et al., 1994), especially in regards 
to family risk factors. In reflecting the synchronicity of numerous risk factors in real life, the summed risk 
strategy retains high ecological validity, although causality is difficult to infer. In order to understand how 
protective factors mediate the relationship between risk or resilience to MDD it may prove more effective to 
examine factor-analytic or structural models (Catalano et al., 2011, Holahan and Moos, 1991, Schok et al., 
2010) rather than simply investigating sum scores.   
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2.3. Positive adaptation 
In conjunction with investigating adversity, resilience to MDD needs also to assess positive adaptation. Positive 
adaptation has been described by Luthar and colleagues (2000) as ―behaviorally manifested social competence, 
or success at meeting stage-salient developmental tasks‖ (p. 858) and by Masten and Obradovic (2006) as 
―symptoms related to internal well-being‖ (p. 15) in response to risk. However, competence must be 
conceptually appropriate to the adversity assessed (Luthar et al., 2000, Luthar et al., 2006). For example, in 
depressed children an indicator of positive adaptation can be indexed by the attainment of social or educational 
milestones appropriate to their developmental stage (Luthar et al., 2000, Masten, 2001), whilst in soldiers 
returning from war the absence of psychopathology would be more fitting. Furthermore, the indicators used to 
assess positive adaptation must also be appropriately stringent; it is the nature of an adversity that should 
determine the level of adaptation needed to demonstrate resilience. To illustrate, in individuals with a high 
genetic risk for MDD or those exposed to a serious adversity, positive adaptation could be defined as a lack of 
MDD symptomology as opposed to evidence of ‗normal‘ functioning at work, home and socially from an 
individual after a relationship breakdown.  
 
Akin to adversity, multiple methodologies are employed to measure positive adaptation with the most common 
being multiple-item inventories assessing adjustment on a continuum and the presence or absence of 
psychopathology (Luthar and Cushing, 1999). In using questionnaire measures of adaptation, it is important to 
ensure they are suitable to the individual(s) being assessed. For example, in psychiatric populations at risk for 
MDD, it would be fitting to assess self-harm and suicidality, whereas among community samples, it would be 
appropriate to assess psychological distress (Goldberg and Hillier, 1979) when MDD is suspected. It is often 
difficult to gauge positive adaptation using multiple-item inventories as they are often administered only to the 
reference group, and so the individuals reflecting the highest competence within the sample may only illustrate 
the best of a generally poorly functioning population when compared with a normative group (Mulholland et al., 
1991). For instance, when administering the General Health Questionnaire (GHQ; Goldberg and Hillier, 1979) 
to a group of individuals with a history of MDD, those scoring lowest on psychological distress – i.e. those who 
are better adapted – may still score statistically higher than individuals who have never been depressed. A 
similar caveat pertains to the Beck Depression Inventory (BDI; Beck et al., 1961). The BDI is a self-report 
measure commonly used to make case/control classifications of MDD and to quantify the intensity of depressive 
symptoms. However, it is well-known that the BDI is heavily weighted towards measuring cognitive aspects of 
depressive symptomology (Campbell et al., 1984, Carroll et al., 1981, Oliver and Simmons, 1984) and as such 
low scores (indicative of positive adaptation) may not reflect the multidimensional facets of the disorder but 
rather favour individuals who meet a specific symptom cluster (Depue and Monroe, 1978). 
 
Psychological resilience encapsulates both a transient period of depressive illness followed by gradual 
restoration to healthy levels of functioning and maintenance of a relative stable trajectory of healthy functioning 
when depression would otherwise be expected (Fletcher and Sarkar, 2013). However, some researchers assert 
that the mere absence of depression in the face of risk or adversity is evidence enough of positive adaptation. 
Bonanno (2004), for example, argues that individuals who experience mild depressive symptomology before 
returning to baseline exhibit recovery rather than resilience, but to quantify adaptation in such a way is too 
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simplistic. In particular, individuals who are at sub-threshold for diagnosis of MDD tend to exhibit other 
threshold and subthreshold forms of psychopathological syndromes (Marshall et al., 2001). In other words, 
although they are clinically unaffected by MDD they may also be significantly symptomatic and distressed in 
regard to other psychiatric disorders. To overcome this simplification, Amstadter and colleagues (2016) posited 
that positive adaptation (resilience) should be computed as the residual between actual and predicted psychiatric 
symptoms, based on the total number of stressful life events one has experienced. Although this method is more 
rigorous than that proposed by Bonanno (2004) it still relies on assessing positive adaptation and adversity in 
one domain. Such approaches raise a further caveat in issues of timing. A great deal of variation is likely to be 
found in positive adaption as a function of the point at which it was measured; recovery periods are typically 
quite long in depressive illnesses, with research indicating that adverse life events retain their capacity for 
conferring MDD risk long-term, potentially years post-event (Monroe and Simons, 1991). 
 
As noted previously, it is the nature of an adversity that should determine the level of competence that needs 
demonstrating. However, positive adaptation needs also be examined across numerous domains to avoid an 
overly narrow conceptualisation (Luthar and Zelazo, 2003, Luthar et al., 2006), as competence in one particular 
area does not necessitate generalizability to other domains. At present, resilience is routinely evaluated from a 
Western perspective, and as such, cross-culturally validated studies are scarce. As positive adaptation is 
manifest across many contexts, it is vital to be sensitive to the sociocultural factors that contextualize how it is 
defined. A recent investigation spanning five continents found great variation in adaptation cross-culturally, 
even in individuals facing similar adversities (Ungar, 2008, Ungar et al., 2007) which demonstrates the 
necessity for resilience research to be culturally sensitive. In understanding positive adaptation from within the 
cultural context from which competence emerges, we will be able to take an ecologically valid approach (Ungar, 
2008). 
 
2.4. Protective factors  
Unlike the risk factors described in Chapter 1 which confer vulnerability to MDD, the field of resilience 
research has identified several protective factors that enable an individual to maintain a stable mental health 
trajectory. Limited research has specifically examined the association between protective factors and resilience 
as agreement on a definition of the concept has yet to be reached. Rather, research has focused on factors that 
associate with positive mental health outcomes. These factors are not necessarily the antithesis of risk but rather 
an independent set of variables that could potentially mediate or moderate the relationship between adversity 
and positive adaptation. 
 
Initially, the resilience enquiry focused on demographic factors which may underlie variability in MDD 
susceptibility. For example, resilience to MDD has been robustly associated with older age, greater education, 
and male gender (Bonanno et al., 2007, Murrell and Norris, 1983). Other research suggests that ethnicity may 
provide a predictive role in resilience whereby African American and Latino groups experience poorer mental 
health (Adams and Boscarino, 2005) and decreased levels of resilience (Bonanno et al., 2006) in the aftermath 
of traumatic events, compared to Caucasians. However, the effects of ethnicity are often confounded with low 
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socioeconomic status (Norris et al., 2002) and when socioeconomic status is adjusted for, the predictive value of 
race on resilience diminishes (Bonanno et al., 2007). 
 
2.4.1. Personality 
An important debate to emerge from extant literature concerns the conceptualisation of resilience as either a trait 
or a process (Windle, 2011). Initially, resilience was widely regarded as a personality trait (Connor et al., 2003, 
Schok et al., 2010) and much research was conducted on protective psychological traits such as ‗ego resilience‘ 
(Block and Block, 1980). A number of questionnaire measures have now been developed to assess ego resilience (e.g., The 
ER 89; Block and Kremen, 1996 and Ego Resiliency; Klohnen, 1996), and subsequently, a wealth of personality 
traits have been associated with positive adaptation. For example, hardiness (Bonanno, 2004) is found to buffer 
against exposure to risk (Kobasa et al., 1982) by providing individuals with increased confidence and the ability 
to appraise adversity in a less threatening way (Florian et al., 1995). Similarly, creativity (Simonton, 2000) and 
humour (Wolin and Wolin, 1993) are also thought to confer resilience by virtue of cognitive flexibility which 
can exert a stress-inoculation effect (Werner, 1993). Dispositional optimism (Alarcon et al., 2013, Amstadter et 
al., 2016, Chang and Sanna, 2001) has been shown to positively associate with better life adjustment and 
negatively correlate with psychiatric illness. Spirituality is also believed to aid individuals in resisting MDD, 
although this may form one component of a wider belief system that provides meaning, appreciation of oneself 
and a cohesive life narrative (Bogar and Hulse-Killacky, 2006, Miller et al., 2014, Urman et al., 2001). Self-
efficacy (Bachay and Cingel, 1999) and frequent experiences of positive affect, too, are considered protective 
against the psychological burden of extreme stress (Cohn et al., 2009, Zautra et al., 2005).  
 
Numerous studies have linked the use of positive emotions to resilience as it is thought that positive 
emotionality and high self-esteem promote habituation to stressors, encouraging efficacious interpersonal 
behaviours and prompt cognitive reappraisal away from depressive mood states (Amstadter et al., 2016, 
Buhrmester et al., 2011). Positive emotions provide a multitude of adaptive benefits (Fredrickson, 2001, 
Kaltman and Bonanno, 2003) crucial in daily life and feature prominently in the context of adversity and risk 
(Bonanno, 2005, Bonanno, 2004). Extraversion is a personality trait characterised by positive emotionality and 
assertiveness, which has been hypothesised to protect against MDD by facilitating positive affective (Campbell-
Sills et al., 2006). Although empirical evidence specifically demonstrating any relationship between 
extraversion and resilience is lacking, it stands to reason that extraversion will likely be directly associated with 
the promotion of mental health (Matthews et al., 2009). Such a hypothesis stems mostly from the observation 
that traits such as neuroticism which are characterised by negative emotionality are inversely associated with 
resilience (Amstadter et al., 2016). As discussed in Chapter 1, neuroticism has been extensively associated with 
psychopathological outcomes (Hettema et al., 2006, Ormel et al., 2013) with strong associations being found 
between neuroticism and MDD (Lahey, 2009). A current debate in the literature pertains to whether or not 
resilience and neuroticism are in fact opposite sides of the same construct; that resilience (characterised by 
positive emotions) is the flip side of neuroticism (charactersied by negative emotions). At present, conflicting 
findings preclude a definitive answer (Amstadter et al., 2016, Simeon et al., 2007), although subsequent 
chapters in this thesis will seek to address this question.  
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Although research has yielded compelling results linking personality traits with positive psychological outcomes 
(Luthar et al., 2000), their explanatory power is often overestimated (Mischel, 1969). A major caveat of a trait-
based conceptualisation of resilience is that it does not necessitate the experience of adversity or risk, an 
essential element of psychological resilience (Luthar et al., 2000, Rutter, 2006, Windle et al., 2011). 
Furthermore, personality may be influenced by adversity, especially when it is measured subsequent to 
occurrence of the adversity (Bonanno and Mancini, 2008).  
 
2.4.2. Interpersonal factors and coping 
It is unlikely that any one factor is solely attributable to resilience, but rather numerous factors coalesce, each 
contributing to the overall likelihood of a resilient outcome (Bonanno et al., 2007, Bonanno and Mancini, 2008). 
It is important to differentiate between a resilient or favourable outcome, and the resilience factors that predict 
positive outcomes. Whereas factors such as personality remain relatively stable across time, others will likely 
fluctuate across the lifespan (Hobfoll, 2002, Hobfoll, 1989). Indeed, it is now widely accepted that resilience 
varies contextually and temporally, intimating that it is a dynamic process (Kent et al., 2014, Luthar et al., 2000, 
Norris et al., 2009, Sapienza and Masten, 2011) reflecting active adaptive mechanisms rather than a static 
property of the individual (Friedman et al., 2014, Mancini and Bonanno, 2009, Russo et al., 2012). 
 
Coping is an active adaptive factor involving direct efforts to modify adverse encounters (Campbell-Sills et al., 
2006), and although often used interchangeably, there is a growing body of evidence to suggest that resilience 
and coping are conceptually distinct constructs (Campbell-Sills et al., 2006, Fletcher and Sarkar, 2013, Tugade 
and Fredrickson, 2004, Van Vliet, 2008). Numerous studies highlight the importance of coping with resilience 
(Clauss-Ehlers, 2008, Leipold and Greve, 2009, Sinclair and Wallston, 2004, Tugade and Fredrickson, 2004), 
but it is crucial to distinguish between coping ‗behaviours‘ and ‗style‘. Whereas specific behaviours are more 
likely to mediate the link between adversity and depression (Folkman and Moskowitz, 2004), dispositional 
coping styles may function as a protective factor that moderates components of depressive illness (Campbell-
Sills et al., 2006). To illustrate, emotion-oriented coping is characterised by the regulation of distressing 
emotions, whereas task-oriented coping denotes purposeful efforts aimed at problem solving (Folkman and 
Lazarus, 1988). Avoidance-oriented coping is defined by behaviours aimed at avoiding difficult circumstances 
(Cosway et al., 2000). It has been found that task-oriented coping styles associate with better psychological 
outcomes in comparison to emotion- and avoidance-oriented coping styles which have been associated with 
poorer outcomes for mental health (Higgins and Endler, 2006). Furthermore, for individuals receiving treatment 
for MDD, task-oriented coping has been found to associate with less severe symptomology and better prognosis, 
whereas emotion-oriented coping styles associated with greater psychological dysfunction (Billings and Moos, 
1984). It is likely that positive, task-oriented coping styles increase an individual‘s confidence to appraise 
adversity with a sense of control, resulting in an increase in positive emotions fostering active problem-oriented 
behaviours which modify detrimental emotional and neurobiological responses and ultimately buffer against 
MDD (Southwick and Charney, 2012). These findings suggest that coping style may be an integral factor in 
resilience, although it is important to note that one‘s coping style likely consists of a sophisticated repertoire of 
behavioural manifestations and personality traits (Tugade and Fredrickson, 2004), developed in childhood and 
fortified across the lifespan  
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Social support has also been hypothesised as an important proximal factor in the aftermath of severe adversity 
(Ozer et al., 2003, Rutter, 1987, Werner, 1993). Research associates emotional support with positive adjustment 
following disaster (Kaniasty and Norris, 2009, La Greca et al., 1996), and multivariate disaster studies have 
provided compelling evidence for an explicit link between social support and resilient outcomes (Bonanno et al., 
2007, Bonanno and Mancini, 2008). However, because social support is the result of a transaction between the 
individual and their environment, it is not only the number and function of such relationships that are critical, 
but also the perception of such support (Procidano and Heller, 1983). Feder and colleagues (2009) posit that 
openness to social support is paramount in ensuring resilience, as a negative view to the support being offered 
may result in less support being perceived and received. This demonstrates an intrinsic link between personality 
and social support as positive emotions have been linked to the promotion of resilience (Bonanno, 2004, Luthar 
et al., 2000, Tugade and Fredrickson, 2004) through openness to support, ease of forming attachments with 
others, and the ability to seek out social interaction (Campbell-Sills et al., 2006). Extraverted personalities, for 
example, experience strong positive emotions and tend to have better social networks than individuals scoring 
highly on neuroticism (Campbell-Sills et al., 2006). Therefore, although social support facilitates resilience to 
depression, it is a dynamic and reciprocal process that encapsulates one's personal disposition and coping style. 
Furthermore, research suggests that high levels of social support not only associate positively with active 
problem-focused coping, self-esteem and optimism, but together these mitigate detrimental neurobiological 
processes associated with MDD (Kaufman et al., 2006, Southwick and Charney, 2012, Taylor et al., 2011).  
 
2.4.3. The brain 
Numerous neurobiological factors are hypothesized to foster resilience to MDD (Russo et al., 2012). For 
example, a recent brain-imaging study demonstrated that cognitive reappraisal can influence brain regions 
involved in emotion processing (Ochsner et al., 2002) and therefore may promote resilience to depression. 
Specifically, cognitive reappraisal of aversive photographs resulted in decreased negative affect which suggests 
that resilience is dependent on effective prefrontal cortical modulation of emotion-processing systems (e.g., 
amygdala and medial orbitofrontal cortex). This is supported by the knowledge that the human limbic system is 
responsible for the regulation of personality, emotional reactivity and social behaviour (Folkman and 
Moskowitz, 2000, Isen et al., 1987, LeDoux, 1993). Further findings from the limbic system suggest that pre-
existing differences in hippocampal volume may partly underlie resilience (Baaré et al., 2010, Chen et al., 
2010). Specifically, in individuals with familial risk for MDD, reduced hippocampal volumes were strongly 
associated with MDD (Baaré et al., 2010, Chen et al., 2010, Cole et al., 2011, Rao et al., 2010). A recent study 
by Chan and colleagues (Chan et al., 2016) also supports this hypothesis and suggests that larger hippocampal 
volumes may be a biomarker for resilience. Never-depressed individuals with high risk personality factor for 
depression showed a significant increase in hippocampal volume, and, because the age of the sample was above 
that expected for typical age of onset for MDD, participants with a larger hippocampus who remained 
asymptomatic despite personality risk could be an indicator for psychological resilience (Chan et al., 2016). 
Furthermore, it has been purported that mesolimbic dopamine pathways in the brain may be more reward 
responsive and/or stress resistant in individuals who remain optimistic in the face of adversity (Charney, 2004). 
Together this neural circuitry is believed to mediate successful adaptation (Amstadter et al., 2016, Feder et al., 
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2009, Fredrickson, 2001). Differences in the balance and interaction of these biological factors may underlie 
inter-individual variability in resilience to MDD, which is likely mediated by the expression of dispositional 
traits and coping styles, or by previous adversity (Davidson et al., 2000, Davidson and McEwen, 2012, Feder et 
al., 2009, Forgeard et al., 2011). Whilst a number of behavioural and psychosocial factors have been associated 
with neurobiological factors in resilience, it is likely that their covariance is largely attributable to genetics 
(Miller et al., 2014).  
 
2.4.4. Genetics 
Genetic factors may be fundamental in an individual‘s response to adversity (Feder et al., 2009) as our genetic 
architecture influence the expression of many biological processes and behavioural manifestations. An 
increasing number of genome-wide studies (GWAS; Ripke et al., 2013) are being conducted to parse the 
complex genetic contributions to both MDD and resilience, but at present, GWAS have not proven particularly 
successful in identifying specific genetic risk or protection variants (Cross-Disorder Group of the Psychiatric 
Genomics Consortium, 2013, Hek et al., 2013, Sullivan et al., 2009, Wray et al., 2012). To overcome this, 
researchers are now using candidate genes to focus on individuals at genetic risk for maladaptation who do not 
develop depression (Luthar et al., 2000). The best-studied genetic factor for resilience pertains to a variation in 
the serotonin transporter gene (5-HTTLPR) (Caspi et al., 2010). Both the short form of 5-HTTLPR and a single 
base substitution in the long form of 5-HTTLPR are associated with reduced reuptake of serotonin from the 
synaptic cleft. As such, lower expression of 5-HTTLPR alleles are associated with increased risk for MDD 
through changes in the amygdala–ventromedial prefrontal cortex (PFC), a finding demonstrated in children 
exposed to maltreatment (Karg et al., 2011). It must be noted, however, that the examination of genes related to 
the hypothalamus-pituitary-adrenal (HPA) axis (Binder et al., 2008, Ressler et al., 2011), and serotonergic 
systems (Murrough and Charney, 2011, Stein et al., 2009) have thus far yielded only weak to moderate 
associations with resilient phenotypes, with inconsistent replicability. More compelling results have been found 
when examining the complex interactions between specific genes and neurochemical stress response systems 
(for a comprehensive review see Feder et al, (2009) which suggest that an individual‘s genes shape neural and 
biochemical processes that are expressed psychologically and behaviourally as resilience. Several genetic 
polymorphisms have been found which directly affect limbic reactivity and prefrontal-limbic connectivity, 
influencing behavioural responses to adversity in addition to cognitive reappraisal of negative events (de Kloet 
et al., 2007, Heinz and Smolka, 2006, Ising et al., 2008, Zhou et al., 2008). Furthermore, genetics research also 
suggests that putative ―risk alleles‖ operate in a dynamic interplay with the environment (Rende, 2012). To 
illustrate, social support has been associated with protection to MDD in maltreated children, even in children 
with the short form 5-HTTLPR gene (Kaufman et al., 2006), although studies suggest that genetic influences on 
biological responses are far greater than the genetic effects on complex behavioural and psychosocial responses 
(Feder et al., 2009). 
 
2.5. Resilience measurement 
Although research on resilience has substantially increased in the last two decades (Haskett et al., 2006), the 
confusion over its definition has created considerable difficulty in developing an operational definition of the 
construct. Divergent approaches to measuring resilience have resulted in inconsistencies regarding the nature of 
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potential risk factors and protective processes, and prevalence estimates (Haskett et al., 2006, Luthar et al., 
2000). For example, the proportion of individuals reported to be resilient ranges from 25% to 84%, even in 
populations who have experienced similar adversity (Vanderbilt-Adriance and Shaw, 2008). Such diversity 
raises an important question as to the extent to which resilience is being measured, or an entirely different 
construct. Currently, there exists no consensus on how resilience should be quantified. As illustrated in Figure 
2.2, resilience can be measured in a number of ways, although each necessitate a favourable outcome given the 
presence of underlying risk. Alternatively, several quantitative measures of resilience have now been developed 
and validated, although they are not widely adopted, and no one scale if preferable over another (Connor and 
Davidson, 2003). 
 
   
 Psychological resilience is typically defined as a favourable outcome given the presence of 
underlying risk, and can be quantified as: 
 
   
 1.  The absence of psychopathology across diagnostic categories  
   
 2. High levels of well-being on a quantifiable scale  
   
 3. Better than expected adjustment in comparison to a group ‗average‘  
   
 
   Figure 2.2. Possible ways to quantify psychological resilience 
 
A comprehensive review of resilience scales (Windle et al., 2011) suggests that at present, the Connor-Davidson 
Resilience Scale (CD-RISC), the Resilience Scale for Adults (RSA) and the Brief Resilience Scale (BRS) are 
the most preferable quantitative scales for resilience measurement in adult populations, based on extensive 
criteria. However, it is important to note that not even these three measures thoroughly satisfied all 
psychometric properties specified in the systematic review (Windle et al., 2011). Currently, resilience measures 
capture state resilience, rather than assessing resilience across the lifespan. Furthermore, the majority of current 
inventories focus predominately on assessing the availability of implicit assets and resources which facilitate 
positive adaptation during times of adversity (Olsson et al., 2003). However, the Brief Resilience Scale aims to 
assess resilience as an outcome – the ability to ‘bounce back’. As such, the BRS is a preferable measure to 
investigate the processes leading to a resilience outcome, or for researchers interested in ascertaining the 
presence or absence of these resources. It is important to note, however, that the Brief Resilience Scale does 
reflect a sense of personal agency (Windle et al., 2011), and so no quantitative measure of resilience is entirely 
perfect. 
 
With increasing evidence to suggest that resilience is an interactive phenomenon which varies across multiple 
domains, methods with greater explanatory power are needed to investigate psychological resilience. Given the 
heterogeneity of the construct, it is likely that there are multiple, independent predictors of resilient outcomes 
which are correlated, and perhaps dependent upon each other. Ultimately, consensus on what resilience is and 
how it should be measured needs to consider the multidimensional examination of risk, protective factors and 
positive adaptation in a dynamic fashion.  
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2.6. Summary and PhD aims 
The study of psychological resilience remains at an early stage with no agreement on how it should be defined 
and measured. However, it is generally assumed that resilience is the ability to ‗bounce back‘. Whilst it is 
widely agreed that both adversity (or risk) and positive adaptation are crucial components in defining resilience 
to occur, conceptual discrepancies hinder the evaluation and comparison of research findings (Davydov et al., 
2010) and the progress of resilience research. There are likely multiple pathways to resilience whereby a 
combination of factors interact dynamically to enable an individual to cope and function successfully, despite 
significant risk or adversity (Rutter, 1993). Resilience is a multifaceted phenomenon and so to fully delineate 
the concept it is imperative to examine adversity/risk, protective factors, and positive adaptation not only at 
multiple phenotypic levels but also behaviourally, psychologically and biologically. Identifying reliable 
predictors that could determine who is most likely to be resilient to MDD would enable researchers and 
clinicians to prospectively forecast the trajectory of an individual‘s resilience to and recovery from mental 
illness. This will represent a valuable step towards the development of strategies for protecting individuals prior 
to disease onset. 
 
It is now imperative to harmonise our approach to resilience, moving beyond description towards an explanation 
of the individual differences in resilience to MDD. To fully disentangle prediction to resilience, prospective, 
multivariate designs are necessary. This thesis aims to attempt to quantify psychological resilience and elucidate 
its mechanisms by investigating resilience from multiple perspectives over three main chapters. Firstly, a study 
investigating intelligence as a form of resilience will be introduced and discussed (Chapter 3). This chapter aims 
to provide evidence for the protective effects of intelligence on mental health in high-risk individuals, and 
ascertain if vulnerability and protection mechanisms in MDD are worthy of independent investigation. A new 
dataset is introduced in Chapter 4 which was specifically designed to measure psychological resilience. 
Measures from this dataset will be used in subsequent chapters to examine resilience from multiple perspectives. 
In Chapter 5, the mediating effects of resilience and neuroticism on the association between genetic liability for 
MDD and the disorder itself are examined. The study presented within this chapter had two overarching aims; to 
investigate if neuroticism and resilience are downstream mediators of genetic vulnerability for MDD, and to 
determine if neuroticism and resilience are independent constructs representing risk and protection mechanisms. 
The aetiology of resilience will also be investigated (Chapter 6). Specifically, the proportion of the phenotypic 
variance attributable to genetic and shared-environmental factors will be calculated for resilience and coping 
style. Additionally, genetic correlations between resilience, coping style and neuroticism will be calculated with 
the aim of investigating a shared genetic architecture. Finally, a summary of this thesis will be provided in 
















As outlined in Chapter 1, mood disorders such as Major Depressive Disorder (MDD) have a long history of 
association with negative emotions (Jackson, 1986). Not only is MDD characterised by poor modulation of 
emotional response, the disorder is also highly associated with traits that elicit negative emotions. Specifically, 
the personality trait neuroticism is strongly positively associated with MDD across the lifespan (Kotov et al., 
2010, Malouff et al., 2005). As such, it is widely accepted that high levels of neuroticism confer risk to indices 
of mental health, including depression and psychological distress (Chan et al., 2007, Fanous et al., 2007, Jylhä 
and Isometsä, 2006, Lahey, 2009). Although MDD is primarily considered an illness of emotional 
dysregulation, the disorder is commonly associated with cognitive impairment (Beck et al., 1979). Indeed, 
deficits in the domains of memory, executive functioning, and processing speed are frequently observed in 
patients during depressive episodes (Baune et al., 2010, Marazziti et al., 2010). However, a great body of 
research suggests that despite cognitive deficits at times of illness, higher cognitive ability (intelligence) 
attenuates the risk for depressive illness throughout the life course (Batty et al., 2005, Gale et al., 2010, Koenen 
et al., 2009, Scult et al., 2017, Wraw et al., 2016). This suggests that symptoms of MDD effect cognitive 
performance only at the time of measurement, rather than cognitive ability being a risk factor for depression. 
Such findings indicate that cognitive ability - specifically intelligence - may act as a protective factor in MDD, 
and as such is a useful variable to examine in the resilience enquiry.  
 
Studies investigating physical health suggest that higher intelligence mitigates the detrimental effects of 
neuroticism on indices of physical health and mortality (Leikas et al., 2009, Weiss et al., 2009), although it is 
not yet known if such an interaction exists for mental health. It is likely that neuroticism and intelligence exert 
divergent effects on MDD whereby neuroticism increases risk for MDD and intelligence provides protection, as 
indicated above. To determine if intelligence acts as a moderator in the relationship between neuroticism and 
MDD, multiple regression analyses can be utilised (e.g., Aguinis, 2004; Jaccard & Turrisi, 2003; Jose, 2013). 
Such a method would enable researchers to determine if intelligence affects the direction and/or strength of the 
relationship between neuroticism and MDD. Furthermore, such an analysis may enable researchers to determine 
the usefulness of examining risk and protective factors simultaneously in regard to resilience. For example, if 
intelligence is associated with protection against MDD in individuals at high risk for the disorder it would 
suggest that resilience mechanisms act independently to risk factors.  
 
This chapter introduces an original study and replication examining the protective effects of general intelligence 
(g) on indices of mental health. Specifically, the aim of this study was to determine if g would provide 
protection against both psychological distress and/or MDD in individuals high in neuroticism (a known risk 
factor for MDD), as such an association has been identified for physical health and mortality (Leikas et al., 
2009, Weiss et al., 2009). A subsidiary aim of this study was to ascertain if vulnerability and protection 
mechanisms are of equal importance when studying resilience. This study is summarized, below, in the 
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manuscript entitled ‗Intelligence and neuroticism in relation to depression and psychological distress‘ which has 
been published in European Psychiatry. As first author for this publication, I conceived the experimental design, 
performed all data analysis and wrote the manuscript for publication. To acknowledge the contributions of co-
authors, ―we‖ will be used instead of ―I‖ throughout this chapter. 
 
3.2 Paper: Intelligence and neuroticism in relation to depression and psychological distress 
 
3.3 Abstract 
Background: Neuroticism is a risk factor for selected mental and physical illnesses, and is inversely associated 
with intelligence. Intelligence appears to interact with neuroticism and mitigate its detrimental effects on 
physical health and mortality. However, the inter-relationships of neuroticism and intelligence for major 
depressive disorder (MDD) and psychological distress have not been well examined.  
 
Methods: Associations and interactions between neuroticism and general intelligence (g) on MDD, self-reported 
depression, and psychological distress were examined in two population-based cohorts: Generation Scotland: 
Scottish Family Health Study (GS:SFHS, N = 19,200) and UK Biobank (N = 90,529). The Eysenck Personality 
Scale Short Form-Revised measured neuroticism and g was extracted from multiple cognitive ability tests in 
each cohort. Family structure was adjusted for in GS:SFHS.  
  
Results: Neuroticism was strongly associated with increased risk for depression and higher psychological 
distress in both samples. Although intelligence conferred no consistent independent effects on depression, it did 
increase the risk for depression across samples once neuroticism was adjusted for. Results suggest that higher 
intelligence may ameliorate the association between neuroticism and self-reported depression although no 
significant interaction was found for clinical MDD. Intelligence was inversely associated with psychological 
distress across cohorts. A small interaction was found across samples such that lower psychological distress 
associates with higher intelligence and lower neuroticism, although effect sizes were small.  
 
Conclusions: From two large cohort studies, our findings suggest intelligence acts a protective factor in 
mitigating the effects of neuroticism on psychological distress. Intelligence does not confer protection against 
diagnosis of depression in those high in neuroticism. 
 
3.4 Introduction 
Major depressive disorder (MDD) is a leading cause of disease burden worldwide (Ferrari et al., 2013). 
Although MDD aetiology remains elusive, a large proportion of its genetic covariance is attributable to 
neuroticism (Jardine et al., 1984, Kendler et al., 1993), suggesting a causal relationship. Neuroticism is a 
partially-heritable personality trait representing high emotionality and stress sensitivity (Matthews et al., 2009), 
which correlates highly with MDD (Jylhä and Isometsä, 2006). Cross-sectional studies suggest a strong positive 
association between neuroticism and MDD (Chan et al., 2007, Muris et al., 2005, Roelofs et al., 2008), whilst 
higher neuroticism prospectively associates with depression longitudinally (Fanous et al., 2007, Farmer et al., 
2008, Hirschfeld et al., 1989, Kendler et al., 2006, Kendler et al., 1993), even when controlling for overlapping 
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criteria (Fergusson et al., 1989, Schmutte and Ryff, 1997, Spijker et al., 2007) and demographics (Kendler et 
al., 2004, Neeleman et al., 2001). Whist the public health impacts of neuroticism are wide-ranging (for a 
comprehensive review see Lahey, 2009), neuroticism may be an indirect measure of later MDD risk, rather than 
the causative risk factor itself. Whilst MDD is often recurrent (Hardeveld et al., 2013), neuroticism is a stable 
trait (Conley, 1985) suggesting that their correlation is unlikely to be substantially attributable to an effect of 
MDD on neuroticism. 
 
General intelligence (g) is a latent construct theorized to explain the common observation that people who excel 
in one type of cognitive task tend to excel in others (Humphreys, 1979). When reduced to a single factor (g) 
these correlations explain approximately 50% of the covariance between tests. Lower intelligence in early life 
has been found to be a risk factor for poor physical health (Wraw et al., 2015) and early mortality in adulthood 
(Calvin et al., 2011, Deary et al., 2010). Although research specifically regarding MDD is relatively sparse 
(Gale et al., 2008), there is evidence to suggest that g is impaired in depression (Marazziti et al., 2010, Sackeim 
and Steif, 1988) with longitudinal studies suggesting lower g in childhood or adolescence confers vulnerability 
to psychopathology in adulthood (Gale et al., 2009, Gale et al., 2010, Maccabe, 2008, Zammit et al., 2004). 
 
Psychological distress represents a cluster of emotional symptoms linked to depression (Beck et al., 1979, 
Goldberg et al., 1987, Snaith, 1987). Although symptoms of distress are common in population samples, 
(Kessler and Wang, 2008, Singleton et al., 2003) they indicate only subthreshold mental health problems. With 
self-report measures of distress (Goldberg and Hillier, 1979, Kroencke et al., 2001) freely available in 
epidemiological research, their measurement provides greater detective power to make distinctions between 
syndrome and subthreshold symptoms. Longitudinal research suggests neuroticism has a strong, direct effect on 
psychological distress (Ormel and Wohlfarth, 1991). Low childhood intelligence strongly associates with 
increased psychological distress in adulthood (Gale et al., 2009, Hatch et al., 2007), which may precede MDD 
onset (Gulliver et al., 2012). However, this is not a universal observation, particularly in studies accounting for 
socioeconomic status (SES). 
 
Intelligence and neuroticism may interact to influence indices of health. A longitudinal study of war veterans 
(Weiss et al., 2009) found high neuroticism and low cognitive ability were separate risk factors for mortality. 
Specifically, a 1-standard deviation increase in neuroticism resulted in a 33% increase in mortality; a 1-standard 
deviation decrease in intelligence associated with a 27% increase in mortality. An interaction (hazards ratio of 
0.89) suggested that high neuroticism with low cognitive ability associates with high risk of poor health and 
reduced lifespan. Furthermore, high cognitive ability moderates the adverse effects of neuroticism on adjustment 
(Leikas et al., 2009). Whether similar interactions exist with regard to their effects on depression remains 
unknown. No investigation has yet examined how intelligence and neuroticism influence risk for MDD and how 
they may moderate each other‘s associations in depression and psychological distress. Such an analysis may 
serve to clarify the mechanisms underlying MDD. 
 
In this study, two large population-based cohorts were examined - Generation Scotland: Scottish Family Health 
Study (GS: SFHS) (Smith et al., 2013a, Smith et al., 2006) and UK Biobank (Allen et al., 2012, Sudlow et al., 
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2015). As previous studies suggest strong associations of neuroticism with risk of MDD (Jylhä and Isometsä, 
2006, Kendler et al., 1993), the same effect was hypothesised here. We hypothesised that higher intelligence 
may reduce MDD risk by mitigating the adverse effects of neuroticism, similarly to the interaction identified for 
mortality (Weiss et al., 2009). This reasoning transfers to psychological distress, hypothesising a positive 
association between neuroticism and psychological distress would be ameliorated by higher intelligence. 
 
3.5. Method 
3.5.1. GS:SFHS Overview 
GS:SFHS is a family and population-based cohort recruited throughout Scotland between 2006 and 2011 (Smith 
et al., 2013a). During clinic assessment, participants aged 18-98 (N = 24,084) provided clinical, cognitive and 
biological data. Full details are provided elsewhere (Smith et al., 2013a, Smith et al., 2006). The GS:SFHS 
sample is predominately female (59%), and generally healthier and wealthier than the Scottish population 
(Smith et al., 2013a). This study includes 19,200 individuals with complete data of interest. Demographic 
information from this cohort is provided in Table 3.1 and in Appendix A. 
 
3.5.2. Study assessments  
During clinic assessment, participants were screened for lifetime history of MDD using a structured clinical 
interview (First et al., 1997). Diagnosis of MDD follows DSM-IV criteria; if either symptoms of depressive 
mood or anhedonia are endorsed, a minimum of four further symptoms must also be endorsed. Clinical 
significance must be endorsed, too (ie., symptoms lasting nearly all day, every day for a minimum of two 
weeks). This study includes 2,481 individuals meeting criteria for lifetime history of MDD (13%), and 16,719 
non-MDD cases (87%). 
 
Four cognitive tests measuring intelligence were administered during clinic assessment (Smith et al., 2013a, 
Smith et al., 2006). The Wechsler Digit Symbol Substitution Task (Wechsler, 1958) measured processing speed. 
One paragraph from The Weschler Logical Memory Test I & II (Wechsler, 1945) measured verbal declarative 
memory. The Verbal Fluency Test measured executive function (Wechsler, 1958) using phonemic lists of C, F 
and L. Vocabulary was measured with The Mill-Hill Vocabulary Test (Raven, 1958), using combined junior and 
senior synonyms. General intelligence (g) was extracted from these tests, as the first un-rotated principal 
component (Marioni et al., 2014), explaining 41% of the variance. Loadings for processing speed, vocabulary, 
verbal declarative memory and executive function were 0.57, 0.68, 0.63 and 0.69 respectively. 
 
The self-reported Eysenck Personality Questionnaire Short Form-Revised (EPQ-SF) (Eysenck, 1991) measured 
neuroticism. Twenty-four questions assessed neuroticism and extraversion, with total scores on each subscale 
ranging from 0-12. Higher scores indicate higher levels of each trait. This scale has been concurrently validated 
(Gow et al., 2005) with high reliability (Eysenck et al., 1985). 
 
Psychological distress was self-reported using the General Health Questionnaire (GHQ-28) (Goldberg and 
Hillier, 1979). Twenty-eight items were scored from 0 (―not at all‖) to 3 (―much more than usual‖) with a total 
score ranging from 0-84. Higher scores indicate increased psychological distress. 
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The Scottish Index of Multiple Deprivation (SIMD) (Payne and Abel, 2012) is an official tool which identifies 
deprivation by combining different indicators (eg., income, crime) into a single index. The SIMD divides 
Scotland into 6,505 small areas based on participant postcode, and assigns them a relative ranking from 1 (most 
deprived) to 6505 (least deprived). 
 
3.5.3. UK Biobank Overview 
UK Biobank is a population cohort recruited across the UK from 2006-2010. During extensive baseline 
assessments (Smith et al., 2013b) participants aged 40-69 (N = 502,682) provided biological, physical, and 
touch-screen questionnaire measures of socio-demographics (e.g., age, sex), psychosocial factors (e.g., mental 
health), and cognitive function. UK Biobank represents a wide range of exposures typical within the UK 
population (UK Biobank, 2011), and has been described in detail elsewhere (Allen et al., 2012, Sudlow et al., 
2015). In this study, 147 individuals were removed from analysis due to participation in GS:SFHS. In total, 
90,529 individuals with complete data of interest were included. Demographic information is provided in Table 
3.1 and in Appendix A. 
 
3.5.4. Study assessments  
Between 2008-2010, a touch-screen questionnaire was added to the protocol to assess probable depression (N = 
172,751) (UK Biobank, 2012). Although depression was not assessed using a precise diagnostic tool, the 
classification followed a self-report approach within the guidelines of the ICD- 10 (World Health Organisation, 
1992) and the DSM-IV (American Psychiatric Association, 1994). Lifetime history of depression was assessed 
using items relating to the lifetime experience of depressive symptoms and help-seeking for mental health. A 
detailed description of how this phenotype was derived is provided elsewhere (Smith et al., 2013b). This study 
included 30,127 (33%) individuals self-reporting lifetime history of depression, and 60,402 (67%) non-
depressed cases. 
 
Three novel cognitive tests were administered via touch-screen questionnaire measuring reaction time, verbal-
numerical reasoning, and visual memory (Smith et al., 2013b). A timed symbol matching test measured reaction 
time as the mean response time in ms over 12 trials; higher reaction times equate to poorer performance. 
Thirteen logic/reasoning-type questions assessed verbal-numerical reasoning - the total number of correct 
answers given within two-minutes was analysed. A visuo-spatial memory task measured the number of errors 
made when matching card pairs, higher scores reflect poorer cognitive function. From these tests, g was 
extracted as the first un-rotated principal component (Marioni et al., 2014), explaining 44% of the variance in 
scores. Loadings onto g were: -0.61 (verbal-numeric reasoning), 0.57 (visual memory), and 0.55 (reaction time). 
 
Neuroticism was assessed using 12 questions from the Eysenck Personality Questionnaire Short Form-Revised 
(EPQ-SF) (Eysenck, 1991), administered via a touch-screen questionnaire. A total score from 0-12 was 
produced, with higher scores reflecting increasing neuroticism. 
 
The first four questions of the Patient Health Questionnaire – 9 (PHQ9; Kroencke et al., 2001) were 
administered by touch-screen questionnaire to measure psychological distress. Responses on a scale from 0 
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(―Not at all”) to 3 (―Nearly every day”) were aggregated and a higher total score denoted higher levels of 
psychological distress. 
 
The Townsend Deprivation Index (Townsend, 1987) is a census-based measure of deprivation, incorporating 
unemployment, non-car ownership, non-home ownership and household overcrowding into a single index. 
Small geographical areas based on postcode information are allocated Townsend Scores. Higher scores 
represent greater deprivation. 
 
3.6. Statistical analysis 
3.6.1. GS:SFHS 
In GS:SFHS, the MCMCglmm package was used. The Markov Chain Monte Carlo estimator produces 
generalised linear mixed models for binary outcomes (using the ―threshold‖ family with a probit link function). 
The threshold link is unique to MCMCglmm, and although produces very similar results to a logit function, 
threshold links most closely match the underlying assumptions of latent normal errors in pedigree-based mixed 
effect models (Lynch and Walsh, 1998). MCMCglmm was essential to control for genetic relatedness of the 
sample, which was fitted as a random effect using an inverse pedigree matrix. Due to limitations within 
MCMCglmm with missing predictor variables, only complete data can be used. An interaction was fitted to 
estimate the moderating effect of g on the contribution of neuroticism to MDD. Another model examined this 
interaction while conditioning on deprivation. Regression coefficients are reported as odds ratios. In a second set 
of analyses, GHQ was modelled as a normally distributed outcome variable. Neuroticism and GHQ were 
standardised to have a mean of zero and a standard deviation of 1. Age (standardised) and sex were used as 
fixed effects throughout. 
 
3.6.2. UK Biobank 
In UK Biobank, generalized linear regression analyses were conducted as kinship need not be accounted for. 
The main effects of neuroticism and g were examined as predictors for self-reported depression. The interaction 
between neuroticism and g on depression was modelled. Another model examined this interaction while 
adjusting for deprivation. Generalized linear regressions were fitted with a logit link function and odds ratios 
reported. A second set of analyses examined psychological distress (PHQ) using linear regression models. 
Neuroticism and PHQ were standardised to have a mean of zero and a standard deviation of one. Reaction time 
was log transformed due to a significantly positive skew. Visual memory was transformed with a log+1 





As seen in Table 3.1, MDD cases were younger, predominately female, and had higher GHQ and neuroticism 
scores. No group differences were found in general intelligence; (t(3243.38) = -1.39, p = 0.17, Cohen‘s d = .03). 
Group differences were found in processing speed and executive function. MDD cases were from less deprived 
areas; (t(3171.20) = 9.93, p = 2.20x10ˉ16, Cohen's d = .22). Full statistical output can be found in Appendix A.
 











Table 3.1. Demographic, clinical, and cognitive characteristics of GS:SFHS and UK Biobank individuals in the current study 
 GS:SFHS UK Biobank 
 Total 
(N = 19,200) 
Control 
(N = 16,719) 
Lifetime MDD 
(N = 2,481) 
Total 
(N = 90,529) 
Control 
(N = 60,402) 
Lifetime MDD 
(N = 30,127) 
Age 47.16 (14.97) 47.23 (15.27) 46.39 (12.89) * 56.64 (8.13) 57.15 (8.16) 55.60 (7.98) * 
Sex (% female) 59 57 72 * 52 46 65 * 
Neuroticism 3.84 (3.16) 3.45 (2.94) 6.45 (3.32) * 4.36 (2.86)  2.65 (2.43)  5.09 (2.06) * 
GHQ score 15.93 (8.81) 14.93 (7.56) 22.70 (12.77) * - - - 
PHQ score - - - 1.36 (1.91) 0.89 (1.33) 2.30 (2.47) * 
Wechsler Digit Symbol Substitution Task 72.31 (17.09) 72.45 (17.23) 71.44 (16.06) * - - - 
Mill-Hill Vocabulary Test 30.06 (4.76) 30.05 (4.75) 30.15 (4.84) - - - 
Wechsler Logical Memory Test I & II 31.01 (8.04) 30.99 (8.09) 31.02 (7.68) * - - - 
Verbal Fluency Test 25.68 (8.10) 25.60 (8.11) 26.21 (8.01) * - - - 
Reaction Time - - - 564.00 (119.87) 564.70 (119.98) 562.58 (119.66) * 
Visual Memory - - - 4.04 (3.21) 4.04 (3.23) 4.04 (3.17) 
Verbal-numerical Reasoning - - - 6.09 (2.14) 6.07 (2.16) 6.12 (2.11) * 
SIMD 3903.82 (1851.91) 3957.58 (1832.28) 3541.51 (1941.03) * - - - 
Townsend score - - - -1.37 (2.84) -1.47 (2.77) -1.06 (2.94) * 
Abbreviations: GS:SFHS, Generation Scotland: Scottish Family Health Study; MDD, Major Depressive Disorder; GHQ, General Health Questionnaire; PHQ, Patient Health 
Questionnaire; SIMD, Scottish Index of Multiple Deprivation 
With the exception of sex, value indicate mean (SD) 
* ..Significantly different from controls at p < .05 
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3.7.1.1. Associations of neuroticism and g with MDD status 
Higher neuroticism was strongly associated with increased risk for MDD. A 1SD increase in neuroticism 
increased MDD risk by an odds ratio of 3.61 ([95% CIs = 3.28, 4.01], p < 1.00x10ˉ4). Although no age effects 
were found, being female increased risk for MDD by an odds ratio of 1.76 ([95% CIs = 1.52, 2.03], p < 
1.00x10ˉ4).  g had no independent effect on risk for MDD (OR = 1.02, [95% CIs = 0.99, 1.07], p = 0.53).  
 
3.7.1.2. Interaction between neuroticism and g on MDD 
No interaction was found between neuroticism and g (OR = 1.03, [95% CI = 0.98, 1.08], p = 0.32), see Figure 
3.1 and Table 3.2, even after co-varying for SIMD. However, the main effect of neuroticism was strongly 
associated with MDD risk (OR = 3.71, [95% CI = 3.37, 4.12], p < 1.00x10ˉ4) whilst g was associated with a 
small increase in MDD risk (OR = 1.14, [95% CIs = 1.07, 1.20], p < 1.00x10ˉ4). A main effect was found 





Figure 3.1. Predicted risk for MDD and self-reported depression from the interaction of neuroticism and g in 
both GS:SFHS and UK Biobank 
 
 
3.7.1.3. Associations of neuroticism and g with psychological distress 
Neuroticism was associated with increased psychological distress; a 1SD increase in neuroticism was associated 
with an increase in GHQ of ß = 0.52 ([95% CIs = 0.50, 0.53], p < 1.00x10ˉ4). A small inverse relationship was 
found whereby higher g was associated with decreased levels of psychological distress (ß = -0.08, [95% CIs = -
0.09, -0.07], p < 1.00x10ˉ4).  
 
3.7.1.4. Interaction between neuroticism and g on psychological distress 
A small interaction suggested higher g interacts with neuroticism to mitigate neuroticism‘s detrimental 
association on GHQ (ß = -0.05, 95% [CIs = -0.06, -0.04], p < 1.00x10ˉ4), see Figure 3.2 and Table 3.2. This 
interaction remained after co-varying for deprivation. 
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Table 3.2. Results of MCMC generalised linear  mixed models from GS:SFHS predicting odds ratios for MDD status, beta coefficients for psychological distress (GHQ), 
p-value, upper and lower 95% confidence intervals and the Deviance Information Criterion AND results of a logistic regression from UK Biobank predicting odds ratios 
for MDD status, beta coefficients for psychological distress (PHQ), p-value, upper and lower 95% confidence intervals, the Akaike Information Criterion and adjusted R2 
value for the model 
Sample Outcome Variables Odds Ratio β Lower 95% CIs 
Upper 95% 
CIs P value DIC AIC R
2 
GS:SFHS MDD Age 1.00 - 0.99 1.01 9.71x10-2 12,561.35 - - 
  Sex (F) 1.71 - 1.48 1.97 < 1.00x10-4    
  Neuroticism 3.71 - 3.37 4.12 < 1.00x10-4    
  g 1.14 - 1.07 1.20 < 1.00x10-4    
  Neuroticism * g 1.03 - 0.98 1.08 0.32    
UK Biobank MDD Age 0.98 - 0.99 0.99 < 2.00x10-16 - 98,785.00 - 
  Sex (F) 1.34 - 1.32 1.36 < 2.00x10-16    
  Neuroticism 2.40 - 2.36 2.44 < 2.00x10-16    
  g 1.06 - 1.04 1.07 5.08x10-14    
  Neuroticism * g 0.96 - 0.95 0.98 1.09x10-7    
GS:SFHS GHQ Age - 0.00 0.00 0.00 0.59 47,873.87 - - 
  Sex (F) - 0.04 0.02 0.07 2.63x10-3    
  Neuroticism - 0.50 0.49 0.52 < 1.00x10-4    
  g - -0.04 -0.05 -0.03 < 1.00x10-4    
  Neuroticism * g - -0.05 -0.06 -0.04 < 1.00x10-4    
UK Biobank PHQ Age - -0.02 -0.02 -0.01 < 2.00x10-16 - - 0.2976 
  Sex (F) - -0.02 -0.02 -0.01 1.57x10-8    
  Neuroticism - 0.51 0.51 0.52 < 1.00x10-4    
  g - -0.05 -0.06 -0.05 < 1.00x10-4    
  Neuroticism * g - -0.02 -0.03 -0.02 < 1.00x10-4    
Abbreviations: MCMC, Markov Chain Monte Carlo; GS:SFHS, Generation Scotland: Scottish Family Health Study; GHQ, General Health Questionnaire; PHQ, Patient 









Figure 3.2. Psychological distress scores from the interaction of neuroticism and g in both GS:SFHS (GHQ) 
and UK Biobank 
 
 
3.7.2. UK Biobank 
As reported in Table 3.1, MDD cases were younger, predominately female, and had higher psychological 
distress (PHQ) and neuroticism scores than non-depressed cases. Significant differences were found in verbal-
numerical reasoning (in which non-depressed cases performed better) and reaction time (in which depressed 
cases performed better). g was higher in depressed cases (t(61357) = -2.65, p = 8.12x10ˉ3, Cohen‘s d = .02). 
Non-depressed cases had lower deprivation scores than depressed cases; (t(57110) = -20.08, p = 2.2x10ˉ16, 
Cohen‘s d = .14), although this difference was small. See Appendix A for full statistical output. 
 
3.7.2.1. Associations of neuroticism and g with MDD status 
Higher neuroticism was associated with increased likelihood of self-reported depression. For every 1SD 
increase in neuroticism, the odds for depression increased by 2.39 (95% CIs = [2.35, 2.43], p < 2.00x10ˉ16). No 
main effects of g were found (OR = 1.00, [95% CIs = 0.99, 1.01], p = 0.86). Small effects of age and sex were 
found. 
 
3.7.2.2. Interaction between neuroticism and g on MDD 
A small interaction was found in which high levels of intelligence and neuroticism associate with reduced self-
reported depression (OR = 0.96, [95% CIs = 0.95, 0.98], p = 1.09x10ˉ7), see Table 3.2 and Figure 3.1. This 
interaction remained after co-varying for deprivation.  
 
3.7.2.3. Associations of neuroticism and g with psychological distress 
Neuroticism was moderately associated with increased levels of psychological distress. For every 1SD increase 
in neuroticism, PHQ increased by ß 0.52 ([95% confidence intervals = 0.51, 0.52], p < 2.00x10ˉ16). g was 
associated with a small reduction in PHQ (ß = -0.08, [95% CIs = -0.08, -0.07], p < 2.00x10ˉ16).  
- 32 -  
 
3.7.2.4. Interaction between neuroticism and g on psychological distress 
A small interaction was found in which g moderates the detrimental effects of neuroticism on psychological 
distress (ß = -0.02, [95% CIs = -0.03, -0.02], p < 2.00x10ˉ16), see Table 3.2 and Figure 3.2. This interaction 
remained after co-varying for deprivation. 
 
3.8. Discussion 
The cross-sectional associations between neuroticism, general intelligence (g), MDD, self-reported depression, 
and psychological distress were examined in two large population based cohorts; GS:SFHS and UK Biobank. 
Neuroticism was strongly associated with increased risk for both MDD diagnosis and self-reported depression, 
replicating previous findings (Chan et al., 2007, Muris et al., 2005). Intelligence conferred no consistent 
independent effects but associated with an increased risk for depression once neuroticism was adjusted for. UK 
Biobank data suggest an interaction whereby higher g has a small effect in reducing the impact of neuroticism 
on self-reported depression. This interaction was small, both absolutely, and in comparison to the main effects 
of neuroticism. No such interaction was found in GS:SFHS using a clinical measure of MDD. However, across 
samples, the risk conferred by neuroticism after co-varying for g appears to be increased in terms of the absolute 
OR value when compared to basic models. Overall, results demonstrate an association whereby intelligence 
provides modest protection against the risk-conferring effects of neuroticism on self-reported depression, but not 
clinical MDD. 
 
Consistent and replicable findings were found suggesting higher neuroticism associates with increased 
psychological distress, whereas higher intelligence associates with reduced psychological distress. A small 
interaction was found across samples such that lower distress associates with higher intelligence and lower 
neuroticism. Although these results are of small magnitude, they suggest an important interaction whereby 
higher g lessens the strength of the neuroticism-distress association. 
 
This is the first study of intelligence‘s potential protective influence on MDD (Robinson and Oishi, 2006), self-
reported depression, and psychological distress in high neuroticism individuals. Consistent with previous 
research the strong link between neuroticism with increased risk for depression and psychological distress was 
replicated with moderate effect sizes. Although longitudinal work suggests intelligence provides protection to 
mental health (Gale et al., 2010, Gale et al., 2008, Maccabe, 2008), we found g increased the risk for depression 
when adjusted for neuroticism. The magnitude of this risk was very small, however. Across cohorts, intelligence 
associated with decreased levels of psychological distress. A modest association of intelligence as a mitigating 
factor in reducing psychological distress in individuals with high neuroticism was found in both cohorts. 
Although this study suggests intelligence provides a protective function in self-reported depression and 
psychological distress which mirrors previous research (Calvin et al., 2011, Leikas et al., 2009, Weiss et al., 
2009), intelligence was not found to be protective against diagnosis of depression in those high in neuroticism. 
 
It is unclear why intelligence associates with protection to risk for psychological distress, but not MDD. One 
supposition is that individuals with higher intelligence may be more likely to seek help, and therefore are more 
likely to receive a clinical diagnosis of depression. Another postulation could be that intelligence has an effect 
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only during times of depressive episode. A state-dependent association of cognitive ability has been suggested 
in which variability in intelligence co-varies with depressive episode and remission (for a comprehensive 
review, see Sackeim and Steif, 1988). As such, subsequent investigations may benefit from addressing the same 
hypotheses examining individuals with current MDD in comparison to individuals in remission, and controls. 
Increased psychological distress is an established symptom of depression and often used in clinical diagnosis 
(Beck et al., 1979, Snaith, 1987). Goldberg (1987) described distress as representing the overall severity of 
depression and so it is likely that individuals scoring highly on measures of psychological distress may be more 
likely to self-report the disorder, irrespective of its clinical significance. However, we must be mindful of the 
complexities of causality; whilst it is likely that the neuroticism trait prospectively predicts later distress and 
self-reported depression, we cannot be certain that these factors are not manifestations of the same underlying 
risk. 
 
Intelligence could be a marker of system integrity (Deary, 2012) in which increased intelligence circumvents 
negative mood biasing in individuals high in neuroticism that may lead to distress and disorder (Hasler et al., 
2004). Alternatively, more intelligent individuals may be better able to employ successful coping mechanisms 
during times of distress: higher intelligence associates with increased resilience to adversity in children 
(Fergusson et al., 2005). Research suggests that psychosocial factors are associated with resilience to mood 
disorders (Garmezy et al., 1984). Proactive and psychosocial coping mechanisms may enable individuals to 
decrease transient feelings of distress and to implement established, effective strategies learned from previous 
exposure to distress or depression (LeDoux and Gorman, 2001). This possibility is consistent with the finding 
that whereas g and neuroticism interacted to associate with reduced psychological distress, the same interaction 
was not found in clinical MDD. It would be interesting to explore intelligence‘s influences on coping style 
(Higgins and Endler, 2006) and subsequent psychological distress and MDD diagnosis in future investigations. 
Intelligence may influence the adoption of specific coping strategies, and this could be a mediating factor in the 
‗depressogenic‘ process. 
 
Some caveats merit comment. Different cognitive tasks were used to generate g across our samples. In 
GF:SFHS, pre-existing, standardized measures were used, whereas UK Biobank used bespoke cognitive tasks. 
Further replication utilising standardised measures would be beneficial. A second limitation is the differing 
MDD phenotypes used in each sample. In GS:SFHS, MDD was determined using a semi-structured interview 
(First et al., 1997), obtaining a robust MDD phenotype based on a standardised diagnostic tool. In UK Biobank, 
self-reported questionnaires were aggregated to form a depression phenotype; this data is not as comprehensive. 
Although it is of benefit to have conducted an independent replication within this study, the disparity in 
depression phenotypes may explain not only the difference in prevalence rates across samples, but also why an 
interaction was found in UK Biobank and not GS:SFHS. Thirdly, this investigation only examined neuroticism. 
Personality represents stable individual dispositions in emotional reactivity, behavioural tendencies, and 
cognitive styles (Deary et al., 2010, Roberts et al., 2007), which may be moderated by intelligence in predicting 
mental health outcomes. Examining such associations between all major dimensions of personality in 
subsequent research is advised. As neuroticism and MDD share genetic aetiology (Jardine et al., 1984, Kendler 
et al., 1993), causality cannot be inferred here, although the associations reported do make a significant 
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contribution to the literature. Because neuroticism is a stable trait and MDD is a disease with a given age of 
onset, we can use neuroticism to predict an individual‘s risk for depression, without needing to infer causality. 
 
In conclusion, this study fails to demonstrate that intelligence confers protection to clinical MDD in those with 
high neuroticism. However, in both samples, a modest interaction was found in which higher intelligence 
appears to ameliorate the detrimental association between neuroticism and psychological distress. It would be 
useful to determine this relationship prospectively in a sample where incident cases of MDD can be identified. 
An important corollary of this work may inform risk and resilience mechanisms in MDD. Future studies to 
disentangle the mechanisms driving depression are an important next step in further elucidating the aetiology of 
the disorder. 
 
3.9. Chapter conclusions 
This study confirms previous reports which suggest that neuroticism is a risk factor for both psychological 
distress and depression. It also demonstrates that intelligence can mitigate the detrimental effects of neuroticism 
in eliciting unpleasant thoughts and feelings at sub-threshold levels, but fails to confer protection against clinical 
depression. However, whilst g was found to act as a protective factor in this study, its effect sizes were small 
which suggests that other factors are likely to be more important in conferring protection, or mitigating risk, of 
mental health disorders. These results also indicate that risk and resilience mechanisms are of equal importance 
to examine in depression research as they may elicit independent and divergent effects on mental health 
outcomes. Furthermore, given the robust associations between neuroticism and mental health, and resilience and 
indices of mental health, it is important to understand the mechanisms underlying these associations. This work 
has laid the foundation for the following chapters of this thesis, where efforts were made to specifically examine 
the associations between risk and resilience mechanisms in depression, in addition to examining the architecture 

























In Chapter 2, the three core components of psychological resilience were introduced: adversity, positive 
adaptation, and protective factors. It is important that any study investigating resilience incorporates these 
fundamental components as without adversity or risk, an individual cannot demonstrate the ability to ‗bounce 
back‘. Furthermore, as indicated in Chapter 3, the role of protective factors is important to examine as they can 
ameliorate the negative effects of adversity/risk on mental health outcomes, and may represent a central 
mediating mechanism in resilience to MDD. At present, few datasets are specifically designed to examine 
psychological resilience, and as such our knowledge of the concept remains in its infancy. In order to fully 
elucidate resilience mechanisms and aetiology, it would be preferable to have access to a dataset that contains 
measures of MDD risk, adversity, mental health incidence, and putative resilience factors such as coping style. 
Moreover, a dataset which contains a quantitative measure of resilience, in addition to variables which 
specifically assess adversity, positive adaptation and protective factors would be most optimal. 
 
This chapter introduces a new resource which was designed specifically to investigate psychological resilience. 
In re-contacting participants from the Generation Scotland: Scottish Family Health Study, this new dataset may 
enable researchers to prospectively predict which individuals are most likely to be resilient to MDD. Such 
predictions can be made from the repeated assessment of MDD and psychological distress. Furthermore, this 
dataset provides researchers the opportunity to assess measures directly related to resilience such as negative life 
events and coping style. Most importantly, this dataset includes a quantitative self-report measure assessing an 
individual‘s ability to ‗bounce back‘ from adversity which will enable researchers to investigate psychological 
resilience in a multitude of ways. This new dataset is summarized, below, in the manuscript entitled ‗Cohort 
Profile: Stratifying Resilience and Depression Longitudinally (STRADL): A questionnaire follow-up of the 
Generation Scotland: Scottish Family Health Study (GS:SFHS)‘ which has been published in the International 
Journal of Epidemiology. Whilst the funding application leading to the generation of this dataset was conceived 
by senior members of Generation Scotland committee, as first author for the publication I was involved in 
discussions around the development of these questionnaires, and I was responsible for quality control of the raw 
data and subsequent scoring of questionnaire items. Furthermore, I performed all data analysis and wrote the 
manuscript for publication. To acknowledge the contributions of co-authors, ―we‖ will be used instead of ―I‖ 
throughout this chapter. 
 
4.2 Paper: Cohort Profile: Stratifying Resilience and Depression Longitudinally (STRADL): A 
questionnaire follow-up of the Generation Scotland: Scottish Family Health Study (GS:SFHS). 
 
4.3. Why was the cohort set up? 
Common health conditions such as heart disease, stroke and depression are a common cause of chronic suffering 
and economic burden worldwide (Smith et al., 2013). Scotland has a high prevalence of these conditions, and 
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because of its comparatively stable population (Scottish Government, 2010), it provides a useful citizenry to 
study their prevalence and impact. Generation Scotland (GS) is a multi-institutional, cross-disciplinary 
collaboration aiming to promote research into genetics and healthcare throughout Scotland (Generation 
Scotland). Between 2006-2011 GS undertook its first major study – Generation Scotland: Scottish Family 
Health Study (Smith et al., 2013, Smith et al., 2006) (GS:SFHS). This large, family-based intensively-
phenotyped and genotyped population cohort was designed to examine a diverse range of illnesses such as those 
aforementioned. The work of GS is especially important to epidemiological research as it provides a means of 
separating genetic and shared environmental contributions to common non-communicable diseases. 
Furthermore, the ability to re-contact GS participants and obtain broad consent for future use of their data and 
samples is especially valuable for prospective studies associated with health outcomes.  
 
In 2015, a strategic award by the Wellcome Trust provided funding for ‗STRADL: Stratifying Resilience and 
Depression Longitudinally‘. This project aimed to re-contact participants from GS:SFHS for a further 
assessment of mental health, specifically depression. Major Depressive Disorder (MDD) is a leading cause of 
global disease burden with a lifetime prevalence of approximately 10% (Kessler et al., 2003, Levinson, 2006). 
In coming decades, the prevalence and impact of depression will likely increase (Smith et al., 2006) making the 
understanding of its aetiology of substantial importance to public health. STRADL was designed to investigate 
the aetiology of depression and its stratification as it is hypothesised that the diagnosis may group together 
several causally distinct but symptomatically related syndromes (Kessing, 2007). The increased kinship among 
STRADL participants created a rich dataset to conduct genetic studies of MDD aetiology in addition to 
examining the complex genetic and environmental interactions which may increase risk for different depression 
phenotypes.  
 
STRADL was also designed to investigate psychological resilience (Luthar, 2006, Luthar et al., 2000, Luthar et 
al., 2006) – the ability to ‗escape‘ psychopathology despite exposure to known risk factors. Whilst the 
investigation of resilience may be expected to reveal similar results to studying MDD itself, it has the potential 
to elucidate protective factors in MDD, even in at-risk individuals. Indeed, examining the variability in response 
to known MDD risks may not just further our understanding of MDD but a better understanding of resilience 
mechanisms may also inform future interventions long before the development of the illness (Fergus and 
Zimmerman, 2005). Ultimately, the work of STRADL has the potential to identify causal mechanisms and 
pathways of depression sub-types and elucidate mechanisms which give rise to better than expected adjustment. 
 
4.4. Who is in the cohort? 
The original GS:SFHS protocol and cohort characteristics has been described extensively elsewhere (Smith et 
al., 2013, Smith et al., 2006). Between 2006 and 2011, 24,084 participants were extensively phenotyped in 
addition to providing DNA samples for whole-genome genotyping. GS:SFHS was largely female (59%), and 
generally healthier and wealthier than the Scottish population.  
 
STRADL sought to recruit GS:SFHS participants for a follow-up assessment of mental health and resilience (N 
= 24,084). Individuals were eligible to participate if they had taken part in GS:SFHS, had a Community Heath 
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Figure 4.1. STRADL recruitment flow diagram 
Initially took part in GS:SFHS 
(N = 24,084) 
Must have a Community Health 
Index (CHI) number 
(N = 21,992) 
Must have given consent for 
 re-contact 
(N = 23,581) 
Eligible for re-contact 
(N = 21,525) 
Send questionnaire booklet 
(N = 21,525) 
Completed online version 
(N = 785) 
Returned paper copy 
(N = 8,833) 
STRADL respondents 
(N = 9,618) 
Index (CHI) number, were alive and living in Scotland, and had given consent for re-contact. A total of 21,525 





















Study packages were sent to potential participants (N = 21,525) that consisted of a study invitation letter, 
detailed information sheet and a paper booklet containing the STRADL questionnaires. Study packages were 
mailed by an independent party. Participants were given the option to complete the questionnaires on paper and 
return them via Freepost envelope or use a given URL link for online submission. The opportunity to return an 
email address for further contact was also provided. 
 
'Broad' consent was obtained from participants permitting the use of their data for ‗future medical research into 
health, illness and medical treatment‘ without further specification. Participants were informed their data would 
remain anonymous and be added to that already held by GS. 
 
A total of 9,618 participants responded (45%) at follow-up. A total of 2,460 families (N = 7,158 individuals) of 
between 2-18 family members and 2,460 unrelated individuals formed the STRADL cohort. The majority 
completed the paper version of the questionnaire (N = 8,833), and 8% completed online (N = 785). Henceforth, 
individuals who participated in STRADL will be referred to as ‗respondents‘ and those who did not reply will 
be referred to as ‗non-respondents‘. 
 
All components of STRADL received formal, national ethical approval from the NHS Tayside committee on 
research ethics (reference 14/SS/0039).  
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Whilst age and sex information were collected in STRADL, all other demographic data were obtained from 
GS:SFHS (Table 4.1). The STRADL cohort was predominately female (62%) and were older (Mean = 50.48, 
SD = 13.41) than non-respondents (Mean = 44.28, SD = 15.70, t(21457) = -31.25, p < .001, Cohen‘s d = .42) at 
baseline. STRADL respondents were from less socio-economically deprived areas compared to non-respondents 
(t(19812) = -15.15, p < .001, Cohen‘s d = .21) in the Scottish Index of Multiple Deprivation 2009 (SIMD) 
(Payne and Abel, 2012). The STRADL cohort was generally healthier and wealthier, with a different age–sex 
profile in comparison to GS:SFHS, although important similarities were apparent (Table 4.1). Whilst STRADL 
may not be truly representative of the Scottish population, the sample includes data on participants from all 
socio-economic status strata. 
 
Table 4.1. Some baseline comparisons between STRADL respondents and non-respondents and full baseline 
sample (GS:SFHS) 
 Respondents 
(N = 9,618) 
Non-respondents 
(N = 11,907) 
GS:SFHS Total 
(N = 21,525) 
Median age (years)    
          Male 54 43 48 
          Female  52 45 48 
Gender (% female) 62 57 59 
Employment (those aged up to 75 years) (%)    
          Unemployed 4 5 5 
          Retired 18 13 15 
Employed (full or part-time, or self-employed) 71 71 71 
Education (%)    
          Degree 37 28 32 
          No qualification 7 9 8 
Annual income > £30,000 (%) 63 57 60 
SIMD 4123 (1777) 3733 (1875) 3910 (1842) 
Abbreviations: STRADL, Stratifying Resilience and Depression Longitudinally; GS, Generation Scotland; 
GS:SFHS, Generation Scotland: the Scottish Family Health Study; SIMD, the Scottish Index of Multiple 
Deprivation 2009 
With the exception of age and SIMD, values represent percentage 
SIMD represents Mean rank (SD) 
 
 
4.5. What has been measured? 
A summary of all data collected and its completeness is shown in Table 4.2. All data were anonymised using a 
barcode system which linked with a unique participant identification number at the time of data analysis. Paper 
questionnaires were scanned into an electronic database with detailed in-built validity checks.  
 
Although data collection was largely cross-sectional, repeated measures of GS:SFHS measures were collected 
which enabled longitudinal examination. Pearson's chi-squared (χ²) tests were conducted to illustrate group 
differences for categorical data during GS:SFHS. As an alternative to the independent t-test, comparisons 
between respondents and non-respondents at baseline are reported using the Mann–Whitney–Wilcoxon (U) test. 
Wilcoxon Signed Rank (W) tests have been reported for differences between respondents across GS:SFHS and 
STRADL as a nonparametric test equivalent to the dependent t-test. Calculations for group differences and 
changes over time have ignored the relatedness of the sample, which will be appropriately controlled for in 
future publication of the data. These differences are shown in Table 4.3.  
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Table 4.2: Summary of phenotype data available, and percentage providing valid/useable data (N = 9,618) 
  Phenotype % 
    
1.  Demographics  
 a. Age 100 
 b. Sex 100 
 c. Email address 79.99 
    
2.  Medical History  
 a. Stoke or mini stroke (TIA) 98.55 
 b. Heart attack or angina 98.44 
 c. Other heart disease 98.16 
 d. Pains in leg muscles 98.07 
 e. Diabetes (blood sugar problems) 98.54 
 f. High blood pressure 98.47 
 g. High blood cholesterol 98.03 
    
3.  Brief Resilience Scale (BRS) 98.00 
    
4.  List of Threatening Experiences (LTE) 99.00 
    
5.  Composite International Diagnostic Interview – Short Form (CIDI-SF) 97.08 
    
6.  General Health Questionnaire-28 (GHQ-28) 93.94 
 a. GHQ somatic 98.09 
 b. GHQ anxiety 98.52 
 c. GHQ social dysfunction 98.53 
 d. GHQ depression 95.96 
    
7.  Alcohol and tobacco consumption  
 a. Have you ever smoked tobacco? 99.12 
 b. Are you a current smoker? 46.20 
 c. If yes, how many cigarettes do you smoke in an average week? - 
 d. If yes, how many cigars do you smoke in an average week? - 
 e. If yes, how many 25g packets of tobacco do you smoke in an average week? - 
 f. Do you currently drink any alcoholic drinks? 98.22 
 g. Have you ever felt you should cut down on your drinking? 80.06 
 h. Have people annoyed you by criticising your dinking? 80.13 
 i. Have you ever felt bad or guilty about your drinking? 80.06 
 j. Have you ever had a drink first thing in the morning to steady your nerves or to get rid of a 
hangover? 
80.14 
 k. In an average week, how many units of alcohol do you consume? 79.67 
    
8.  Coping Inventory for Stressful Situations (CISS)  
 a. Task-oriented coping 93.37 
 b. Emotion-oriented coping 94.93 
 c. Avoidance-oriented coping 94.30 
 d. Distraction 95.47 
 e. Social Diversion 96.22 
    
 
 
4.5.1. Substance Use 
At baseline, 17% of all participants smoked although respondents were less likely to smoke (13%), compared to 
non-respondents (21%) (χ²(1) = 260.58, p < .001, r = 0.11). At follow-up, the percentage of respondents 
smoking increased to 17% (χ²(1) = 1563.60, p < .001, r = 0.60).  
 
At baseline, 90% of participants drank alcohol with respondents more likely to drink alcohol than non-
respondents (χ²(1) = 5.23, p = 0.02, r = 0.02). Respondents consumed less units per week (Mean = 9.64, SD = 
10.79) than did non-respondents (Mean = 10.32, SD = 12.25) at baseline, (t(13221) = 3.39, p < .001, Cohen‘s d 
= 0.06) although this difference was small in magnitude. The number of respondents who drink alcohol 
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decreased at follow-up (χ²(1) = 2575.7, p < .001, r = 0.53). Respondent alcohol consumption substantially 
increased at follow-up (W = 3149600, p < .001), although extreme values were reported (Mean = 13.91, SD = 
22.42, Range = 0 - 914). Respondent‘s alcohol consumption was moderately correlated between time points (r = 
0.50).  
 
Table 4.3. Repeated measures between respondents and non-respondents during GS:SFHS (baselines) and 
STRADL (follow-up) 
 GS:SFHS STRADL 
 STRADL 
Non-respondents 
(N = 11,907) 
STRADL 
Respondents 
(N = 9,618) 
Respondents 
(N = 9,618) 
Currently smoke (%) 21 13 * 17 ** 
Currently drink (%) 90 91 * 80 ** 
Alcohol units per week 10.3 (12.3) 9.7 (10.8) * 13.9 (22.4) ** 
Meets SCID criteria for MDD (%) 13 13 - 
Meets CIDI-SF criteria for MDD (%) - - 16 
Meets CIDI-SF criteria for Bipolar Disorder (%) - - 1.3 
Meets CIDI-SF criteria for hypomanic episode (%) - - 0.4 
Total GHQ score 16.4 (9.1) 15.4 (8.4) * 16.9 (9.3) ** 
GHQ depression score 0.97 (2.4) 0.80 (2.2) * 1.0 (2.2) ** 
GHQ anxiety score 4.0 (3.8) 3.6 (3.5) * 4.4 (4.2) ** 
Abbreviations: GS, Generation Scotland; GS:SFHS, Generation Scotland: the Scottish Family Health Study; 
STRADL, Stratifying Resilience and Depression Longitudinally; SCID, Structured Clinical Interview for DSM-
IV; MDD, Major Depressive Disorder; CIDI-SF, Composite International Diagnostic Interview – Short Form; 
GHQ, General Health Questionnaire 
Unless denoted by (%), results represent mean (SD) 
GHQ scores calculated using the Likert method 
** Significantly different from non-respondents in Wave 1 at p < .05 
** Significantly different from respondents in Wave 2 at p < .05 
 
 
4.5.2. Mental Health Assessment 
GS:SFHS participants were screened for a lifetime history of Major Depressive Disorder (MDD) using the 
Structured Clinical Interview for DSM-IV Disorders (SCID) (First et al., 2002). Whilst the SCID has the 
potential to make inferences on an array of Axis I disorders, only case/control classifications for MDD were 
ascertained. The threshold for lifetime prevalence of MDD follows Diagnostic and Statistical Manual of Mental 
Disorders (American Psychiatric Association, 2003) (DSM) criteria. Where either symptoms of either depressed 
mood or anhedonia were endorsed a minimum of four further symptoms must also be endorsed and their clinical 
significance confirmed (ie. symptoms lasting nearly all day, every day for a minimum period of two weeks).  
 
STRADL participants completed the Composite International Diagnostic Interview – Short Form (CIDI-SF) 
(Kessler et al., 1998). The CIDI-SF is a self-report questionnaire measure of psychiatric symptoms developed 
from the larger CIDI by the World Health Organization (Robins et al., 1988) according DSM-IV (American 
Psychiatric Association, 2003) criteria. The CIDI-SF used a stem-branch logic in which two symptomatic 
screening questions (symptoms of depressive mood or anhedonia) must be endorsed and reach clinical 
significance (lasting nearly all day, every day for two weeks or more). A minimum of four other symptoms must 
also be endorsed in addition to at least one screening question. Respondents who meet criteria for lifetime 
history of MDD reliably meet full diagnostic criteria with excellent accuracy if given the long version of CIDI 
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(Kessler et al., 1998). As the CIDI-SF can be completed in a relatively short period (approximately ten minutes), 
it is a scalable and acceptable measure for epidemiological studies. 
 
At baseline, an identical proportion of respondents (13%) and non-respondents (13%) met criteria for a lifetime 
history of MDD as established using the SCID, (χ²(1) = 0.55, p = .457, r = 0.01). In STRADL, 16% of 
respondents met the CIDI-SF criteria for lifetime MDD (N = 1,506) of which 16% reported being currently 
depressed. Lifetime history of MDD was moderately correlated between the two measures (r = 0.30).  
 
4.5.3. Psychological distress 
The General Health Questionnaire-28 (GHQ-28) (Goldberg, 1978) was administered across time-points as a tool 
used to identify milder psychiatric problems in the general population (Snaith, 1987). As psychological distress 
represents a cluster of emotional symptoms linked to depression, the GHQ-28 was used alongside clinical 
measures to make better distinctions between syndrome and sub-threshold symptoms (Goldberg and Hillier, 
1979, Kroencke et al., 2001). Responses were scored using the Likert method (0-1-2-3) whereby higher scores 
represent higher levels of psychological distress. Individual domain scores gave information on somatic 
symptoms, anxiety, social dysfunction and depression.  
 
Non-respondents experienced more psychological distress at baseline than respondents (U = 44888000, p < 
.001) although levels of psychological distress increased over time in STRADL respondents (W = 9713600, p < 
.001). Total GHQ-28 score of respondents across time-points was moderately correlated (r = 0.46). 
 
Symptoms of GHQ depression appeared greater in non-respondents than respondents at baseline, (U = 
44607000, p < .001). GHQ depression scores increased in respondents between time-points (W = 1409700, p < 
.001). GHQ depression scores were moderately correlated (r = 0.46) in respondents between assessments. 
 
Symptoms of GHQ anxiety were higher in non-respondents than respondents at baseline, (U = 45042000, p < 
.001). Anxiety scores increased in respondents between time-points (W = 8937100, p < .001), and were 
moderately correlated (r = 0.45). 
 
4.5.4. New measures 
Questionnaire measures of psychological resilience (Smith et al., 2008), coping style (Endler and Parker, 1990), 
threatening life experiences (Brugha et al., 1985) and medical conditions were obtained in STRADL, and are 
summarised in Tables 4.4, 4.5 and 4.6.  
 
4.5.4.1. Brief Resilience Scale 
The Brief Resilience Scale (Smith et al., 2008) (BRS) assessed the ability to ‗bounce back‘ from stress. Six 
questions were answered on a five-point scale from ―Strongly Disagree‖ to ―Strongly Agree‖. A total score was 
calculated as the mean of the six items, with appropriate reverse scoring of odd-numbered questions. The BRS 
has previously shown good internal consistency and test-retest reliability (Smith et al., 2008).  
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Table 4.4 Respondent results of resilience, coping style and psychological distress testing in STRADL 
 n Theoretical maximum score Mean SD Median Range 
BRS 9411 5 2.99 0.36 3 1-5 
CISS       
    Task-oriented  8980 80 54.33 12.28 56 16-80 
    Emotion-oriented 9130 80 37.61 12.57 37 16-80 
    Avoidant-oriented 9070 80 39.41 10.52 40 16-80 
    Distraction-oriented 9182 40 17.46 6.01 17 8-40 
    Social Diversion-oriented 9254 25 14.33 4.84 15 5-25 
GHQ-28       
    GHQ-aᵃ 9432 21 4.58 3.76 3 0-21 
    GHQ-bᵃ 9476 21 4.37 4.17 3 0-21 
    GHQ-cᵃ 9477 21 7.60 2.48 7 0-21 
    GHQ-dᵃ 9229 21 1.01 2.24 0 0-15 
    GHQ total 9035 84 16.88 9.28 14 0-65 
Abbreviations: STRADL, Stratifying Resilience and Depression Longitudinally; SD, Standard deviation; BRS, 
Brief Resilience Scale; CISS, Coping Inventory for Stressful Situations; GHQ-28, General Health 
Questionnaire-28 
ͣ GHQ-28 domain scores give information on: (a) somatic symptoms; (b) anxiety/insomnia; (c) social 
dysfunction; and (d) depression 
GHQ scores calculated using the Likert method 
 
4.5.4.2. Coping Inventory for Stressful Situations 
The Coping Inventory for Stressful Situations (CISS) (Endler and Parker, 1990) was a self-report questionnaire 
measuring three coping style scales: task-oriented, emotion-oriented and avoidance-oriented coping. Two sub-
scales of avoidance-oriented coping were also derived: distraction and social diversion. Each item was rated on 
a five-point scale from (1) ―Not at all‖ to (5) ―Very much‖. The CISS has proven a robust measure of assessing 
situation-specific coping strategies, with a stable factor structure and high construct validity (Cosway et al., 
2000, Endler and Parker, 1990). 
 
Table 4.5. Results from respondents completing the List of Threatening Experiences summarizing the number 
of individuals who endorsed each event and their ratings of its impact 
 n¹ n² Theoretical maximum score Mean SD Median Range 
Serious injury or assault to yourself 794 783 3 2.18 0.73 2 1-3 
Serious injury or assault to a close 
relative 1880 1831 3 2.19 0.73 2 1-3 
Did a parent, spouse, child or sibling die 1145 1126 3 2.40 0.71 3 1-3 
Close family friend or other relative die 1841 1798 3 1.75 0.74 2 1-3 
Separation due to marital difficulties or 
break off a steady relationship 427 425 3 2.27 0.73 2 1-3 
Serious problem(s) with close friend, 
neighbour or relative 1059 1047 3 2.13 0.68 2 1-3 
Made redundant or sacked from job 301 292 3 1.82 0.81 2 1-3 
Seeking work unsuccessfully for more 
than one month 367 342 3 1.76 0.73 2 1-3 
Major financial crisis (such as losing 
three months income) 436 413 3 2.11 0.79 2 1-3 
Problems with the police involving court 
appearance 111 108 3 2.15 0.83 2 1-3 
Something of value lost or stolen 372 361 3 1.91 0.76 2 1-3 
Yourself or partner gave birth 393 353 3 2.71 0.61 3 1-3 
Abbreviations: SD, Standard deviation 
n¹ - The number of participants who indicated they experienced the event within the last six months 
n² - The number of individuals who subsequently gave criterion contextual threat ratings of the event 
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4.5.4.3. List of Threatening Experiences 
The List of Threatening Experiences (LTE) (Brugha et al., 1985) was a self-report measure consisting of 12 
common and threatening life events that may have occurred in the six months prior to completion. For each 
threatening event endorsed, criterion contextual threat ratings are measured on a scale from 3 (―Very bad‖) to 1 
(―Not too bad‖). The LTE has been shown to have excellent test-retest reliability and high sensitivity (Brugha 
and Cragg, 1990).  
 
Table 4.6. Self-reported diagnosis of common illnesses among respondents 
 n % 
Stoke or mini stroke (TIA) 302 3 
Heart attack or angina 466 5 
Other heart disease 382 4 
Pains in leg muscles when walking or in bed at night 1703 18 
Diabetes (blood sugar problems) 575 6 
High blood pressure 2257 24 
High blood cholesterol 1887 20 
 
4.6. How often have they been followed up? 
STRADL is a mental health questionnaire follow-up of GS:SFHS. Although data collection was cross-sectional 
STRADL becomes a longitudinal cohort because of NHS data linkage using Community Health Index (CHI) 
numbers which are allocated to every individual registered with a GP in Scotland. The ability to link with 
routinely collected NHS data will allow validation of the self-reported illness recorded in the study, and provide 
information on clinical endpoints and follow-up. Furthermore, the utilisation of NHS linkage converts this two-
phase cohort study into a potentially lifelong study of resilience and depression. Future parts of the STRADL 
study will include DNA methylation analysis and depression-focussed neuroimaging measures of brain 
structure, function and connectivity. 
 
As with any epidemiological study, a key question is often whether consenting participants are representative of 
the population from which they are drawn. As indicated in Table 4.1, STRADL participants appear to be an 
older, wealthier and a more affluent, largely female subset of GS:SFHS. This is not surprising as these 
characteristics are associated with higher response rates to follow-up surveys (Curtin et al., 2000, Koloski et al., 
2013). Whilst results from STRADL may under-represent what would be reflected in the general Scottish 
population, the cohort size results in large amounts of data which represent the full adult spectrum of ages, sex 
and demography.  
 
Attrition between time-points has been described in Figure 4.1. It is possible that the response to STRADL 
(45%) is due to a response bias whereby individuals with mental health difficulties were more likely to respond 
to a mental health questionnaire when the purpose has been clearly communicated. Whilst the use of paper 
questionnaires enabled many near-complete participant responses, it is possible that the majority of potential 
participants forgot to complete or return their questionnaire booklets.  
 
It is worth noting the disparity in the proportions of paper and online responses. Baseline differences between 
paper and online respondents are presented in Table 4.7. Several reasons have been hypothesized for these 
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differences. The older demographic of STRADL may have oversampled GS:SFHS participants who did not 
have access to a personal computer with internet access, or those that were not confident or willing to complete 
an online survey. Furthermore, the URL provided in the written letter was also very long (53 characters) and it is 
possible that manually typing a long URL in a browser‘s address bar may have been intimidating or 
inconvenient for many respondents, especially if IT knowledge was limited. 
 
Table 4.7. Some baseline (GS:SFHS) comparisons between STRADL paper and online respondents 
 Paper respondents 
(N = 8,833) 
Online respondents 
(N = 785) 
Median age (years)   
          Male 55 50 
          Female 52 43 
Gender (% female) 63 46 
Employment (those aged up to 75 years) (%)   
          Unemployed 4 3 
          Retired 16 8 
          Employed (full or part-time, or self-employed) 73 81 
Education (%)   
          Degree 36 47 
          No qualification 7 2 
Annual income > £30,000 62 74 
SIMD 4115 (1777) 421409 (1781) 
Abbreviations: GS:SFHS, Generation Scotland: Scottish Family Health Study; STRADL, Stratifying Resilience 
and Depression Longitudinally; SIMD, the Scottish Index of Multiple Deprivation 2009 
With the exception of age and SIMD, values represent percentage 
SIMD represents Mean (SD) 
 
 
4.7. What has it found? Key findings and publications 
Baseline differences between GS:SFHS and STRADL are summarized above (Tables 4.1 and 4.3), whilst 
differences between online and paper respondents are given in Table 4.7. This cohort represents a new and 
potentially valuable data resource to examine incident depressive symptoms, longitudinal outcomes and 
mechanisms of psychological resilience. No articles have yet been published with this data but the power of this 
resource is extensive. Genomic and pedigree based approaches to this data will enable us to estimate trait 
heritability and the contribution of shared and non-shared environmental effects to depression (Zeng et al., 
2016). This data may provide clues to how people can modify behaviour to reduce their risk of depression and 
psychological distress. Furthermore, STRADL will allow us to conduct genetic epidemiological analysis on 
indices of mental health, building upon existing data held by GS. 
 
4.8. What are the main strengths and weaknesses?   
The STRADL cohort includes important phenotypes to allow population-based genetic and epidemiological 
research on the stratification of MDD and resilience. The strengths of this cohort lie in the repeated assessment 
of mood disorders, psychological distress and substance use, making it a valuable dataset to investigate the 
pathogenic mechanisms that underlie psychopathology in addition to making longitudinal predictions on 
depression and resilience. As data can be linked anonymously to NHS records STRADL can be converted from 
a cross-sectional analysis into a longitudinal cohort covering a wide range of clinically-relevant outcomes. 
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Furthermore, the availability for longitudinal sampling is of benefit in obtaining repeated measures of mental 
health and resilience, that might be missed by a single measure (Toombs, 1990, von Peter, 2010). 
 
Further, specific limitations of this cohort warrant consideration. Firstly, like other population cohorts such as 
UK Biobank (Allen et al., 2012, Sudlow et al., 2015), STRADL participants were more likely to be graduates 
and to come from less socio-economically disadvantaged areas. Nevertheless, participants from all 
socioeconomic strata were represented in both baseline (GS:SFHS) and follow-up samples. 
 
Differences in prevalence rates of MDD were found in STRADL (using the CIDI-SF), compared to the use of 
the SCID at baseline. This may be because the SCID is administered face-to-to-face by trained researchers, and 
may have better psychometric properties than the self-reported CIDI-SF (Ekselius et al., 1994). However, 
previous research suggests that the diagnostic classifications obtained using the CIDI-SF accurately reflect those 
made in the larger Composite International Diagnostic Interview (Kessler et al., 1998). In future, the CIDI-SF 
will be compared to the SCID and to linked NHS records so that a comparison of each technique can be made 
and potential issues of recall bias can be overcome.  
 
Overall, the GS:SFHS follow-up (STRADL) represents a valuable resource to investigate the stratification of 
depression and mechanisms of psychological resilience in a large, family-based, cohort.  
 
4.9. Chapter conclusions   
This chapter introduced a new resource specifically designed to investigate psychological resilience. The 
STRADL dataset has several important features that are of particular benefit when studying resilience. Firstly, 
the inclusion of the List of Threatening Experiences provides a measure of recent adversity, a key component 
for resilience. Secondly, in re-assessing both depression and psychological distress this dataset enables 
researchers to potentially make predictions on who is most likely to be resilient by computing the residual for 
actual and predicted symptoms given the number of life events each individual has experienced. Such a method 
would encompass two key facets of resilience; adversity and positive adaptation. Finally, this dataset includes a 
quantitative measure of psychological resilience that assesses an individual‘s ability to bounce back from 
adversity. Specifically, the Brief Resilience Scale is framed in regard to the negative events an individual has 
experienced and so negates the necessity to assess adversity simultaneously. Furthermore, the Brief Resilience 
Scale assumes a trait-based conceptualisation of resilience which infers it is a stable concept over time. Future 
follow-up of this cohort aims to re-assess resilience using the same methodology and so future investigations 
can determine if resilience is a stable trait, or a dynamic process which varies temporally. The Brief Resilience 
Scale will be used in the preceding chapters as a measure of psychological resilience in an attempt to elucidate 














As discussed in Chapter 1, Major Depressive Disorder (MDD) has a complex genetic aetiology. Current 
research suggests that the disorder is likely to be polygenic, whereby genetic vulnerability to MDD is resultant 
from the cumulative effect of many genetic loci which together have a stronger effect on MDD risk than any one 
individual locus (Hyman, 2014). Such polygenic risk has been confirmed in several studies of MDD (Hyman, 
2014, Levine et al., 2014, Ripke et al., 2013) suggesting that genetic liability for the disorder increases risk for 
disease onset. However, despite greater liability for MDD, not all individuals go on to develop the disorder, as 
illustrated in family studies of depressed patients which estimate heritability at approximately 37% (Geschwind 
and Flint, 2015, Sullivan et al., 2000). Such findings demonstrate that genetic factors do not deterministically 
result in MDD and indicate that there may be mitigating or mediating factors that influence risk or protection to 
MDD in individuals genetically susceptible to the disorder. 
 
Two factors that may underlie risk and protection in MDD are neuroticism and resilience. Preceding chapters of 
this thesis have highlighted the risk-conferring effects of neuroticism, and demonstrated that high levels of 
neuroticism predispose individuals to increased risk for MDD (Kotov et al., 2010, Malouff et al., 2005, Navrady 
et al., 2017b). Resilience, however, has been found to negatively associate with MDD risk (Campbell-Sills et 
al., 2006, Wingo et al., 2013). Whilst neuroticism is characterised by negative emotionality, resilience is typified 
by a range of positive emotions (Amstadter et al., 2016, Campbell-Sills et al., 2006) which could potentially 
reflect independent mechanisms between risk and protection. However, as discussed in Chapter 2, it has been 
argued that neuroticism and resilience may represent opposite ends of the same underlying trait and as such 
reflect a continuum of susceptibility to MDD whereby positive emotionality confers reduced risk and negative 
emotionality confers increased risk. Such an assertion is supported by a longitudinal twin study which revealed a 
strong negative phenotypic association between neuroticism and resilience and approximately two-thirds 
overlap in  their genetic aetiology (Amstadter et al., 2016). Furthermore, an additional study found a strong 
negative genetic correlation between neuroticism and positive affect which has been indirectly related to 
resilience (Weiss et al., 2016). However, cross-sectional research has revealed an incremental validity of 
resilience which captures a better prediction of psychiatric symptoms following adversity than does neuroticism 
alone (Simeon et al., 2007). Specifically, resilience was found to moderate the relationship between childhood 
emotional neglect and psychiatric symptoms to a greater extent than did the predictive value of neuroticism 
alone which suggests that neuroticism and resilience may be independent mechanisms in MDD aetiology.  
 
It is important to identify the pathways through which genetic liability for MDD associates with the disorder, as 
genetic vulnerability does not always result in MDD. Research suggests that neuroticism and resilience could 
potentially mediate the association between genetic risk and MDD and as such it is important empirical question 
to address. This chapter introduces an original study which aims to investigate if neuroticism and resilience are 
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downstream mediators of genetic risk for depression. Furthermore, this chapter aims to examine if neuroticism 
and resilience are independent mechanisms or represent opposite ends of the same underlying construct. 
Building upon the work presented in Chapter 3, this chapter will also examine if consistent effects are found 
across clinical and self-reported measures of MDD, as divergent effects were found previously. This study is 
summarized, below, in the manuscript entitled ‗Genetic risk of Major Depressive Disorder: the moderating and 
mediating effects of neuroticism and psychological resilience on clinical and self-reported depression‘ which has 
been published in Psychological Medicine. As first author for this manuscript, I conceived the experimental 
design, performed all data analysis and wrote the manuscript for publication. To acknowledge the contributions 
of co-authors, ―we‖ will be used instead of ―I‖ throughout this chapter. 
 
5.2. Paper: Genetic risk of Major Depressive Disorder: the moderating and mediating effects of 
neuroticism and psychological resilience on clinical and self-reported depression 
 
5.3. Abstract 
Background: Polygenic risk scores (PRS) for depression correlate with depression status and chronicity, and 
provide causal anchors to identify depressive mechanisms. Neuroticism is phenotypically and genetically 
positively associated with depression, whereas psychological resilience demonstrates negative phenotypic 
associations. Whether increased neuroticism and reduced resilience are downstream mediators of genetic risk 
for depression, and whether they contribute independently to risk remains unknown. 
 
Methods: Moderating and mediating relationships between depression PRS, neuroticism, resilience and both 
clinical and self-reported depression were examined in a large, population-based cohort, Generation Scotland: 
Scottish Family Health Study (N = 4,166), using linear regression and structural equation modelling. 
Neuroticism and resilience were measured by the Eysenck Personality Scale Short Form Revised and the Brief 
Resilience Scale, respectively.   
 
Results: PRS for depression was associated with increased likelihood of self-reported and clinical depression. 
No interaction was found between PRS and neuroticism, or between PRS and resilience. Neuroticism was 
associated with increased likelihood of self-reported and clinical depression, whereas resilience was associated 
with reduced risk. Structural equation modelling suggested the association between PRS and self-reported and 
clinical depression was mediated by neuroticism (43-57%), while resilience mediated the association in the 
opposite direction (37-40%). For both self-reported and clinical diagnoses, the genetic risk for depression was 
independently mediated by neuroticism and resilience.  
 
Conclusions: Findings suggest polygenic risk for depression increases vulnerability for self-reported and clinical 
depression through independent effects on increased neuroticism and reduced psychological resilience. In 
addition, two partially independent mechanisms—neuroticism and resilience—may form part of the pathway of 
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5.4. Introduction 
Major depressive disorder (MDD) is a pervasive and disabling psychiatric condition characterized by periods of 
low mood and anhedonia, with an estimated lifetime prevalence of 16% (Levine et al., 2014). MDD has 
substantial public health implications, with research suggesting the disorder increases mortality risk and 
exacerbates cognitive decline (Ferrari et al., 2013, Reddy, 2010). Depression is substantially heritable (Sullivan 
et al., 2000) and has a complex genetic architecture (Liu et al., 2011, Schulze et al., 2014). Whilst modest 
progress has been made to understand the heterogeneity of genetic risk factors for MDD (Caspi et al., 2003, 
Duncan and Keller, 2011, Wray et al., 2012), genome-wide association studies have indicated that MDD risk is 
influenced by a large number of common allelic variations of small effect rather than specific susceptibility loci 
(Lubke et al., 2012). 
 
A now-commonplace method applied to examine these genetic influences is Polygenic Risk Scores (PRS) 
(Demirkan et al., 2011) which are used as a measure of ―genetic liability‖ associated with a particular phenotype 
(Wray et al., 2008). PRS are founded on the assumption that whereas genetic variants with very small individual 
effects may not meet genome-wide significance thresholds (depending on statistical power), their cumulative 
associations may have a much stronger effect (Wray et al., 2007, 2008). Polygenic vulnerabilities have been 
identified in several psychiatric disorders (Purcell et al., 2009, Ripke et al., 2013). Specifically to MDD, PRS 
have been found to correlate with both the status and chronicity of the disorder (Levine et al., 2014, Ripke et al., 
2013). However, to date, PRS typically account for only 1-2% of variance in MDD (Cross-Disorder Group of 
the Psychiatric Genomics Consortium, 2013, Demirkan et al., 2011, Ripke et al., 2013) suggesting other factors 
are also influencing risk for the disorder.  
 
Personality is frequently linked with vulnerability to psychiatric illness (Fanous and Kendler, 2004), with one of 
the strongest associations being between MDD and neuroticism (Kotov et al., 2010). Neuroticism is a partly-
heritable personality trait characterised by emotional instability, negative emotional response, and stress 
sensitivity (Lahey, 2009). Phenotypically, neuroticism is strongly positively associated with MDD both cross-
sectionally (Chan et al., 2007, Navrady et al., 2017b, Roelofs et al., 2008), and prospectively (Farmer et al., 
2008, Kendler et al., 2006). There is also evidence that neuroticism and depression are strongly genetically 
correlated (Jardine et al., 1984, Kendler et al., 1993). For example, evidence from twin studies indicates that 
neuroticism and MDD share up to two thirds of their genetic variance (Carey and DiLalla, 1994, Fanous et al., 
2002, Hettema et al., 2006). Furthermore, de Moor and colleagues (2015) found that neuroticism and MDD can 
be equally well explained by neuroticism PRS (up to 1.05% variance explained), in addition to being able to 
predict MDD based on neuroticism PRS alone. As neuroticism is a relatively stable trait (Lahey, 2009), it is 
hypothesised that it may act as an indirect measure of later risk for MDD, and as such is an important phenotype 
for MDD genetic studies.  
 
Whereas research into MDD risk has dominated the field, interest in psychological resilience has grown 
substantially over recent decades (Luthar et al., 2006, Russo et al., 2012, Southwick and Charney, 2012). 
Resilience is often described as the positive pole of individual differences in people's susceptibility to MDD, as 
it is widely observed that not all individuals at risk for the disorder become unwell (Alim et al., 2008, Collishaw 
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et al., 2007). Resilience has been related to increased positive and reduced negative affect (Smith et al., 2010), 
which suggests potentially different mechanisms for vulnerability and protection (Fredrickson, 2001). Cross-
sectionally, it was found that individuals scoring higher on self-reported resilience (using The Connor-Davidson 
Resilience Scale questionnaire) reported fewer psychiatric symptoms following childhood emotional neglect 
than did those with lower levels of resilience (Campbell-Sills et al., 2006). Using the same measure, higher 
resilience has been found to mitigate the severity of depressive symptoms in individuals exposed to trauma 
(Wingo et al., 2013). Furthermore, reports suggest that resilience reduces risk for depression in individuals with 
high genetic loading for the disorder (Geschwind et al., 2010, Wichers et al., 2008, Wichers et al., 2007). 
 
Current research suggests a positive association between neuroticism and MDD; self-reported resilience and 
depression show a negative association. However, studies often fail to adequately consider how MDD is 
measured (Adli et al., 2006, Cameron et al., 2011). Whilst moderate associations between clinical and self-
reported measures of MDD suggest the two approaches are interchangeable (Kessler et al., 1998, Rush et al., 
2006), important distinctions between clinical and self-reported depression have been found. Specifically, self-
reported and clinical measures of depression have each been found to provide unique information about the 
disorder not captured by the other (Uher et al., 2012) that may help to elucidate underlying mechanisms (Fava et 
al., 1986, Möller, 2000).  
 
Here, we report a moderation and a mediation analysis of a large population-based cohort (Generation Scotland: 
Scottish Family Health Study) who completed both self-reported and clinical measures of MDD. First, in a 
series of moderation analyses, we investigated whether the association between PRS for MDD and clinical and 
self-reported depression (Levine et al., 2014, Ripke et al., 2013) was moderated by neuroticism or resilience. 
We predicted that neuroticism would be associated with increased likelihood of both clinical and self-reported 
depression, whilst resilience would associate in the opposite direction, in line with previous findings. Second, 
using structural equation modelling, we examined if neuroticism mediates the relationship between PRS for 
MDD and both clinical and self-reported MDD to increase risk for the disorder, and if resilience would mediate 
in the opposite direction. The path models we tested are illustrated in Figure 5.1.  
 
 
Figure 5.1. The theoretical mediation models tested in the present study 
 
 




Participants were sampled from the Generation Scotland: Scottish Family Health Study (GS:SFHS) – a family-
based epidemiological cohort recruited between 2006 and 2011 (Smith et al., 2013, Smith et al., 2006). At 
baseline, participants provided extensive data, including personality measures, a structured interview for clinical 
MDD diagnosis and DNA extraction. In 2014, GS:SFHS participants were re-contacted and asked to take part in 
a follow-up assessment of mental health and resilience (Navrady et al., 2017a), providing a range of 
questionnaire measures including resilience and self-reported MDD. Full details of the initial recruitment and 
follow-up have been given elsewhere (Navrady et al., 2017a, Smith et al., 2013, Smith et al., 2006) and in 
Appendix B. This study includes 4,166 unrelated individuals (Meanage = 56.01, SD = 12.31, Nfemale = 2,634) 
with complete data of interest. 
 
GS:SFHS received ethical approval from the NHS Tayside Committee (reference 05/S1401/89 and 14/SS/0039). 
All participants provided written informed consent.  
 
5.5.2. Study assessments 
DNA was extracted from participants for whole-genome genotyping, the procedures for which have been 
reported extensively elsewhere (Smith et al., 2006, Zeng et al., 2016). Genome-wide genotype data were 
available for all participants in the current study from which polygenic risk scores (PRS) were created. Using 
the genotype data and PRCise software (Euesden et al., 2015), PRS were calculated by computing the genome-
wide sum of trait-associated alleles across genetic loci, weighted by their effect in an independent genome-wide 
association study (GWAS). The GWAS summary statistics used for these PRS were those from the large, 
published meta-analysis of MDD from the Psychiatric Genetics Consortium (PGC MDD29; 130,664 MDD 
cases vs 330,470 controls), although GS:SFHS participants were removed from these summary statistics before 
calculating PRS. Here, we only report findings using a PRS threshold of 0.50 as preliminary analysis indicated 
that this threshold was most predictive of both self-reported and clinical MDD in this sample (see Appendix B).  
 
Neuroticism was assessed using the self-report questionnaire Eysenck Personality Questionnaire Short Form-
Revised (EPQ-SF; (Eysenck, 1991). The neuroticism subsection of the EPQ-SF consists of 12 ‗Yes/No‘ 
questions (e.g., ―Are you a worrier?‖). Scores range from 0 to 12, with higher scores indicative of higher levels 
of neuroticism. This scale has been concurrently validated with other quantitative measures of neuroticism (Gow 
et al., 2005) with high reliability (Eysenck et al., 1985). 
 
Psychological resilience was assessed using the Brief Resilience Scale (BRS; (Smith et al., 2008), a self-report 
questionnaire used to assess an individual‘s ability to ‗bounce back‘ or recover from stress. The BRS consists of 
six statements (e.g., ―I usually come through difficult times with little trouble‖) answered on a five-point scale 
from ―Strongly Disagree‖ to ―Strongly Agree‖. After reverse coding of even-numbered questions, a total 
resilience score was calculated by computing the mean of six questions. The BRS has been found to have a one 
factor structure, demonstrating good internal consistency and test-retest reliability (Smith et al., 2008).  
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Participants were screened for clinical diagnosis of MDD at baseline using the Structured Clinical Interview for 
DSM-IV Axis I Disorders (SCID; First et al., 2002). Diagnosis of MDD followed DSM-IV criteria (American 
Psychiatric Association, 2003); if either symptoms of depressive mood or anhedonia are endorsed, a minimum 
of four further symptoms must also be endorsed. These symptoms must have lasted nearly all day, every day for 
a minimum of two weeks. Interview procedures and quality control protocol have been described elsewhere 
(Fernandez-Pujals et al., 2015). As the interviews were conducted by a trained researcher SCID MDD status can 
be used as a proxy for clinical MDD. In this sample, 664 individuals met criteria for clinical MDD (16%), and 
3,502 were non-MDD cases (84%).  
 
During re-contact, self-reported MDD was assessed using a questionnaire developed by the World Health 
Organization: the Composite International Diagnostic Interview – Short Form (CIDI-SF; (Kessler et al., 1998). 
The CIDI-SF evaluates self-reported MDD according to DSM-IV criteria (American Psychiatric Association, 
2003) and employs a stem-branch logic to eliminate individuals who fail to endorse a minimum of four 
symptoms (in addition to depressed mood and/or anhedonia) with clinical significance. Although the CIDI-SF is 
a self-report measure of MDD, respondents meeting MDD criteria with the CIDI-SF have been shown to 
reliably meet full diagnostic criteria with excellent accuracy if given the full version of the questionnaire 
(Kessler et al., 1998). A total of 1,068 individuals in the mental health follow-up sample met criteria for self-
reported MDD (26%), with 3,098 classified as non-MDD cases (74%).  
 
5.6. Analyses 
All analyses were conducted using R version 3.2.3 (http://www.R-project.org).  
 
5.6.1. Moderation 
We performed generalised linear models to examine the moderating associations of both neuroticism and 
resilience on the relationship between PRS for MDD and clinical and self-reported MDD (SCID and CIDI-SF, 
respectively). As MDD status is a dichotomous variable, we specified a ―binary‖ family with a logit link 
function in the analysis. Three moderation models were computed for each MDD category (self-reported and 
clinical). A basic, first-step model was estimated to examine the validity of the PRS by testing for an association 
between genetic risk for depression and both clinical and self-reported MDD status. In the second step of the 
analysis, an interaction model was fitted to estimate the moderating association of neuroticism (total EPQ-SF 
score) on the contribution of genetic liability to both clinical and self-reported MDD. Another model was then 
fitted to examine the interaction between PRS and resilience (total BRS score) on susceptibility to clinical and 
self-reported MDD. Regression coefficients are reported as odds ratios with 95% confidence intervals. The p-
values presented are raw and uncorrected for multiple testing. All continuous variables have been scaled to have 
a mean of 0 and a standard deviation of 1. As neuroticism and resilience were measured at different time-points, 
neuroticism was controlled for age at baseline (Aget1) and resilience was controlled for age at re-contact (Aget2) 
prior to them entering the moderation models. All models were controlled for four ancestry-informative 
principal components to take account of possible population stratification; results of these associations are 
presented in Appendix B.  
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5.6.2. Mediation 
The structural equation modelling package ‗lavaan‘ (Rosseel, 2012) was used in R to estimate and compare 
models of the types shown in Figure 5.1. Diagonally Weighted Least Squares (DWLS) estimation was used in 
all models to account for MDD being a binary variable. The variance of each latent construct was fixed to 1 so 
as to identify each model. To assess the absolute fit of each model, a range of model-fit indices are reported 
(MacCallum et al., 1996, McQuitty, 2006); Root Mean Square Error of Approximation (RMSEA; values 
indicating good fit <.05), Comparative Fit Index (CFI; values >.95), and Tucker–Lewis index (TLI; values 
>.95). To calculate the percentage mediation in each model we divided the sum of the indirect paths by the total 
variance explained by the model (Rosseel, 2012). For comparison of one- and two-factor models, we performed 
chi-squared tests, as an Akaike Information Criterion (AIC) cannot be computed when using the DWLS method. 
 
As seen in Figure 5.1, four mediation models have been produced each for SCID and CIDI-SF MDD status to 
examine association between PRS and clinical and self-reported MDD, respectively. ‘A‘ models examined the 
mediating effects of neuroticism (estimated as a latent variable using individual EPQ-SF items) on the 
relationship between PRS and MDD. A second set of models (‗B‘) investigated resilience as a latent variable 
indicated by individual BRS items as a mediator between PRS and MDD. ‗C‘ models examined neuroticism and 
resilience as two separate latent mediating variables between PRS and MDD. We also examined the phenotypic 
correlation between these latent variables within the model. Finally, we created a latent variable, named 
‗Neuroticism+Resilience‘, consisting of all individual EPQ-SF and BRS questionnaire items to determine if one 
general factor can better explain the relationship between PRS and clinical and self-reported MDD (‘D‘ models).  
 
5.7. Results 
Descriptive statistics and a correlation matrix are provided in Table 5.1. As illustrated in Table 5.1, resilience 
and neuroticism were moderately negatively correlated (r = -0.48, p < 0.001). Further demographic information, 
a full correlation matrix, and the differences and overlap between clinical and self-reported MDD measures in 
this study are outlined in Appendix B.  
 
5.7.1. Moderation  
5.7.1.1. Validity of the MDD PRS 
Polygenic risk for MDD was found to be associated with increased likelihood of clinical MDD (see Table 5.2). 
A 1SD increase in genetic liability to depression was associated with an increased likelihood of clinical 
depression by an odds ratio of 1.20 ([95% CIs = 1.11, 1.31], p < 0.001). Age was found to be associated with 
clinical MDD, and being female increased clinical MDD likelihood by an odds ratio of 1.71 ([95% CIs = 1.42, 
2.07], p < 0.001). 
 
Similar results were obtained for self-reported MDD, see Table 5.2. Specifically, a 1SD increase in polygenic 
risk for depression increased likelihood of self-reported depression by an odds ratio of 1.18 ([95% CIs = 1.10, 
1.27], p < 0.001). Age had a small negative association with self-reported MDD, whereas being female 
increased self-reporting of depression by an odds ratio of 1.94 ([95% CIs = 1.66, 2.28], p < 0.001). 
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Table 5.1. Correlation Matrix and Descriptive Statistics for baseline age, age at re-contact, sex, resilience, neuroticism, clinical and self-reported MDD status 
 Aget1 Aget2 Sex (F) Resilience Neuroticism SCID CIDI-SF Mean (SD) N (%) 
Aget1 -       50.28 (12.34)  
Aget2 -0.99 ** -      56.01 (12.31)  
Sex (F) -0.09 ** -0.09 ** -      2,634 (63) 
Resilience -0.05 ** -0.05 ** -0.10 ** -    3.52 (0.82)  
Neuroticism -0.14 ** -0.14 ** -0.17 ** -0.48 ** -   3.70 (3.17)  
SCID -0.04 ** -0.04 ** -0.18 ** -0.31 ** 0.36 ** -   664 (16) 
CIDI-SF -0.08 ** -0.08 ** -0.14 ** -0.35 ** 0.29 ** 0.60 * -  1,068 (26) 
Abbreviations: Aget1, Age at baseline; Aget2, Age at re-contact; Resilience, Total score from the Brief Resilience Scale; Neuroticism, Total score from the Eysenck 
Personality Questionnaire Short-Form; SCID, Structured Clinical Interview for DSM-IV Axis I Disorders representing clinical MDD; CIDI-SF, Composite International 
Diagnostic Interview – Short Form representing self-reported MDD 
N.B. All p-values significant at p < 0.01 
Demographic information for Sex represent the number and percentage of females in this sample. Demographic details for SCID and CIDI-SF represent the number and 
percentage of participants meeting criteria for clinical and self-reported MDD, respectively 
All coefficients represent Pearson correlations except those denoted by * which represent the tetrachoric coefficient – resultant from both variables being binary, and those 
denoted by ** which represent point biserial correlations – resultant from binary and continuous variables 
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Table 5.2.  Results of a generalised linear model predicting odds ratios for self-reported and clinical MDD 
status, p value, upper and lower 95% confidence intervals and the Akaike Information Criterion 
MDD 




95% CIs p value AIC 
SCID Aget1 0.99 0.99 1.00 < 0.031 3607.60 
 Sex (F) 1.71 1.42 2.07 < 0.001  
 PRS 1.20 1.11 1.31 < 0.001  
       
CIDI-SF Aget2 0.99 0.98 0.99 < 0.001 4632.80 
 Sex (F) 1.94 1.66 2.28 < 0.001  
 PRS 1.18 1.10 1.27 < 0.001  
       
SCID Age t1 0.99 0.99 1.00 < 0.026 3155.90 
 Sex (F) 1.33 1.09 1.63 < 0.005  
 PRS 1.16 1.05 1.29 < 0.004  
 Neuroticism 2.49 2.28 2.72 < 0.001  
 PRS * Neuroticism 0.92 0.84 1.00 < 0.062  
       
CIDI-SF Age t2 0.99 0.98 0.99 < 0.001 4366.40 
 Sex (F) 1.66 1.41 1.95 < 0.001  
 PRS 1.13 1.05 1.22 < 0.002  
 Neuroticism 1.81 1.68 1.95 < 0.001  
 PRS * Neuroticism 0.97 0.90 1.04 < 0.416  
       
SCID Age t1 0.99 0.99 1.00 < 0.030 3251.90 
 Sex (F) 1.53 1.26 1.86 < 0.001  
 PRS 1.17 1.06 1.30 < 0.002  
 Resilience 0.44 0.40 0.48 < 0.001  
 PRS * Resilience 1.06 0.97 1.16 < 0.211  
       
CIDI-SF Age t2 0.99 0.98 0.99 < 0.001 4156.80 
 Sex (F) 1.80 1.52 2.12 < 0.001  
 PRS 1.14 1.06 1.24 < 0.001  
 Resilience 0.43 0.40 0.47 < 0.001  
 PRS * Resilience 1.07 0.99 1.17 < 0.080  
 
Abbreviations: SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, representing clinical MDD; 
CIDI-SF, Composite International Diagnostic Interview – Short Form, representing self-reported MDD; MDD, 
Major Depressive Disorder; AIC, Akaike Information Criterion; PRS, Polygenic Risk Score; Aget1, Age at the 
time of baseline; Aget2, Age at the time of re-contact 
N.B. Neuroticism has been controlled for Aget1 and resilience has been controlled for Aget2 before entering the 
model. Four principal components controlling for population stratification have been adjusted for and are 
reported in the supplementary material 
 
5.7.1.2. Interaction between Neuroticism and PRS on MDD 
No interaction was found between neuroticism and PRS on clinical MDD status (OR = 0.92, [95% CI = 0.84, 
1.00], p = 0.062), see Table 5.2. PRS remained associated with clinical MDD (OR = 1.16, [95% CIs = 1.05, 
1.29], p = 0.004), and neuroticism independently associated with increased likelihood of clinical MDD status 
(OR = 2.49, [95% CI = 2.28, 2.72], p < 0.001).  
 
No interaction was found between neuroticism and PRS on self-reported MDD (OR = 0.97, [95% CI = 0.90, 
1.04], p = 0.416), see Table 5.2. PRS remained associated with self-reported depression when co-varying for 
neuroticism (OR = 1.13, [95% CIs = 1.05, 1.22], p = 0.002), and neuroticism also remained strongly 
independently associated with self-reported MDD status (OR = 1.81, [95% CI = 1.68, 1.95], p < 0.001).  
 
5.7.1.3. Interaction between Resilience and PRS on MDD 
No interaction was found between PRS and resilience in association with clinical MDD (OR = 1.04, [95% CI = 
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0.95, 1.14], p = 0.373), see Table 5.2. The main effect of PRS was associated with clinical MDD (OR = 1.19, 
[95% CI = 1.08, 1.32], p = 0.001). A strong inverse relationship was found between resilience and clinical 
depression (OR = 0.44, [95% CI = 0.40, 0.48], p < 0.001).  
 
No interaction was found between PRS and resilience on self-reported MDD (OR = 1.06, [95% CI = 0.97, 1.16], 
p = 0.211; see Table 5.2). Whereas the main effect of PRS was associated with increased likelihood of self-
reported depression (OR = 1.17, [95% CI = 1.06, 1.30], p = 0.002), resilience was found to be associated with a 
reduction in self-reported MDD (OR = 0.44, [95% CI = 0.40, 0.48], p < 0.001).  
 
5.7.2. Mediation  
5.7.2.1. Mediation of Neuroticism 
Model 1A showed no direct association between PRS and clinical MDD status (β = 0.04, p = 0.077), although 
this pathway was estimated to explain 4.4% of the variance. The path from PRS to neuroticism demonstrated a 
small positive association (β = 0.07, p < 0.001). A larger association between neuroticism and clinical MDD was 
found (β = 0.87, p < 0.001). This indirect pathway explained 5.8% of the variance. As shown in Table 5.3, 
Model 1A had good fit to the data, and suggested that 57% of the association of genetic liability for depression 
on clinical MDD was mediated by neuroticism.  
 
In Model 2A, the direct path between PRS and self-reported MDD (β = 0.06, p = 0.013), was estimated to 
explain 5.5% of the variance. A small association between PRS and neuroticism was found (β = 0.06, p < 
0.001), whilst the path from neuroticism to self-reported MDD showed a much stronger association (β = 0.65, p 
< 0.001). Together, this indirect pathway explained 4.2% of the variance. As shown in Table 5.3, Model 2A had 
good fit to the data. This model suggested that 43% of the association of genetic liability for depression with 
self-reported MDD was mediated by neuroticism. 
 
5.7.2.2. Mediation of Resilience 
In Model 1B, a direct association between PRS and clinical MDD was found (β = 0.06, p = 0.008, explaining 
6.4% of the variance). However, a small negative association between PRS and resilience (β = -0.07, p < 0.001), 
and a larger negative association from resilience to clinical MDD (β = -0.58, p < 0.001), explained 3.8% of the 
variance.  Model 1B‘s fit to the data was also good (see Table 5.3), and suggested that 37% of the association 
between PRS and clinical MDD was mediated by resilience. 
 
A direct association between PRS and self-reported MDD was found in Model 2B (β = 0.06, p = 0.008) which 
was estimated to explain 5.8% of the variance. A small, negative association between PRS and resilience was 
found (β = -0.07, p < 0.001), in addition to a larger negative association between resilience and self-reported 
MDD (β = -0.60, p < 0.001), which together explained 3.9% of the variance. Model 2B‘s fit to the data was also 
good (see Table 5.3), and suggested that 40% of the association between PRS and self-reported MDD was 
mediated by resilience. 
 












Table 5.3. Fit statistics for the mediation models tested with both clinical and self-reported MDD status as an outcome 
Model MDD outcome Model description df χ² CFI TLI Null RMSEA RMSEA RMSEA Lower CI 
RMSEA 
Upper CI 
1A SCID Neuroticism as a mediator 142 165.97 0.977 0.972 0.038 * 0.006 0.000 0.010 2A CIDI-SF 155 168.93 0.986 0.983 0.036 * 0.005 0.000 0.009 
           
1B SCID Resilience as a mediator 56 159.05 0.992 0.989 0.201 0.021 0.017 0.025 2B CIDI-SF 49 152.31 0.992 0.989 0.214 0.022 0.019 0.027 
           
1C SCID Neuroticism & resilience as separate mediators 281 336.70 0.996 0.996 0.107 * 0.007 0.003 0.010 2C CIDI-SF 281 336.62 0.997 0.996 0.109 * 0.007 0.003 0.010 
           
1D SCID Neuroticism & resilience as one underlying 
mediating factor: Neuroticism+Resilience 
289 637.17 0.978 0.975 0.107 * 0.017 0.015 0.019 
2D CIDI-SF 289 596.99 0.981 0.978 0.109 * 0.016 0.014 0.018 
           
Abbreviations: SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, representing clinical MDD; CIDI-SF, Composite International Diagnostic Interview – 
Short Form, representing self-reported MDD; MDD, Major Depressive Disorder; RMSEA, root mean square error of approximation; CFI, comparative fit index; TLI, 
Tucker-Lewis index 
* TLI and other incremental fit indices may not be that informative, because the RMSEA of the baseline model is lower than 0.158 (Kenny et al., 2011) 
 
- 57 - 
 
5.7.2.2. Mediation of Resilience 
In Model 1B, a direct association between PRS and clinical MDD was found (β = 0.06, p = 0.008, explaining 
6.4% of the variance). However, a small negative association between PRS and resilience (β = -0.07, p < 0.001), 
and a larger negative association from resilience to clinical MDD (β = -0.58, p < 0.001), explained 3.8% of the 
variance.  Model 1B‘s fit to the data was also good (see Table 5.3), and suggested that 37% of the association 
between PRS and clinical MDD was mediated by resilience. 
 
A direct association between PRS and self-reported MDD was found in Model 2B (β = 0.06, p = 0.008) which 
was estimated to explain 5.8% of the variance. A small, negative association between PRS and resilience was 
found (β = -0.07, p < 0.001), in addition to a larger negative association between resilience and self-reported 
MDD (β = -0.60, p < 0.001), which together explained 3.9% of the variance. Model 2B‘s fit to the data was also 
good (see Table 5.3), and suggested that 40% of the association between PRS and self-reported MDD was 
mediated by resilience. 
 
5.7.2.3. Two-factor mediation 
As shown in Figure 5.2, Model 1C found no association between PRS and clinical MDD was found (β = 0.04, p 
= 0.108), although this direct path was estimated to explain 3.9% of the variance. Whilst a small positive 
association was found between PRS and neuroticism (β = 0.06, p < 0.001), a small inverse relationship was 
found between PRS and resilience (β = -0.07, p < 0.001). A positive association was found between neuroticism 
and clinical MDD (β = 0.68, p < 0.001), whereas a negative association was found between resilience and 
clinical depression (β = -0.30, p < 0.001). Neuroticism and resilience were moderately negatively correlated (r = 
-0.25). Table 5.3 indicates that Model 1C had good fit to the data. Approximately 61% of the association 
between PRS and clinical MDD was found to be mediated by neuroticism and resilience, as two separate 
factors. 
 
In Model 2C, we examined the mediating associations of both neuroticism and resilience as separate constructs 
between PRS and self-reported MDD, within the same model. As shown in Figure 5.2, the direct association 
between PRS and CIDI-SF (β = 0.05, p = 0.033), was estimated to explain 4.7% of the variance. A small 
positive association was found between PRS and neuroticism (β = 0.06, p < 0.001), and an inverse relationship 
found between PRS and resilience (β = -0.07, p < 0.001). The same direction of association was evident in the 
path between neuroticism and self-reported MDD (β = 0.30, p < 0.001) and between resilience and self-reported 
depression (β = -0.47, p < 0.001). Neuroticism and resilience were found to be negatively correlated (r = -0.25). 
As shown in Table 5.3, Model 2C had good fit to the data, with neuroticism and resilience as two separate 
factors explaining approximately 52% of the association between PRS and self-reported MDD. 
 
5.7.2.4. Neuroticism and Resilience as one underlying factor 
Model 1D examined if neuroticism and resilience reflect opposite ends of the same trait by creating a latent 
variable (Neuroticism+Resilience) comprising of all the individual item responses from both the EPQ-SF and 
the BRS. A small association between PRS and clinical MDD was found (β = 0.06, p = 0.023), explaining 6% of 
the variance. An association between PRS to Neuroticism+Resilience was found (β = 0.04, p < 0.001) in  
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Figure 5.2. Path diagram of Models 1C and 2C, which include a direct bath between PRS and MDD status, an 
indirect path through neuroticism and an indirect path through resilience 
 
 
addition to a positive association between Neuroticism+Resilience and clinical MDD (β = 1.19, p < 0.001). In 
total, Model 1D explained 47% of the mediation between PRS and clinical MDD. As shown in Table 5.3, Model 
1C appears to fit the data much better than does Model 1D X2(8) = 300.48, p < 0.001, suggesting that 
neuroticism and resilience reflected two partially separate constructs independently mediating the relationship 
between PRS for MDD and clinical depression. 
 
Model 2D also investigated whether one underlying factor can better explain the mediation of the PRS-
depression relation by neuroticism and resilience. A small association was found between PRS and self-reported 
MDD (β = 0.05, p = 0.025) which was estimated to explain 4.9% of the variance. A small association between 
PRS and Neuroticism+Resilience was found (β = 0.04, p < 0.001) in addition to a positive association between 
Neuroticism+Resilience and self-reported MDD (β = 1.21, p < 0.001). Together, these indirect paths explained 
4.8% of the variance, whilst the model itself explained 49% of the mediation between PRS and self-reported 
MDD. Model 2D‘s fit to the data was significantly poorer than that of Model 2C (see Table 5.3), X2(8) = 
260.37, p < 0.001. This suggests neuroticism and resilience should be considered partially independent 
constructs associated with different mediating mechanisms in the association between genetic liability for MDD 
and self-reported depression. 
 
5.8. Discussion 
Here, we report the first study investigating the moderating and mediating associations of neuroticism and 
resilience on genetic liability for MDD on both clinical and self-reported depression in a large cohort of 
individuals. Our results suggest that polygenic risk for MDD is associated with an increased likelihood of both 
clinical and self-reported depression, replicating previous findings (Levine et al., 2014, Ripke et al., 2013). 
Consistent with existing literature (Farmer et al., 2008, Navrady et al., 2017b, Roelofs et al., 2008), neuroticism 
is associated with increased likelihood of both clinical and self-reported MDD, whereas resilience was found to 
associate in the opposite direction (Geschwind et al., 2010, Wingo et al., 2013). Overall, our moderation 
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likelihood of both clinical and self-reported depression, independently, whereas resilience associates with 
reduced likelihood for both clinical and self-reported depression, even after adjusting for genetic vulnerability. 
However, neuroticism and resilience did not show a multiplicative relation with the PRS, boosting and reducing 
the size of its association with depression, respectively. Structural equation modelling of this data suggests that 
genetic liability for MDD is largely mediated by neuroticism to increase risk for clinical and self-reported 
depression, whilst resilience mediates PRS to mitigate risk for both clinical and self-reported MDD. Results 
from this study demonstrate that neuroticism and resilience independently mediate the effects of genetic risk on 
depression, for both self-reported and clinical measures of MDD. 
 
Whereas the results from our moderation analyses results are consistent with those previously found for PRS 
(Levine et al., 2014), neuroticism (de Moor et al., 2015), and resilience (Geschwind et al., 2010), our 
meditational analyses reported novel findings. Consistent with the possibility that polygenic genetic differences 
shape susceptibility to MDD, our findings further suggest that this relationship is driven by two partially 
separate mediating mechanisms; one in which neuroticism increases risk for both clinical and self-reported 
MDD, the other in which resilience reduces the same risk. Evidence for neuroticism and resilience being 
partially independent mechanisms comes from our finding that the two measures are not perfectly correlated (r = 
-0.48), in addition to our structural equation models which demonstrate two separate associations.  
 
It is possible that the meditational associations of neuroticism and resilience can be explained by the role of 
positive and negative emotions. It is well-documented that neuroticism is characterised by a range of negative 
emotions highly associated with MDD (Chan et al., 2007, Navrady et al., 2017b). Although resilience has 
received less empirical attention, researchers have hypothesized that resilience is characterised by positive 
emotionality (Block and Kremen, 1996, Masten, 2001, Wolin and Wolin, 1993) which over time provide 
individuals with an enduring capacity to ―bounce back‖ when MDD would otherwise be expected (Lazarus, 
1993, Masten, 2001). Indeed, Fredrickson (2001) has developed the ―broaden-and-build‖ hypothesis of positive 
emotions which posits that whereas negative emotions narrow an individual‘s cognitive biases to increase 
likelihood of depressive symptoms, positive emotions broaden one‘s though-action repertoires to navigate away 
from the disorder (Fredrickson, 2004). In the present study, PRS for MDD increased vulnerability to both 
clinical and self-reported depression. This relationship is mediated and increased by neuroticism as the negative 
emotions it elicits are congruent with the disorder. Resilience may mediate and ameliorate the relationship 
between PRS for depression and MDD by promoting habituation to stressors, encouraging efficacious coping 
behaviours and prompting cognitive reappraisal away from depressive mood states (Amstadter et al., 2016, 
Buhrmester et al., 2011). These findings may have clinical applications insofar that therapeutic interventions for 
MDD may benefit from focusing on positive emotions to facilitate recovery and resilience rather than 
exclusively focused on alleviating psychiatric symptoms (Fredrickson and Joiner, 2002). 
 
Resilient individuals are believed to ‗bounce back‘ from adversity quickly and efficiently, akin to the way a 
spring stretches but still returns to its original form (Lazarus, 1993). Current resilience measures often fail to 
assess the concept across the lifespan or recognise that risk or adversity is an essential element of resilience 
(Windle et al., 2011). Although the Brief Resilience Scale assumes a trait-based conceptualisation of resilience, 
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the measure is framed in regard to negative events (Smith et al., 2008), which frequently contribute to the onset 
of the disorder. Moreover, the inclusion of PRS in our analysis provide a measure of MDD risk that precede the 
outcome. PRS provide a causal anchor for our mediation analyses as they are a biological measure not subject to 
reverse causality. Whilst the use of genetic factors is unusual in structural equation modelling, they are helpful 
within this study as we can be more certain of the causal path directions, and as such this is not just a 
correlational analysis. However, a replication would be beneficial. Furthermore, additional work should fully 
elucidate the concept of resilience, as wide discrepancies exist in its definition and measurement (Bonanno et 
al., 2015). We argue that future research needs to assess resilience across the lifespan to fully understand the 
processes and mechanisms that underlie it, and how it associates with depression. 
 
Some limitations to this study warrant mention. Firstly, our measures of MDD were taken at different time-
points. Although our results were robust across the two measures of MDD, we must note the difference in 
prevalence rates between the clinical (16%) and self-reported (26%) measures. This may be due to a sampling 
bias at re-contact in which participants with mental health problems were more likely to take part in a study 
specifically aimed to investigate mental health. Although it has been argued that structured clinical interviews 
have better psychometric properties than self-report measures of MDD (Ekselius et al., 1994), research does 
suggest that the diagnostic classifications obtained using measures such as the CIDI-SF accurately reflect those 
made using the SCID (First et al., 2002). Whilst clinical and self-reported measures have been found to provide 
unique information on MDD due to disproportionate weighting of symptoms within each measure (Uher et al., 
2012), it is widely reported that they each correlate highly when measuring the presence of absence of MDD 
rather than the severity of symptoms (Fava et al., 1986). For this reason, we believe that the use of a self-
reported and clinical measure of MDD is advantageous, despite some limitations. In addition, the concept of 
resilience was entirely self-reported; there is no consensus on how to measure resilience, and other measures 
(e.g. the off-diagonal method used by van Harmelen et al., 2017) may have produced different results. It is also 
possible that MDD and neuroticism may influence the recall of experienced events, and that correlations 
between these variables, and resilience, may be introduced as a result. However, despite this potential limitation, 
neuroticism has been demonstrated to be a relatively stable trait in many previous studies and the use of genetic 
PRS scores—which must come causally prior to behaviours—provides an anchor for study that much previous 
research does not have available. A final limitation to this study pertains to the differences in time between 
baseline and re-contact. There is disparity among participants in regard to the time period between their baseline 
testing and re-contact, with some participants having a longer follow-up period than others. As a result, some 
participants might have experienced more negative life events, thus increasing their propensity for MDD.  
 
In conclusion, this study suggests that polygenic risk for MDD increases risk for both clinical and self-reported 
depression through independent effects on increasing neuroticism and reducing resilience. This study suggests 
that two partially separate mechanisms — neuroticism and resilience — influence vulnerability and protection 
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5.9. Chapter conclusions 
This study confirms previous findings that genetic liability for MDD increases risk for the disorder. This work 
also confirms previous reports which suggest that neuroticism and resilience confer independent effects 
associated with increased and reduced risk for MDD, respectively. Importantly, this chapter has demonstrated 
for the first time that neuroticism and resilience represent partially independent pathways. Specifically, this 
study has provided evidence to suggest that neuroticism mediates PRS-MDD associations to increase risk for the 
disorder whilst resilience independently mediates in the opposite direction, which suggests neuroticism and 
resilience are unlikely to be simply polar ends of the same latent construct. Moreover, these associations were 
consistent across both clinical and self-reported measures of MDD which suggest that resilience and neuroticism 
may truly reflect divergent risk and protective pathways in mental health susceptibility. However, due to the 
small negative correlation found between neuroticism and resilience, we can only infer that these pathways are 
partially independent. As such, further work needs to be done to establish the extent of independence between 
the two measures. Moreover, as resilience was found to exert a protective effect on MDD in individuals 
genetically liable to the disorder, it is imperative to investigate the aetiology of resilience. A better 
understanding of potential ‗causes‘ of resilience may facilitate the development of more effacious treatment 
strategies which focus on fostering resilience before the onset of MDD symptomology. In the next chapter, 
efforts have been made to elucidate the aetiology of psychological resilience and investigate if it is genetically 
determined, or the result of environmental influences. Additionally, Chapter 5 will also seek to investigate the 






























In comparison to Mendelian traits (e.g. Huntingdon‘s Disease or Cystic Fibrosis) which are determined by a 
single gene, complex traits have a polygenic architecture, where variation results from the cumulative effects of 
multiple genetic variants, in addition to environmental effects. The total phenotypic variation of a complex trait 
(such as psychological resilience) can be determined by separating genetic and environmental components 
(Lynch and Walsh, 1998). The environmental component, however, can be divided into that unique to the 
individual, and the environment shared between individuals (Tenesa and Haley, 2013). By calculating the 
heritability of a trait using this method researchers may be able to quantify to what extent a given trait is the 
result of genetic factors, or the environment (―nature or nurture‖). Accurately partitioning the phenotypic 
variation of resilience into genetic and environmental components may have important scientific and clinical 
consequences. Firstly, establishing the genetic heritability of resilience may inform molecular studies which 
could potentially produce accurate predictions for risk or protection (Makowsky et al., 2011, Tenesa and Haley, 
2013). Secondly, it may inform both genetic and environmental interventions (Tenesa and Haley, 2013). 
Ultimately, the identification of specific genetic loci or contributing environmental exposures in psychological 
resilience may facilitate the development of interventions for mental health that focus on prevention in addition 
to cure.  
 
Given that psychological resilience is a complex trait, one of the first steps towards identifying its causes and 
consequence is to identify the main sources of phenotypic variation. Specifically, it is important to decipher how 
much of its phenotypic variation is genetic in origin, and how much is influenced by environmental factors. The 
utilisation of recently developed methods for heritability and variance component analysis can answer such 
questions. This chapter contains a novel study which partitioned the phenotypic variation of resilience and 
measured the magnitude of its genetic and environmental components. The aim of this study was to identify the 
major sources of variation in resilience, and measure the relative contribution of the genetics and environmental 
components to coping style (which as discussed in Chapter 2 has previously been associated with resilience). 
Furthermore, this study aimed to disentangle the shared genetic architecture between resilience, coping style, 
and neuroticism using genetic correlation to further determine if they represent distinct constructs. This study 
has been summarized, below, into a manuscript entitled ‗Genetic and environmental contributions to 
psychological resilience and coping‘, which has been accepted by Wellcome Open Research and is currently 
awaiting review. As first author, the study design was conceived by myself, and I analysed the data and wrote 
the manuscript for publication. To acknowledge the contributions of co-authors, ―we‖ will be used instead of ―I‖ 
throughout this chapter. 
 
6.2. Paper: Genetic and environmental contributions to psychological resilience and coping 
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6.3. Abstract 
Background: Genetic and environmental factors contribute to psychological resilience and coping style, but 
estimates of their relative contributions and genetic commonalities with neuroticism are unknown.  
 
Methods: The heritability of resilience and coping style were estimated alongside the variance attributable to 
early and recent-shared environmental effects in a family-based cohort (GS:SFHS, N = 8,734). Bivariate 
analyses estimated genetic correlations between resilience, coping style, and neuroticism. Resilience, coping and 
neuroticism were measured using the Brief Resilience Scale, Coping Inventory for Stressful Situations and 
Eysenck Personality Scale Short Form-Revised, respectively.  
 
Findings: The greatest proportion of the phenotypic variance for resilience was attributable to common-variant 
genetic (𝑕𝐺2  = .06, SE = .04) and family-shared environmental (𝑕𝐹2  = .05, SE = .02) effects. The variance in task- 
and avoidant-oriented coping was mostly attributable to common genetic, sibling- and couple-shared 
environment effects. The greatest proportion of the phenotypic variance for emotion-oriented coping was 
attributable to common genetic, family- and couple-shared environment effects. The estimated genetic 
correlation between resilience and emotion-oriented coping was high (rG = -.79, plrt = .002) as was the 
correlation between resilience and neuroticism (rG = -.83, plrt = .004). Emotion-oriented coping and neuroticism 
were also highly genetically correlated (rG = .63, plrt = .003).  
 
Conclusions: Our results indicate that early environment influences resilience, whereas recent environment 
effects coping style. Strong genetic overlap between resilience, emotion-oriented coping, and neuroticism 
suggests a relationship whereby genetic factors that increase negative emotionality lead to decreased resilience. 
We suggest that genome-wide family-based studies of resilience and coping may help to elucidate tractable 




Aversive life experiences are known risk factors for a broad spectrum of mental health problems (Fergus and 
Zimmerman, 2005, Haskett et al., 2006, Masten et al., 1990, Werner, 1993). However, despite significant risk 
for psychopathology, many individuals exhibit better than expected adjustment. This ability to ‗bounce back‘ 
and maintain or regain mental health despite significant risk is referred to as psychological resilience (Luthar 
and Zelazo, 2003, Luthar et al., 2006, Smith et al., 2008). Resilience has increasingly become a focus of 
behavioural and medical research (Amstadter et al., 2014, Bonanno et al., 2015, Davydov et al., 2010) 
promoting positive mental health and offering an alternative to ‗deficit‘ models of psychopathology (Fergus and 
Zimmerman, 2005). The underlying biological mechanisms of resilience are not, however, well understood. 
Studies seeking to identify the genetic and environmental contributions to resilience are an important starting 
point from which to build an understanding of its aetiology in addition to identifying treatment strategies 
focussing on primary prevention which would have significant impacts on several mental health conditions. 
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Recent studies indicate that genetic factors may be important for understanding individual differences in 
resilience (Rutter, 2003, Silberg et al., 2001). For example, resilience has been found to attenuate the risk for 
depression in individuals with high genetic loading for the disorder (Geschwind et al., 2010, Wichers et al., 
2008, Wichers et al., 2007, Navrady et al., 2017c), although the role of shared environmental factors is not yet 
known. In a twin study, Boardman and colleagues (Boardman et al., 2008) defined resilience as the residual for 
positive affect after controlling for social and interpersonal stressors and found resilience is significantly 
more heritable among men (52%) than women (38%). Similarly, another twin study found modest heritability 
estimates (24-49%) on measures of well-being and mental health which were indirectly related to resilience 
(Hansson et al., 2008). A longitudinal twin study (Amstadter et al., 2014) computed resilience as the residual 
between actual and predicted psychiatric symptoms, based on the total number of stressful life events an 
individual has experienced, and found moderate heritability estimates at both waves of assessment 
approximately five years apart (~31%). The relative genetic and environmental contributions to child resilience 
has been investigated in another twin study (Kim-Cohen et al., 2004) which assessed resilience as the residual 
from a regression predicting children‘s antisocial behaviour from socioeconomic deprivation. The authors found 
that 46% of the variance in resilience was attributable to additive genetic effects, with the remainder accounted 
for by (unexplained) environmental contributors. Together, this research provides strong support for genetic 
and environmental contributions to resilience, although none accounted for the role of recent environmental 
factors, which, to our knowledge, have not yet been studied. 
 
It is likely that coping styles also play an important role in resilience (Bonanno et al., 2015). Whereas resilience 
refers to positive adaptation in the face of adversity, coping encompasses cognitive and behavioural strategies 
used to manage adversity (Folkman and Moskowitz, 2004). Several well-validated questionnaires have been 
developed to measure coping (Cosway et al., 2000, Robinson et al., 1997, Vitaliano et al., 1985) which focus on 
task-, emotion-, and avoidance-oriented coping styles. Emotion-oriented coping is characterised by the 
regulation of distressing emotions, whereas task-oriented coping denotes purposeful efforts aimed at problem 
solving (Folkman and Lazarus, 1988). Avoidance-oriented coping is defined by behaviours aimed at avoiding 
difficult circumstances (Cosway et al., 2000). Coping styles represent strategies and processes sensitive to 
personal and situational factors (Folkman and Moskowitz, 2004), although evidence from twin studies suggests 
they may be genetically and environmentally mediated. A twin study (Jang et al., 2007) found that, whereas 
task-and emotion-oriented coping were modestly heritable (17-20%), avoidance-oriented coping was entirely 
determined by environmental factors. The majority of the variance in coping style was attributable to non-shared 
environmental influences. Furthermore, Kozak et al. (2005) found modest genetic influences to the variation 
seen in each coping style (33-39%), in addition to substantial environmental variance. Kendler et al (1991) 
found that approximately 30% of the total variance in the coping styles of ‗turning to others‘ and ‗problem 
solving‘ was attributable to genetic effects. Interestingly, however, the variability in the use of ‗denial‘ coping 
styles was entirely accounted for by environmental influences. Whilst these studies demonstrate that both 
genetics and environmental influence coping style, no study has yet examined the role of early and recent 
environmental contributors. 
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There is evidence to suggest that neuroticism substantially associates with both resilience and coping styles. 
Neuroticism is a stable, partially-heritable personality trait representing emotional instability and high stress 
sensitivity (Conley, 1985, Matthews et al., 2009). Unlike resilience and coping style, research suggests 
neuroticism has a strong genetic determination with little or no shared-environmental influence (see Lahey, 
2009 for a review). Neuroticism is negatively associated with resilience (Amstadter et al., 2016, Simeon et al., 
2007, Navrady et al., 2017c), which is potentially the result of the divergent use of negative and positive 
emotions. Neuroticism positively correlates with unhealthy and ineffective forms of coping (Drapeau et al., 
2016, Endler and Parker, 1990b), and correlates negatively with active, problem-focused coping styles (Carver, 
1998, Connor-Smith and Flachsbart, 2007). However, although a longitudinal twin study (Amstadter et al., 
2016) has revealed that neuroticism and resilience are genetically correlated (0.67), little is known about the 
genetic overlap between resilience, coping and neuroticism despite evidence to suggest that are phenotypically 
associated. 
 
Phenotypically, resilience has been positively correlated with task-oriented coping, and negatively with indices 
of emotion- and avoidance-oriented coping (Penley et al., 2002, Smith et al., 2008, Zeidner and Saklofske, 
1996), however, the genetic and environmental contributions to these relationships are not fully understood. 
Currently, our knowledge regarding resilience and coping is primarily based on findings from twin studies that 
assess narrow sense heritability. Family studies with genome-wide genotype data provide an opportunity to 
disentangle the differential contributions of molecular and non-additive genetic effects whilst simultaneously 
modelling environmental effects. In the present study we used a family-based genotyped cohort, Generation 
Scotland: Scottish Family Health Study (GS:SFHS) to investigate genetic and environmental contributions to 
both psychological resilience and coping style. We drew on the diverse familial relationships within the sample 
to estimate both molecular and pedigree genetic effects and the contribution of early family environment and 
recent shared environment by analysing family members/siblings and couples respectively. Furthermore, we 
tested whether these traits have significant overlapping genetic architectures, and examined their genetic 
correlations with neuroticism, which has been shown to associate with both resilience and coping style (Connor-
Smith and Flachsbart, 2007, Navrady et al., 2017c).   
 
6.5. Materials and methods 
6.5.1. Generation Scotland: Scottish Family Health Study 
The Generation Scotland: Scottish Family Health Study (GS:SHFS) (Smith et al., 2013, Smith et al., 2006) is a 
family-based population cohort recruited from General Practitioners‘ practices throughout Scotland between 
2006 and 2011. Individuals were eligible for participation if they were aged above 18 years and had at least one 
first-degree relative also willing to participate. A total of 5,628 families spanning up to three generations were 
recruited. In 2014, GS:SFHS participants were re-contacted and asked to take part in a follow-up study of 
mental health and resilience (Navrady et al., 2017a). These are the participants included in the current study. 
Full cohort details and recruitment procedures for baseline and re-contact are described elsewhere (Navrady et 
al., 2017a, Smith et al., 2013, Smith et al., 2006). All components of GS:SFHS, including its protocol and 
written study materials have received national ethical approval from the NHS Tayside committee on research 
ethics (reference 05/s1401/89). 
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6.5.2. Genotyping and Quality Control procedures  
At baseline, blood and salivary DNA samples were collected, stored, and genotyped at the Wellcome Trust 
Clinical Research Facility, Edinburgh (www.wtcrf.ed.ac.uk). Genome-wide genotype data were generated using 
the Illumina HumanOmniExpressExome-8 v1.0 DNA Analysis BeadChip (San Diego, CA, USA) and Infinium 
chemistry (Gunderson, 2009). The details and procedures for DNA extraction and genotyping have been 
reported extensively elsewhere (Kerr et al., 2013, Nagy et al., 2017). Population outliers were removed from the 
sample (Amador et al., 2015). Quality control of genotyped SNPs used inclusion thresholds: call rate > 98%, 
missing SNPs per individual < 2%, Hardy-Weinberg equilibrium p > 1x10-6, and minor allele frequency > 1%. 
In total, 561,125 autosomal SNPs for 8,734 related individuals remained and were used in subsequent analysis. 
Multidimensional scaling (MDS) components were created according to the ENIGMA 1000 genomes protocol 
(ENIGMA Genetics Support Team, 2013) in the software package PLINK (Purcell et al., 2007).   
 
6.5.3. Resilience, coping style and neuroticism 
Psychological resilience was assessed at re-contact using the Brief Resilience Scale (BRS) (Smith et al., 2008), 
(Smith et al., 2008), a self-report questionnaire assessing an individual‘s ability to ‗bounce back‘ or recover 
from stress. The BRS consists of six statements (e.g., ―I usually come through difficult times with little trouble‖) 
answered on a five-point scale from ―Strongly Disagree‖ to ―Strongly Agree‖. After reverse coding of even-
numbered questions, a total resilience score was calculated by computing the mean of six questions. The BRS 
has been found to have a one-factor structure, demonstrating good internal consistency (Cronbach‘s alpha = 
0.80-0.91) and test-retest reliability of 0.69 for one month and 0.62 for three months (Smith et al., 2008).  
 
The Coping Inventory for Stressful Situations (CISS) (Endler and Parker, 1990a) was completed at re-contact. 
The CISS is a 48-item self-report questionnaire in which responders indicate how much they engage in various 
coping activities ―when under stress‖, on a five-point scale from (1) ‗Not at all‘ to (5) ‗Very much‘. Scores are 
summed over three 16-item sub-scales scales measuring task-oriented (e.g. ―when under stress I focus on the 
problem and see how I can solve it‖), emotion-oriented (e.g., ―when under stress I blame myself for having 
gotten into this situation‖) and avoidance-oriented (e.g., ―when under stress I take time off and get away from 
the situation‖) coping styles. The CISS has proven a robust measure of assessing situation-specific coping 
strategies, with a stable factor structure, high internal reliability and construct validity (Cosway et al., 2000).  
 
Neuroticism was assessed at baseline using the Eysenck Personality Questionnaire Short Form-Revised (EPQ-
SF; Eysenck, 1991) The EPQ-SF is a self-report questionnaire measure consisting of twelve Yes/No questions 
assessing neuroticism, with scores ranging from 0 to12. Higher scores represent higher levels of neuroticism. 
This scale has been concurrently validated with other quantitative measures of neuroticism (Gow et al., 2005) 
with high reliability (Eysenck et al., 1985). 
 
6.6. Statistical Analysis 
6.6.1. Narrow-sense heritability 
Using univariate GCTA (Yang et al., 2011) (version 1.22) we calculated the narrow-sense heritability of 
resilience, task-, emotion- and avoidance-oriented coping. Genetic contributions to each trait were measured by 
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partitioning the phenotypic variance using linear mixed modelling (LMM) techniques. This method employs 
two variance component matrices that represent common-variant associated genetics (G) and pedigree-
associated genetics (K) - details of how these were calculated are provided in Appendix C. Narrow-sense 
heritability (𝑕𝑛2 ) is calculated by the summation of both G and K effects. This method has been demonstrated to 
reliably estimate heritability in related samples (Zaitlen et al., 2013) overcoming possible confounding effects 
within family-based cohorts. Each univariate model was adjusted for age, sex, and four MDS components which 
control for population stratification. As the K estimate could potentially be confounded and inflated by shared 
environmental effects we also examined the contribution of genetics and shared environment, below. 
 
6.6.2. Contribution of genetics and familial shared environments to phenotypic variance 
We re-estimated heritability using a recently developed method based on the genomic-relationship-matrix 
restricted maximum likelihood (GREML). Using the methods of Xia et al (Xia et al., 2016, Xia et al., 2017), we 
simultaneously fitted the two genetic components, G and K, alongside three environmental variance 
components: F (effect shared by nuclear families), S (the effect from the shared sibling environment), and C 
(environmental effects due to shared couple environments). We estimated the contribution of each component 
using a linear mixed model (LMM) with statistical significance calculated using likelihood ratio tests (LRT). 
Age, sex and four MDS components were included in each LMM as fixed effects. Details on the construction of 
the variance-covariance matrices can be found in the supplemental material. 
 
The initial model was a full model (‗GKFSC‘) comprising of all genetic and environmental components. 
However, previous studies (Xia et al., 2016, Zeng et al., 2016) suggest that variance estimates may be 
confounded due to correlations between components. To overcome this issue, backward stepwise model 
selection was employed. LRT tests were conducted to test the significance of each variance component, which 
were removed sequentially if they failed to obtain significance (α = 5%), and had the highest p-value. This 
process was repeated until all the remaining components were significant. This method is described in more 
detail elsewhere (Xia et al., 2016, Zeng et al., 2016).  
 
6.6.3. Genetic and phenotypic correlations between traits 
The genetic correlations of common-variant associated (𝑟𝐺 ) and pedigree associated (𝑟𝐾) genetic effects between 
resilience, coping style and neuroticism were estimated. Bivariate GREML analysis in GCTA (Lee et al., 2012, 
Yang et al., 2011) was conducted to estimate the correlations of these genetic components simultaneously. 
These models were controlled for age, sex, and four MDS components. The significance of each genetic 
correlation was estimated using the LRT. We also report the phenotypic correlations between these traits (𝑟𝑝 ).  
 
6.7. Results 
Among the 8,734 participants with genome-wide genotyped data, we recognised 655 couple pairs, 1,925 full 
sibling pairs and 4,508 nuclear families (minimum two individuals). The number of non-zero elements of the 
KFSC matrices for whom genotypic and phenotypic information are available for each trait are shown in 
Appendix C. The mean age of the sample was 56.36 years (SD = 13.15), and 5,403 (62%) were female. 
Demographic details of these individuals are presented within Appendix C.  
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6.7.1. Narrow-sense heritability 
The narrow-sense heritability (𝑕𝑛2 ) of resilience was calculated by summing common-variant associated genetic 
(G) and pedigree-associated genetic (K) effects, and was estimated to be .14 (S.E. = .09, plrt < 0.001) (Table 
6.1). The K component was non-significant, indicating that the total additive genetic variance is primarily due to 
common-variant associated effects, or that the sample was underpowered to separate common- from pedigree-
associated genetic effects. 
 
The 𝑕𝑛2  of task-oriented coping was .24 (S.E. = .10, plrt < 0.001), .24 (S.E. = .10, plrt < 0.001) for emotion-
oriented coping, and .23 (S.E. = .10, plrt < 0.001) for avoidance-oriented coping. Estimates of 𝑕𝑛2  are potentially 
inflated as the K component captures both pedigree-associated genetic effects and shared environmental effects. 
For this reason, we have portioned the phenotypic variance of these traits into genetic and shared environmental 
components, below.  
 
Table 6.1. Age-, sex-, and population stratificationa-adjusted univariate GCTA estimates of narrow-sense 
heritability 
Trait N 𝑕𝐺2  (SE) 𝑕𝐾2  (SE) 𝑕𝑛2  (SE) 
Resilience 8555 0.08 (0.04) 0.06 (0.05) 0.14 (0.09) 
ToC 8170 0.12 (0.05) 0.13 (0.06) 0.24 (0.10) 
EoC 8306 0.14 (0.04) 0.10 (0.06) 0.24 (0.10) 
AoC 8248 0.14 (0.04) 0.09 (0.06) 0.23 (0.10) 
a first four MDS components 
Abbreviations: ToC, Task-oriented Coping; EoC, Emotion-oriented Coping; AoC, Avoidance-oriented Coping; 
𝑕𝐺
2 , additive genetic effect from common variants; 𝑕𝐾2 , genetic effect associated with the pedigree; 𝑕𝑛2 , narrow-
sense heritability (the sum of 𝑕𝐺2  and 𝑕𝐾2 ) 
N.B. text in bold indicate LRT p < 0.05 (one-tailed). Values in parentheses represent standard errors. 
 
 
6.7.2. Full model partitioning phenotypic variation into genetic and shared environmental 
components 
To overcome possible confounding environmental effects, we partitioned the phenotypic variation of each trait 
by modelling two genetic components (G and K) alongside three environmental components representing the 
family, sibling, and couple effects (F, S, C) for each trait. The results of these full models are presented in Table 
6.2 and Appendix C. Neither genetic nor shared environmental components for resilience were statistically 
significant in the full model. However, in comparison with the reduced model which does not account for 
environmental effects (the GK model, above), the full model obtained lower estimates of genetic variance which 
suggests that the full model effectively reduced confounding environmental effects when calculating heritability 
estimates.  
 
For task-oriented coping, the full model estimated that 11% (S.E. =.05, plrt = .006) of the phenotypic variance 
was attributable to common genetic variants (G). The pedigree-associated (K) component of this model was not 
significant, and so the proportion of total additive genetic determination was resultant from the effect of 
common-variant associated genetics (G). Of the three shared-environmental components, both sibling- (𝑒𝑆2=.08, 
SE = .04, plrt = .019) and couple-shared (𝑒𝐶2=.16, SE = .07, plrt < .001) environmental effects were significant. 
For emotion-oriented coping, 14% (S.E. = .04, plrt < 0.001) of its phenotypic variance was determined by 
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common genetic variants, and 14% (S.E. = .07, plrt = 0.002) was resultant from couple-shared environmental 
effects. The environmental effects shared between nuclear family members and full-siblings were not 
significant. For avoidance-oriented coping, 12% (S.E. = .04, plrt =0.002) of its phenotypic variance was 
attributable to common genetic variants (G). Significant effects from sibling- (𝑒𝑆2=.05, SE = .03, plrt = .049) and 
couple-shared (𝑒𝐶2=.14, SE = .07, plrt < .001) environment were also found. These results are illustrated in Table 
6.2, and within Appendix C.  
 
6.7.3. Backward stepwise model selection to identify major genetic/familial-environmental 
contributors 
Using backward stepwise selection for resilience, only the common-variant associated genetic component and 
shared nuclear-family component were retained in the final model (the GF model as shown in Table 6.2 and 
Figure 6.1). Common genetic variants (G) explained 6% (S.E. = .04, plrt = .041) of the phenotypic variation in 
resilience and family-shared environmental (F) effects explained 5% (S.E. = .02, plrt =.020). Using the same 
methodology, 14% of the variance in task-oriented coping was explained by common-variant associated 
genetics (𝑕𝐺2 : S.E. = .03, plrt < .001). Furthermore, 10% of the variance was explained by sibling-shared 
environmental effects (𝑒𝑆2: S.E. = .03, plrt < .001), and a further 18% of the variance was explained by couple-
shared environmental effects (𝑒𝐶2: S.E. = .04, plrt < .001). Similar patterns were found in avoidance-oriented 
coping with 15% of the variance explained by common-variant associated genetics (𝑕𝐺2 : S.E. = .03, plrt < .001), 
7% explained by sibling-shared environmental effects (𝑒𝑆2: S.E. = .03, plrt = .006), and 18% of the variance 
explained by couple-shared environmental effects (𝑒𝐹2: S.E. = .04, plrt < .001). In examining emotion-oriented 
coping, it was found that common genetic (𝑕𝐺2  = .15, S.E. = .04, plrt <.001), family-shared (𝑒𝐹2 = .05, S.E. = .03, 
p = .027) and couple-shared environmental effects (𝑒𝐶2 = .14, S.E. = .05, plrt =.002) were most attributable to the 





Figure 6.1. Sources of phenotypic variance and the proportion of variance they explained in the most 
parsimonious backward stepwise selection models for resilience, task-, emotion-, and avoidance-oriented coping 
styles 
 









Table 6.2. Age-, sex-, and population stratificationa-adjusted variance component analyses results for Resilience, ToC, EoC, and AoC 
         












         
Trait n Model description 𝑕𝐺2  (SE) 𝑕𝐾2  (SE) 𝑒𝐹2 (SE) 𝑒𝑆2 (SE) 𝑒𝐶2 (SE) 
         
Resilience 8555 
Genetics only GK 0.08 (0.04) 0.06 (0.05)    
Full GKFSC 0.06 (0.04) 0.00 (0.12) 0.05 (0.06) 0.00 (0.03) 0.01 (0.07) 
Backward selection GF 0.06 (0.04)  0.05 (0.02)   
ToC 8170 
Genetics only GK 0.12 (0.05) 0.13 (0.06)    
Full GKFSC 0.11 (0.05) 0.02 (0.13) 0.03 (0.06) 0.08 (0.04) 0.16 (0.07) 
Backward selection GSC 0.14 (0.03)   0.10 (0.03) 0.18 (0.04) 
EoC 8306 
Genetics only GK 0.14 (0.04) 0.10 (0.06)    
Full GKFSC 0.14 (0.04) 0.03 (0.12) 0.04 (0.06) 0.00 (0.03) 0.14 (0.07) 
Backward selection GFC 0.15 (0.04)  0.05 (0.03)  0.14 (0.05) 
AoC 8248 
Genetics only GK 0.14 (0.04) 0.09 (0.06)    
Full GKFSC 0.12 (0.04) 0.00 (0.13) 0.03 (0.06) 0.05 (0.03) 0.14 (0.07) 
Backward selection GSC 0.15 (0.03)   0.07 (0.03) 0.18 (0.04) 
 
a first four MDS components 
Variance component analyses were performed on Resilience, ToC, EoC, and AoC using the genetic model (GK), the model accounting for both genetic and three 
environmental effects (the full model), and the most parsimonious model selected by backward selection 
Abbreviations: ToC, Task-oriented Coping; EoC, Emotion-oriented Coping; AoC, Avoidance-oriented coping 
N.B. text in bold indicates significant LRT at p < 0.05 (one-tailed). Values in parentheses represent standard errors 
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6.7.4. Phenotypic and genetic correlations between traits 
Age-, and sex-adjusted Pearson phenotypic correlations are presented in Table 6.3. Resilience was found to 
positively correlate with task-oriented coping (rp = .36, SE = .02). Whereas negative associations were found 
between resilience and emotion-oriented coping (rp = -.52, SE = .01) and resilience and neuroticism (rp = -.45, 




Estimates of common variant-associated and pedigree associated genetic correlations are reported in Table 6.4. 
Since our traits still have contributions from K (based on the full models), we will examine this effect to prevent 
inflation in our G estimates (Xia et al., 2016, Zeng et al., 2016). Furthermore, because there were no consistent 
environmental effects across our traits, and because K in the GK models captured a mixture of both pedigree-
associated genetic and environmental effects, we have omitted the analysis of environmental correlations.  
 
The estimate of the common-variant associated genetic correlation (rG) between resilience and emotion-oriented 
coping was -.79 (S.E. = .19, plrt = .002) (Table 6.4). The correlation between resilience and emotion-oriented 
coping explained by additional genetic variation associated with pedigree (rK) was -.94 (S.E. = .30, plrt = .033), 
although this estimate is potentially influenced by the effects of shared-environment. High genetic overlap was 
found between resilience and neuroticism: rG = -.83 (SE = .23, plrt = .004), rK = -.79 (SE = .28, plrt = .020); and 
between emotion-oriented coping and neuroticism: rG = 0.63 (SE = 0.16, plrt = 0.003), rK = 0.74 (SE = 0.21, plrt 
= 0.009).  
 
6.8. Discussion 
Here, we report a novel study examining the genetic and environmental contributions to resilience and coping 
style in GS:SFHS, a population and family-based sample comprising close and distant relatives with genome-
wide genotyped data. We found that resilience has a relatively low narrow-sense heritability estimate (𝑕𝑛2  = 
0.14), whilst modest heritability estimates of task-, emotion-, and avoidant-oriented coping style were found (𝑕𝑛2  
~ 0.24). However, these estimates are likely inflated as they included shared environmental effects. To 
overcome this, we re-estimated the heritability of each trait using genetic and shared environmental variance 
components simultaneously. We demonstrated that variation in resilience has low contributions from genetic 
and shared environmental factors, with 89% of its phenotypic variance remaining unexplained. We also found 
that each coping style had substantial genetic (~20%) and shared environmental (20-30%) contributions. We  
Table 6.3. Age-, and sex-adjusted phenotypic Pearson correlations 
      
 Resilience ToC EoC AoC Neuroticism 
      
Resilience -     
ToC  0.36 (0.01) -    
EoC -0.52 (0.01) -0.17 (0.01) -   
AoC -0.05 (0.01)  0.27 (0.01)  0.30 (0.01) -  
Neuroticism -0.45 (0.01) -0.21 (0.01) 0.46 (0.01 0.05 (0.01) - 
      
Abbreviations: ToC, Task-oriented coping style; EoC, Emotion-oriented coping style; AoC, Avoidance-oriented 
coping style 
All correlations were significant at p < 0.01. Values in parentheses represent standard errors 
 




Also found large genetic correlations between resilience and emotion-oriented coping for both common-variant 
associated genetic (rG = -0.79) and pedigree-associated genetic (rK = -0.94) effects, which suggests that genetic 
effects have a shared influence of resilience and emotion-oriented coping styles but in opposite directions. 
Furthermore, strong positive genetic correlations were found between neuroticism and emotion-oriented coping, 
whereas strong negative genetic correlations were found between resilience and neuroticism. Together, these 
findings indicate that genetic factors that increase negative emotionality lead to reduced psychological 
resilience, which mirror previous reports that which suggest resilience and neuroticism provide partially 
separate mechanisms to reduce and increase susceptibility to psychopathology, respectively (Navrady et al., 
2017c). 
 
The narrow-sense heritability estimate for resilience in the current sample was substantially less than broad-
sense estimates derived from twin studies (Boardman et al., 2008, Kim-Cohen et al., 2004). In this study, we 
have employed the Brief Resilience Scale, a quantitative trait-based measure of resilience, whereas other 
behavioural genetic studies have found larger genetic effects with both outcome- and process-based approaches 
(Boardman et al., 2008, Kim-Cohen et al., 2004). It is important to make this distinction clear as this difference 
may underlie the different heritability estimates reported in the literature. Furthermore, we demonstrate that the 
heritability of resilience is due to common-variant associated genetic effects, with estimates of pedigree-
associated genetics (which include rare and structural genetic variants) having no significant effect. This is a 
novel finding as previous estimates suggest that for most complex traits over 50% of narrow-sense heritability is 
attributable to pedigree-associated genetic effects (Xia et al., 2016, Zaitlen et al., 2013). Alternatively, our 
analysis may have been underpowered or confounded by correlations between components (Xia et al., 2016, 
Zeng et al., 2016). Narrow-sense heritability estimates of task- and emotion-oriented coping in this study were 
in line with previous reports (Jang et al., 2007, Kendler et al., 1991, Kozak et al., 2005). Specifically, here we 
report the narrow-sense heritability of avoidance-oriented coping to be 23%, whereas other researchers have 
found no genetic effect in avoidance-oriented coping styles. This may be due to our sample being better 
powered to detect genetic components of avoidance-oriented coping in comparison to previous twin studies 
(Jang et al., 2007, Kendler et al., 1991, Kozak et al., 2005) which found conflicting results with much smaller 
samples (n < 1,000). Conversely, our sample may not have had sufficient power to separate out pedigree effects 
from shared environmental effects, indicated by our study failing to detect any significant pedigree effects.  
Table 6.4. Age-, sex-, and population stratificationa-adjusted bivariate GCTA estimates of genetic correlation 
 
 Resilience ToC EoC AoC Neuroticism 
 
Resilience - .20 (.43) -.94 (.30) .36 (.54) -.79 (.28) 
ToC .51 (.26) - -.46 (.34) -.08 (.38) -.06 (.29) 
EoC -.79 (.19) -.05 (.25) - -.42 (.54) .74 (.21) 
AoC -.24 (.30) .48 (.24) .60 (.21) - .05 (.33) 
Neuroticism -.83 (.23) -.64 (.21) .63 (.16) -.17 (.22) - 
 
a first four MDS components 
Abbreviations: ToC, Task-oriented Coping; EoC, Emotion-oriented Coping; AoC, Avoidance-oriented Coping 
N.B. text in bold indicates significant LRT at p < 0.05 (one-tailed). Values in parentheses represent standard 
errors 
The genetic correlations between traits resultant from common genetic variance (rG) are shown on the lower 
diagonal; the upper diagonal shows the genetic correlations between traits associated with the pedigree (rK) 
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Backward stepwise model selection of genetic and environmental variance components suggest that common-
variant associated genetic and family-shared environmental effects were the most significant contributors of 
psychological resilience. Within our study, the family effect represents the ‗nuclear‘ family, an environmental 
influence associated with living in the same family group. It has been found that children with poor familial 
relationships are more likely to develop psychopathology in later life (Fearon et al., 2010), whereas positive 
family relationships have been found to prevent negative mental health outcomes in ‗at-risk‘ children (Jaffee et 
al., 2007), which supports our finding that resilience has a substantial family-shared environment component. 
Behavioural genetics studies suggest that positive familial relationships enable an individual to regulate their 
behaviour and emotions to perceive their environment as manageable, no matter how challenging (Bakermans-
Kranenburg et al., 2004, Bokhorst et al., 2003). Furthermore, previous studies have demonstrated that strong 
familial attachments in childhood have long-lasting impacts on resilience and general well-being in later life 
(Masten et al., 1990) which is important within the context of this study which examined adults who may no 
longer be living within the ‗nuclear‘ family environment, but whose effects are still apparent. 
 
In examining both genetic and environmental effects simultaneously, we also detected an almost equal 
contribution from common-variant associated genetic and couple-shared environment effects for all three coping 
styles. The couple effect reflects the current environment shared between spouses in adulthood, which contrasts 
with both the full sibling and nuclear family effect which reflects the influence of earlier shared environments. 
During stressful circumstances, the support of a spouse (living in the same household) is more likely to be 
sought than support from closely related family members (living in a different household) (Ben-Zur et al., 2001) 
The major contribution of couple-shared environment to coping could potentially capture the effects of 
assortative mating (Vinkhuyzen et al., 2012), and other factors leading to spousal similarity. However, this 
effect may also be explained by couples learning from each other and adapting their coping styles to better face 
the adversity at hand (Soskolne and Kaplan De-Nour, 1989). Comparatively less variance was accounted for by 
sibling- and family-shared environmental effects which may be due to the high correlation between the matrices 
which could potentially impede model fit and estimation (Zeng et al., 2016). Previous simulation of these 
models (Xia et al., 2016) suggest that true components are detected approximately 80% of the time and so the 
small sibling- and family-shared environmental effects found could be due to false positives in the model. 
However, without a larger sample size, it would be difficult to have the power to fully discriminate between 
these components (Xia et al., 2016), and so we advocate further replication in independent samples. 
 
We also examined the genetic correlations between resilience, coping styles and neuroticism. Our results 
revealed very high negative correlations between resilience and emotion-oriented coping for both common-
variant associated genetic and pedigree-associated genetic components. Furthermore, high negative genetic 
correlations were found between resilience and neuroticism, which mirror previous findings (Amstadter et al., 
2016). These findings suggest that there is a strong shared genetic architecture between resilience, emotion-
oriented coping and neuroticism for both common and rare variants whereby genetic factors that increase 
negative emotionality also lead to decreased resilience. The direction of these findings support previous research 
which suggests that individuals high in emotion-oriented coping and neuroticism, and low in resilience are at a 
greater risk for psychopathology (Penley et al., 2002, Smith et al., 2008). We must note, however, that 
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correlations for pedigree-associated genetic components are likely biased due to the influence of shared-
environmental effects which may be contained within the pedigree component, or vice versa. Unfortunately, due 
to a lack of power and model non-convergence, we were unable to report the environmental correlations 
between these traits. It would be of benefit to further investigate the genetic and environmental correlations 
between these traits in a larger sample to underpin important differences between the traits. For example, in 
further investigating the environmental correlations between resilience and coping style, we may be able to 
determine if having a resilient spouse is associated with a particular coping style.  
 
A number of limitations to this study deserve mention. Firstly, as noted above we employed a measure of 
resilience which takes a trait-based conceptualisation. Whilst this is not a problem itself, conceptual 
discrepancies in resilience measurement will hinder comparison between studies and preclude meta-analysis 
(Davydov et al., 2010). Secondly, as the re-contact cohort was a sub-set of the larger GS:SFHS sample, we were 
constrained by a limited number of participants with a reduced familial structure. Future investigation would 
greatly benefit from a larger sample size with an increased number of familial relationships to fully disentangle 
environmental components in the relationship between these traits. Furthermore, although we obtained estimates 
from effects from common-variant and pedigree-associated genetic, our sample is underpowered to detect small 
effects (Xia et al., 2016) which would be overcome by a larger sample size, either related (using our 
methodology) or between two independent datasets (using methods such as LD-score regression (Bulik-Sullivan 
et al., 2015a, Bulik-Sullivan et al., 2015b)). Finally, there may be other major shared and non-shared 
environmental effects of each of our traits that are not specifically captured in our analysis. For example, a great 
body of work suggests that resilience may be associated with stressful life events, growing up in adversity, or 
being raised in care (Beasley et al., 2003, Cicchetti and Rogosch, 2009, Collishaw et al., 2007, Dent and 
Cameron, 2003, DuMont et al., 2007).  
 
Here, we provide evidence that psychological resilience (quantified by a previously validated ordinal scale), is a 
heritable trait with a relatively small proportion of its variance explained by genetic factors. Early childhood 
environment such as that shared by the nuclear family was also found to have a small association with 
resilience. Task-, emotion- and avoidance-oriented coping styles were found to be moderately heritable, 
although substantial environmental effects also contributed to their phenotypic variance. Approximately one 
fifth of the variance in each coping style was attributable to recent environment shared by couples. These results 
indicate that both genetic and environmental contributors to resilience and coping style need to be considered in 
future research. Finally, high negative genetic correlations between resilience and both emotion-oriented coping 
and neuroticism suggests that the traits share an overlapping genetic architecture in which genetic factors that 
increase negative emotionality lead to reduced resilience. We argue that further work with larger samples sizes 
is necessary to fully delineate the genetic and environmental contributions of these traits, and the relationships 
between them to identify modifiable protective factors against psychological distress and illness.  
 
6.9. Chapter Conclusions 
This study sought to answer a fundamental question in resilience research: to what extent are individual 
differences in resilience due to the effect of genetic factors and the environment? Our results indicate that both 
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genetics and early shared-environmental effects contribute to resilience, which suggest it is the result of both 
nature and nurture. However, the majority of its phenotypic variance remains unexplained which illustrates a 
need to further investigate and quantify psychological resilience, so that it can be more reliably measured and 
the effects of non-shared environment separated from random error and noise. We also demonstrated that coping 
style was attributable to both genetic and recent shared-environmental factors. Interestingly, this study provided 
evidence to suggest that resilience, emotion-oriented coping, and neuroticism share an overlapping genetic 
architecture in which genetic factors that increase negative emotionality lead to reduced resilience. This finding 
gives rise to further questions regarding resilience as we need to understand how these genetic and 
environmental factors increase an individual‘s resilience as it could inform future clinical intervention. Moving 
forward, it would be beneficial to use larger samples to replicate these findings and to identify the specific 






























This thesis presented three empirical studies in which multiple and diverse methodological approaches were 
utilised with the aim to elucidate the aetiology and mechanisms of psychological resilience. The findings from 
these studies enabled important questions about the nature of resilience to be addressed: firstly, can protective 
factors mitigate the detrimental effects of known risk factors for Major Depressive Disorder (MDD, Chapter 3); 
secondly, does resilience represent an independent protective mechanism in vulnerability to MDD separate from 
risk (Chapter 5); and thirdly, to what extent is resilience the result of genetic or environmental contributions 
(Chapter 6).  
 
In Chapter 3, moderation analysis suggested that higher general intelligence (g) ameliorates the detrimental 
effects of neuroticism on both psychological distress and self-reported MDD, which suggests that protective 
factors can ameliorate the effects of risk on mental health outcomes. However, the protective effects of g on 
individuals at risk for MDD (by virtue of high levels of neuroticism) where not found in a clinical measure of 
MDD. These findings suggested that g may act as a resilience factor only at sub-threshold or at-risk levels. 
Whilst the protective effects of g were small, both absolutely, and in comparison to the risk conferring effects of 
neuroticism, the findings presented in this chapter suggest that protective factors may be important determinants 
of who is least or most likely to develop psychopathology. This work established a foundation from which to 
examine psychological resilience in subsequent chapters whereby resilience mechanisms and aetiology were 
investigated.  
 
Building upon the work presented in Chapter 3, structural equation modelling analysis in Chapter 5 indicated 
that resilience and risk are partially independent mechanisms in the depressogenic process. Specifically, it was 
found that resilience mediates the association between genetic risk for depression and the disorder itself to 
reduce the likelihood of MDD, whereas neuroticism independently mediates in the opposite direction to increase 
risk for MDD in genetically vulnerable individuals. Importantly, these findings were robust across clinical and 
self-reported measures of MDD. It is likely that risk and resilience represent partially independent mechanisms 
through the divergent use of negative and positive emotionality, respectively. However, it is important to 
determine to what extent these constructs are separate, and, as neuroticism represents a partially heritable 
personality trait, it is necessary to understand if resilience is also genetically determined.  
 
In Chapter 6, variance component analyses were employed to separate the phenotypic variance of both 
psychological resilience and coping style into their genetic and shared-environmental components to elucidate 
their aetiology. Findings suggested that resilience was in part determined by both common-variant associated 
genetic effects and early shared-environmental effects from the nuclear family. However, a large proportion of 
the phenotypic variance in resilience remained unexplained. The phenotypic variance in coping style was largely 
attributable to common-variant associated genetic effects, and recent environmental effects shared by spouses, 
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although divergent contributions were found across task-, emotion-, and avoidance-oriented coping styles. 
Strong negative genetic correlations were identified between resilience and emotion-oriented coping style, and 
between resilience and neuroticism, whereas a strong positive genetic correlation was found between emotion-
oriented coping and neuroticism. Such findings suggest an overlapping genetic architecture in which genetic 
factors that increase negative emotionality also lead to reduced psychological resilience.  
 
Together, these findings provide new insights into psychological resilience, and demonstrate the need to employ 
diverse multivariate methodologies to disentangle the construct. To illustrate, the use of moderation analysis, 
structural equation modelling, and variance component analysis have each revealed unique elements pertaining 
to resilience, and illuminated several important findings that may lay the foundation for future research and 
clinical practise. For example, the identification of protective factors that may ameliorate the detrimental effects 
of known risk factors for MDD may provide clinicians a starting point from which to identify which individuals 
are most likely to ‗bounce back‘ from mental health problems. Specifically, clinicians may be able to determine 
which individuals are most likely to respond to treatment, or remit based on the number/intensity/combination 
of protective factors they possess. Furthermore, as risk and resilience have been found to be partially 
independent pathways exerting divergent effects on MDD, clinicians may benefit from both fortifying ‗existing 
resilience‘ and ‗training‘ individuals to use a number of resilience techniques (such as positive emotionality and 
task-oriented coping) which could be used prior to MDD onset and maintained throughout the life course. 
Moreover, with the identification of genetic architectures and modifiable environmental risk factors, it may be 
possible to foster resilience in childhood and provide individuals with the tools needed to ‗bounce back‘ from a 
young age, which can be strengthened into adulthood. Such work would benefit and build upon existing 
programmes such as the UK resilience programme (UKRP) which was launched in 2007 in order improve the 
psychological well-being of school children. Specifically, UKRP aimed to investigate if teaching resilience 
would affect children‘s wellbeing, behaviour, attendance and academic attainment and found significant short-
term improvements in mental health, school attendance rates and academic attainment in English (Challen et al, 
2011). A better knowledge of the aetiology and mechanisms underlying resilience may enable researchers to 
ensure programmes such as UKRP can exert their effect long term, perhaps even into adulthood. 
Ultimately, resilience research has the potential not only to alleviate individual suffering but also reduce the 
economic burden associated with MDD by focussing on prevention rather than cure. However, further 
replication and advancement is needed in order to generate working hypotheses for psychiatry research and 
practise. The studies presented within this thesis provide a foundation for future research, and raise more 
questions than answers. Indeed, despite producing a number of novel and important findings, this body of work 
is not without its caveats which should be addressed moving forward. 
 
7.2. Limitations 
The limitations associated with each individual study within this thesis have already been discussed within their 
corresponding chapters, and as such, the specific caveats pertaining to each study will not be re-addressed here. 
Rather, presented below are a number of limitations applicable to this thesis in general.  
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(1) Firstly, a limitation pertaining to almost all analyses within this thesis is the use of retrospective 
accounts of lifetime incidence of MDD. Within this thesis, the use self-reported questionnaire measures 
to estimate life-time prevalence of MDD were used, and whilst common in epidemiological cohort 
studies they are subject to several caveats regarding their reliability. For example, there is a growing 
body of evidence to suggest that retrospective accounts of MDD are susceptible to recall bias and 
distortions of memory. A number of studies have reported diminishing recall of past MDD episodes 
with increasingly long intervals between episodes of illness (Thompson et al, 2004, Wells and 
Horwood, 2012, Patten et al, 2012) which suggest the use of retrospective accounts may underestimate 
true lifetime prevalence rates. Although unlikely to be a caveat in this thesis, retrospective accounts of 
MDD may also be impeded in older samples in which recall error is exacerbated by cognitive decline. 
Further research also suggests that retrospective accounts of MDD may be an unreliable metric based 
on current mood state, and co-morbid conditions (Baker et al, 2004, Knäuper and  Turner, 2003, Stone 
et al, 2000).. It is important to note this limitation as it is possible our results have not captured a true 
reflection of MDD prevalence within our samples, despite this being the best method at our disposal. 
The use of NHS data linkage in future studies may overcome such issues and it would be benefit to 
compare retrospective accounts of MDD episodes and prevalence with clinical records.  
 
(2) Secondly, the three studies presented within this thesis are based on individuals of White British 
ancestry, and as such the results may not be generalisable to other populations. As indicated in Chapter 
2, there is evidence to suggest that resilience differs between ethnicities (Adams and Boscarino, 2005, 
Bonanno et al., 2006), a hypothesis that this thesis has not addressed. Furthermore, as the samples used 
in the studies within this thesis are primarily Caucasian, more affluent, and better educated than the 
general population in the UK it does not necessarily mean any results can be inferred across all 
demographic profiles.   
 
(3) Thirdly, the genetic analyses within this thesis are constrained by insufficient power. Specifically, it is 
likely that the sample sizes used within this thesis have precluded precise heritability estimates, 
provided insufficient power to reliably detect and differentiate contributors to phenotypic variance, and 
created uncertainty regarding the generalisability of findings to the general population. Although the 
sample sizes reported in each chapter are some of the largest reported to date, increasing sample sizes 
would provide greater predictive power, and as such further replication with larger sample sizes – 
especially for genetic analysis - is necessary. 
 
(4) This thesis assessed adversity in relatively narrow terms. Whilst both genetic vulnerability and 
neuroticism are well documented risk factors for MDD (Hyman, 2014, Lahey, 2009, Levine et al., 
2014), and important findings have been found demonstrating that resilience can attenuate the 
detrimental effects of these factors on depression, this thesis has failed to examine the effects of 
resilience on other risk factors for the disorder. As discussed in Chapters 1 and 2, a wide range of risk 
factors are associated with MDD (Dobson and Dozois, 2011) across biological, psychological, 
environmental and social domains. This thesis may have benefited from examining the role of 
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resilience across a wider range of MDD risk factors. For example, the moderating effects of g may be 
stronger when examining the risk conferring effects of job stress on MDD onset. Additionally, 
resilience and neuroticism may prove entirely separate mechanisms when mediating the association 
between negative life events and MDD, compared to partially separate mechanisms when investigating 
genetic liability for MDD and the disorder. As such, it would be beneficial to conduct further research 
with an increasing number of risk factors to further elucidate resilience mechanisms across all aspects 
of adversity.  
 
(5) Finally, this thesis has failed to operationalise psychological resilience, an initial aim of this body of 
work. Although the findings reported in this thesis are important for guiding future research, they have 
not provided sufficient insight to be able to define the concept of resilience. This is potentially due to 
the utilisation of the Brief Resilience Scale (BRS). The BRS is a quantitative measure assessing an 
individual‘s ability to ‗bounce back‘, and although it is framed in regard to the negative events an 
individual has experienced it fails to distinguish which protective factors result in high levels of 
resilience. As denoted in Chapter 2, resilience is likely a process, an outcome, influenced by multiple, 
independent predictors and this thesis has failed to determine which factors produce resilience across a 
range of domains (Bonanno et al., 2007, Bonanno and Mancini, 2008). Such a homogenous approach 
has likely restricted the ability to elucidate resilience factors which would aid in the operationalisation 
of the construct.  
  
The findings presented in this thesis are constrained due to homogenous sample demographics, the lack of 
investigating specific resilience factors and the failure to examine resilience to multiple adversities and/or risk. 
However, despite the above limitations, these studies do provide a starting point from which to further 
investigate psychological resilience and elucidate its mechanisms and aetiology.  
 
7.3. Future directions 
Interest in psychological resilience has grown exponentially in recent decades, with research into this field 
developing rapidly. Many methodologies have yet to be utilised in the resilience enquiry, and there exists an 
exciting opportunity for further advancements in the characterisation of resilience phenotypes. Future research 
investigating resilience has the potential to identify targets for more effacious treatments in MDD which focus 
on prevention long before the need for curative strategies. A number of potential directions for future study are 
provided, below. 
 
(1) It is important to recognise that the results presented within this thesis require replication. A first aim 
for future research would be to replicate the studies discussed here in larger, less homogenous samples. 
Increased sample sizes would provide researchers additional statistical power to ensure the effects 
reported are not false positives and would provide scientists the confidence to extrapolate any findings 
for generalisability in the general population. Furthermore, investigating more diverse samples 
representing all demographic strata would enable researchers to infer if the results presented here are 
robust across ethnicity, age, education, and socioeconomic background. 
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(2) Secondly, it is important that future work investigates resilience from multiple perspectives. As 
discussed above, this thesis employed only the Brief Resilience Scale as a measure of psychological 
resilience, although as noted in Chapter 2, several quantitative measures of resilience have been 
validated (Windle et al., 2011). It would be valuable to compare results across different measures of 
resilience so as to investigate their underlying similarities with methods such as factor analysis. Such 
an investigation may further our knowledge of resilience and aid in the quantification of the construct. 
Furthermore, it would be incredibly valuable to examine resilience as the residual between actual and 
predicted psychiatric symptoms based on the total number of negative life events an individual has 
experienced. Such a method is already gaining popularity (Amstadter et al., 2016, van Harmelen et al., 
2017) and satisfies two of the core components of resilience; adversity and positive adaptation. 
Moreover, this methodology would enable researchers to accurately predict which individuals are most 
likely to be resilience to MDD, in addition to examining the protective factors which influence 
resilience. 
 
(3) To build upon the work presented in Chapter 6, it would be highly advantageous to further investigate 
the genetic architecture of psychological resilience so as to elucidate who is most likely to be 
‗resilient‘. A valuable starting point would be to conduct a genome-wide association study (GWAS) to 
determine if there are any specific genetic variants associated with resilience. GWAS can be applied to 
both population- and family-based samples and can be performed on sets of variants categorized by 
genes, pathways or functional regions and so would be a powerful tool to utilise. Such an analysis was 
not performed within this thesis as GWAS requires substantial statistical power, which we currently do 
not have in the GS:SFHS dataset. In future investigation, it would be of benefit to run GWAS on larger 
sample sizes (n > 10,000) and potentially meta-analyse the results across multiple GWAS to overcome 
issues such as homogenous samples. Furthermore, with the availability to GWAS summary statistics, 
polygenic risk profiling would be available to researchers. The creation of polygenic risk scores (PRS) 
provide a quantitative and environmental-free method which can be used to reflect an individual‘s 
genetic propensity for resilience. It would be useful in future studies to employ PRS for resilience to 
investigate how it associates with risks/adversity and mental health outcomes. 
 
(4) Finally, it would be of benefit to examine protective factors in more detail. Specifically, complex 
structural equation models would enable researchers the opportunity to investigate the multifaceted 
associations between genetics, the brain, and a comprehensive range of protective factors and how they 
work together to produce a resilient outcome. Although such an analysis would be largely theoretically 
determined, it could potentially incorporate all known aspects of psychological resilience. Furthermore, 
once a better understanding of protective factors and resilience mechanisms has been reached, 
methodologies such as Machine Learning may provide a suitable way to test proposed causal pathways 
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7.4. General conclusions 
Despite significant risk for psychiatric disorders such as MDD, not all individuals become unwell. This thesis is 
a collection of studies examining psychological resilience; the ability to demonstrate better than expected 
adjustment and ‗bounce back‘ from adversity. At present, no consensus has been reached as to how resilience 
should be defined and measured, with debate remaining as to whether the construct is a trait or an outcome. 
Furthermore, until now, researchers were unsure whether risk and resilience represented independent constructs. 
This thesis comprises three novel studies which sought to investigate resilience from a number of perspectives 
with the aim of elucidating its aetiology and mechanisms. Moderation analyses, structural equation modelling, 
and variance component analysis were each utilised to further understand the facets of resilience. Whilst the 
concept of resilience was not fully elucidated for the purpose of operationalisation, the use of diverse 
multivariate methodologies has revealed several important features of resilience. To illustrate, this thesis 
provides evidence to suggest that risk and resilience are partially independent mechanisms, protective factors 
such as intelligence can mitigate the detrimental effects of known MDD risks, and resilience has a shared 
genetic aetiology with traits such as neuroticism and emotion-oriented coping in which genes responsible for 
negative emotionality reduce resilience. Such results provide an important starting point to build upon our 
knowledge of resilience and suggest that multivariate approaches are necessary. With further resilience research, 
scientists may be able to develop preventative strategies in mental health and circumvent the need for curative 
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Appendix A 
Supplementary material from Chapter 3 
 
 
Table A1 Demographic, clinical, and cognitive differences between full GS:SFHS and UK Biobank cohorts 
and samples within this study 
 
Table A2 Results of a MCMC generalized linear mixed model from GS:SFHS predicting odds ratios of 
MDD status, p value, upper and lower 95% confidence intervals and the Deviance Information 
Criterion 
 
Table A3 Results of a MCMC generalized linear mixed model from GS:SFHS predicting beta coefficients of 
psychological distress (GHQ), p value, upper and lower 95% confidence intervals and the 
Deviance Information Criterion 
 
Table A4 Results of a logistic regression from UK Biobank predicting odds ratios for self-reported MDD 
status, p value, upper and lower 95% confidence intervals and the Akaike Information Criterion 
 
Table A5 Results of a regression from UK Biobank predicting beta coefficients of psychological distress 




Table A1. Demographic, clinical, and cognitive differences between full GS:SFHS and UK Biobank cohorts and samples within this 
study 
 GS:SFHS UK Biobank 
 Full sample 
(N = 24,084) 
Complete cases 
(N = 19,200) 
Full sample  
(N ~ 500,000) 
Complete cases  
(N = 90,529) 
Age  47.64 (15.41) 47.16 (14.97) * 56.53 (8.09) 56.64 (8.13) * 
Sex (% female) 59 59 54 52 
MDD (%) 13 13 33 33 
Neuroticism  3.87 (3.17)  3.84 (3.16)  3.82 (2.91) 3.46 (2.86) * 
GHQ score  16.01 (8.86)  15.93 (8.81)  -  
PHQ score - - 1.59 (2.07) 1.36 (1.91) * 
Wechsler Digit Symbol Substitution Task 72.23 (17.22) 72.31 (17.09)  - - 
Mill-Hill Vocabulary Test 30.06 (4.76) 30.06 (4.76) - - 
Weschler Logical Memory Test I & II 30.70 (8.48) 31.01 (8.04) * - - 
Verbal Fluency Test  22.73 (11.17) 25.68 (8.10) * - - 
Reaction time - - 559.65 (118) 564.00 (119.87) * 
Visual memory - - 4.15 (3.40) 4.04 (3.21) * 
Verbal-numerical reasoning - - 5.98 (2.16) 6.09 (2.14) * 
SIMD 3909.66 (1846.91) 3903.82 (1851.91) - - 
Townsend Score - - -1.29 (3.09) -1.37 (2.84) * 
Abbreviations: GS:SFHS, Generation Scotland: the Scottish Family Health Study; MDD, Major Depressive Disorder ; GHQ, General 
Health Questionnaire; PHQ, Patient Health Questionnaire; SIMD, the Scottish Index of Multiple Deprivation 
With the exception of sex and MDD, values represent Mean (SD) 
N.B. The UK Biobank samples do not include any individuals who have also taken part in GS:SFHS (N = 147) 
* Significantly different to the full sample, using a one-sample t test, p < .05 
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Table A2. Results of a MCMC generalized linear mixed model from GS:SFHS predicting odds ratios of MDD 
status, p value, upper and lower 95% confidence intervals and the Deviance Information Criterion 
Model Variables Odds Ratio Lower 95% CIs 
Upper 
95% CIs p value DIC 
1.0 Neuroticism 3.62 3.29 4.03 < 1.00x10ˉ⁴ 12428.30 
 Age 1.19 1.16 1.23 < 1.00x10ˉ⁴  
 Age² 1.00 1.00 1.00 < 1.00x10ˉ⁴  
 Sex (M) 0.58 0.58 0.66 < 1.00x10ˉ⁴  
1.1 g 0.96 0.91 1.01 <0.12x10ˉˉˉ 13784.89 
 Age 1.20 1.16 1.24 < 1.00x10ˉ⁴  
 Age² 1.00 1.00 1.00 < 1.00x10ˉ⁴  
 Sex (M) 0.37 0.32 0.44 < 1.00x10ˉ⁴  
1.2 Neuroticism 3.68 3.33 4.09 < 1.00x10ˉ⁴ 12421.57 
 g 1.08 1.01 1.14 < 1.54x10ˉ²  
 Age 1.19 1.15 1.23 < 1.00x10ˉ⁴  
 Age² 1.00 1.00 1.00 < 1.00x10ˉ⁴  
 Sex (M) 0.59 0.50 0.68 < 1.00x10ˉ⁴  
 Neuroticism * g 1.04 0.99 1.09 <  0.12x10ˉˉˉ  
1.3 Neuroticism 3.61 3.28 4.00 < 1.00x10ˉ⁴ 12397.53 
 g 1.12 1.05 1.18 <2.05x10ˉ⁴  
 SIMD 0.99 0.99 1.00 < 1.00x10ˉ⁴  
 Age 1.19 1.15 1.22 < 1.00x10ˉ⁴  
 Age² 1.00 1.00 1.00 < 1.00x10ˉ⁴  
 Sex (M) 0.60 0.52 0.69 < 1.00x10ˉ⁴  
 Neuroticism * g 1.04 0.99 1.09 <0.10x10ˉˉ⁴  
Abbreviations: MCMC, Markov Chain Monte Carlo; GS:SFHS, Generation Scotland: the Scottish Family 
Health Study; MDD, major depressive disorder; DIC, Deviance Information Criterion; g, General Intelligence; 
SIMD, Scottish Index of Multiple Deprivation 
 
Table A3. Results of a MCMC generalized linear mixed model from GS:SFHS predicting beta coefficients of 
psychological distress (GHQ), p value, upper and lower 95% confidence intervals and the Deviance Information 
Criterion 
Model Variables β Lower 95% CIs 
Upper 
95% CIs p value DIC 
2.0 Neuroticism -0.51 -0.50 -0.53 < 1.00x10ˉ4 47987.62 
 Age -0.02 -0.01 -0.02 < 1.00x10ˉ4  
 Age² -0.00 -0.00 -0.00 < 1.00x10ˉ4  
 Sex (M) -0.03 -0.06 -0.01 < 1.66x10ˉ2  
2.1 g -0.09 -0.10 -0.08 < 1.00x10ˉ4 52975.92 
 Age -0.03 -0.02 -0.03 < 1.00x10ˉ4  
 Age² -0.00 -0.00 -0.00 < 1.00x10ˉ4  
 Sex (M) -0.22 -0.25 -0.20 < 1.00x10ˉ4  
2.2 Neuroticism -0.59 -0.48 -0.51 < 1.00x10ˉ4 47795.04 
 g -0.05 -0.06 -0.04 < 1.00x10ˉ4  
 Age -0.02 -0.02 -0.02 < 1.00x10ˉ4  
 Age² -0.00 -0.00 -0.00 < 1.00x10ˉ4  
 Sex (M) -0.94 -0.06 -0.02 <1.58x10ˉ3  
 Neuroticism * g -0.05 -0.06 -0.04 < 1.00x10ˉ4  
2.3 Neuroticism -0.50 -0.49 -0.51 < 1.00x10ˉ4 47754.07 
 g -0.04 -0.05 -0.03 < 1.00x10ˉ4  
 SIMD 2.49x10ˉ5 -3.15x10ˉ5 -1.81x10ˉ5 < 1.00x10ˉ4  
 Age -0.02 -0.02 -0.02 < 1.00x10ˉ4  
 Age² -2.11x10ˉ4 -2.61x10ˉ4 -1.65x10ˉ4 < 1.00x10ˉ4  
 Sex (M) -0.04 -0.06 -0.01 <5.00x10ˉ3  
 Neuroticism * g -0.05 -0.06 -0.04 < 1.00x10ˉ4  
Abbreviations: MCMC, Markov Chain Monte Carlo; GS:SFHS, Generation Scotland: the Scottish Family 
Health Study; GHQ, General Health Questionnaire; DIC, Deviance Information Criterion; g, General 
Intelligence; SIMD, Scottish Index of Multiple Deprivation 
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Table A4. Results of a logistic regression from UK Biobank predicting odds ratios for self-reported MDD 
status, p value, upper and lower 95% confidence intervals and the Akaike Information Criterion 
Model Variables Odds ratio Lower 95% CIs 
Upper 
95% CIs p value AIC 
3.0 Neuroticism 2.39 2.35 2.43 < 2.00x10ˉ16 98707 
 Age 1.17 1.14 1.20 < 2.00x10ˉ16  
 Age² 1.00 1.00 1.00 < 2.00x10ˉ16  
 Sex (M) 0.67 0.66 0.69 < 2.00x10ˉ16  
3.1 g 0.99 0.98 1.01 < 0.39x10ˉ²¹ 111620 
 Age 1.17 1.14 1.20 < 2.00x10ˉ16  
 Age² 1.00 0.97 1.02 < 2.00x10ˉ16  
 Sex (M) -0.60. 0.58 0.61 < 2.00x10ˉ16  
3.2 Neuroticism 2.40 2.36 2.44 < 2.00x10ˉ16 98649 
 g 1.05 1.04 1.07 < 5.29x10ˉ12  
 Age 1.16 1.13 1.20 < 2.00x10ˉ16  
 Age² 1.00 1.00 1.00 < 2.00x10ˉ16  
 Sex (M) 0.67 0.65 0.68 < 2.00x10ˉ16  
 Neuroticism * g 0.96 0.95 0.98 <  3.44x10ˉ76  
3.3 Neuroticism 2.39 2.35 2.43 < 2.00x10ˉ16 98421 
 g 1.07 1.05 1.08 < 2.00x10ˉ16  
 Townsend Score 1.04 1.04 1.05 < 2.00x10ˉ16  
 Age 1.16 1.10 1.22 < 2.00x10ˉ16  
 Age² 1.00 1.00 1.00 < 2.00x10ˉ16  
 Sex (M) 0.66 0.65 0.68 < 2.00x10ˉ16  
 Neuroticism * g 0.97 0.95 0.98 < 6.80x10ˉ76  
Abbreviations: MDD, major depressive disorder; AIC, Akaike Information Criterion; g, General Intelligence 
Table A5.  Results of a regression from UK Biobank predicting beta coefficients of psychological distress 
(PHQ), p value, upper and lower 95% confidence intervals and the adjusted R² value for the model 
Model Variables β Lower 95% CIs 
Upper 
95% CIs p value R
2 
4.0 Neuroticism -0.52 -0.51 -0.52 < 2.00x10ˉ16 .2933 
 Age -0.00 -0.01 -0.01 < 0.85x10ˉ⁶   
 Age² -0.00 -0.00 -0.00 <3.56x10ˉ31  
 Sex (M) -0.01 -0.00 -0.03 <1.89x10ˉ51  
4.1 g -0.08 -0.08 -0.07 < 2.00x10ˉ16 .0420 
 Age -0.02 -0.01 -0.03 < 2.32x10ˉ31  
 Age² -0.00 -0.00 -0.00 < 1.31x10ˉ12  
 Sex (M) -0.09 -0.10 -0.08 < 2.00x10ˉ16  
4.2 Neuroticism -0.51 -0.51 -0.52 < 2.00x10ˉ16 .2977 
 g -0.05 -0.06 -0.05 < 2.00x10ˉ16  
 Age -0.00 -0.00 -0.01 < 0.55x10ˉˉˉ  
 Age² -0.00 -0.00 -0.00 < 1.88x10ˉ41  
 Sex (M) -0.02 -0.02 -0.00 < 6.20x10ˉ91  
 Neuroticism * g -0.02 -0.03 -0.02 < 2.00x10ˉ16  
4.3 Neuroticism -0.51 -0.51 -0.52 < 2.00x10ˉ16 .3045 
 g  -0.04 -0.05 -0.04 < 2.00x10ˉ16  
 Townsend Score -0.03 -0.03 -0.03 < 2.00x10ˉ16  
 Age -0.00 -0.00 -0.02 <0.29x10ˉˉˉ  
 Age² -0.00 -0.00 -0.01 < 8.19x10ˉ51  
 Sex (M) -0.00 -0.00 -0.00 <1.33x10ˉ71  
 Neuroticism * g -0.02 -0.03 -0.02 < 2.00x10ˉ16  
Abbreviations: PHQ, Patient Health Questionnaire; g, General Intelligence 
 
- 112 - 
 
Appendix B 
Supplementary material from Chapter 5 
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Participants were sampled from the Generation Scotland: Scottish Family Health Study (GS:SFHS) – a family-
based epidemiological cohort recruited at random from General Practitioners‘ practices throughout Scotland 
between 2006 and 2011 (Smith et al., 2013, Smith et al., 2006). During baseline assessment, participants aged 
18-98 (N = 24,090, Mean = 47.64, SD = 15.41) provided a wealth of clinical, phenotypic and biological data, 
including personality measures such as Neuroticism and a structured interview for clinical MDD diagnosis. 
Blood and salivary DNA was also taken for 98% of the cohort for genome-wide genotyping (Smith et al, 2006; 
Smith et al, 2013). In September 2014, GS:SFHS participants were re-contacted and asked to take part in a 
follow-up assessment of mental health and resilience (Navrady et al., 2017a). A total of 9,618 participants aged 
22-100 (Mean = 56.43, SD = 13.37) provided useable re-contact data including questionnaire measures of self-
reported MDD and resilience. This study includes 4,166 unrelated individuals (Mean age = 56.01, SD = 12.31, n 
female = 2,634) with complete data of interest. 
 




Thresholds for MDD Polygenic Risk Scores 
Table B1. Results of generalized linear mixed models predicting odds ratios for clinical MDD status (SCID), p 
value, upper and lower 95% confidence intervals and the Akaike Information Criterion, from five PRS 
thresholds 
PRS Threshold Odds Ratio Lower 95% CI Upper 95% CI p value AIC 
0.01 1.24 1.14 1.35 < 0.001 3600.90 
0.05 1.25 1.15 1.37 < 0.001 3598.40 
0.10 1.26 1.16 1.37 < 0.001 3597.50 
0.50 1.20 1.11 1.31 < 0.001 3607.60 
1.00 1.20 1.10 1.31 < 0.001 3608.20 
Abbreviations: SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, representing clinical MDD; 
MDD, Major Depressive Disorder; AIC, Akaike Information Criterion; PRS, Polygenic Risk Score 
NB. Each model was adjusted for baseline age (t1: when the SCID was administered), sex and four principal 
components which control for population stratification 
 
 
Table B2. Results of generalized linear mixed models predicting odds ratios of self-reported MDD status (CIDI-
SF), p value, upper and lower 95% confidence intervals and the Akaike Information Criterion, from five PRS 
thresholds 
PRS Threshold Odds Ratio Lower 95% CI Upper 95% CI p value AIC 
0.01 1.13 1.05 1.21 0.001 4642.80 
0.05 1.14 1.06 1.22 < 0.001 4640.90 
0.10 1.16 1.08 1.25 < 0.001 4636.00 
0.50 1.18 1.10 1.27 < 0.001 4632.80 
1.00 1.18 1.10 1.27 < 0.001 4633.20 
Abbreviations: CIDI-SF, Composite International Diagnostic Interview – Short Form, representing self-reported 
MDD; MDD, Major Depressive Disorder; AIC, Akaike Information Criterion; PRS, Polygenic Risk Score 
NB. Each model was adjusted for age at follow-up (t2: when the CIDI-SF was completed), sex and four 











Table B3. Correlation Matrix and Descriptive Statistics 
 
 BRS1 BRS2 BRS3 BRS4 BRS5 BRS6 Resilience EPQ1 EPQ3 EPQ5 EPQ7 EPQ9 EPQ11 EPQ13 EPQ15 EPQ17 EPQ19 EPQ21 EPQ23 Neuroticism Mean (SD) N  
 
BRS1 -                    3.70 (0.96)  
BRS2 .47 -                   3.40 (1.04)  
BRS3 .68 .45 -                  3.49 (1.00)  
BRS4 .56 .63 .51 -                 3.52 (1.04)  
BRS5 .62 .50 .63 .52 -                3.55 (1.01)  
BRS6 .60 .61 .54 .69 .57 -               3.64 (1.04)  
Resilience .81 .77 .79 .82 .80 .84 -              3.52 (0.82)  
EPQ1 -.26+ -.24+ -.27+ -.24+ -.28+ -.24+ -.32+ -              1513 
EPQ3 -.30+ -.26+ -.28+ -.26+ -.29+ -.27+ -.34+ .63* -             1310  
EPQ5 -.15+ -.14+ -.14+ -.13+ -.15+ -.14+ -.18+ .52* .36* -            1105 
EPQ7 -.22+ -.20+ -.23+ -.23+ -.23+ -.22+ -.27+ .40* .42* .30* -           1847 
EPQ9 -.30+ -.27+ -.27+ -.26+ -.27+ -.27+ -.34+ .70* .66* .47* .45* -          1276 
EPQ11 -.24+ -.24+ -.23+ -.23+ -.24+ -.24+ -.30+ .43* .40* .36* .47* .40* -         990  
EPQ13 -.27+ -.27+ -.27+ -.27+ -.30+ -.25+ -.34+ .50* .47* .39* .57* .49* .58* -        2382 
EPQ15 -.23+ -.22+ -.20+ -.20+ -.20+ -.20+ -.26+ .52* .43* .50* .47* .44* .69* .66* -       653 
EPQ17 -.23+ -.20+ -.21+ -.22+ -.24+ -.20+ -.27+ .40* .42* .28* .60* .43* .50* .62* .46* -      1796 
EPQ19 -.23+ -.24+ -.22+ -.22+ -.24+ -.23+ -.29+ .47* .43* .38* .41* .46* .75* .61* .70* .43* -     848  
EPQ21 -.22+ -.18+ -.19+ -.18+ -.20+ -.21+ -.25+ .57* .55* .36* .44* .67* .38* .42* .45* .40* .43* -    582 
EPQ23 -.24+ -.20+ -.24+ -.23+ -.23+ -.21+ -.28+ .49* .50* .34* .51* .48* .48* .59* .49* .66* .48* .49* -   1107 
Neuroticism -.41 -.37 -.39 -.38 -.40 -.38 -.48 .64+ .60+ .49+ .59+ .64+ .60+ .64+ .58+ .61+ .59+ .51+ .61+ - 3.70 (3.17)  
Aget1 .04 .04 .04 .03 .04 .05 .05 -.15+ -.13+ -.14+ -.04+ -.14+ -.06+ -.04+ -.04+ -.06+ -.12+ -.02+ -.05+ -.14 50.28 (12.34)  
Aget2 .05 .04 .04 .03 .04 .05 .05 -.15+ -.13+ -.13+ -.03+ -.13+ -.06+ -.04+ -.04+ -.06+ -.12+ -.01+ -.04+ -.14 56.01 (12.31)  
Sex (F) -.10+ -.06+ -.09+ -.09+ -.11+ -.06+ -.10+ .10* .22* -.06* .37* .06* .16* .26* .15* .27* .04* .20* .26* .17+  2634 
SCID -.27+ -.23+ -.24+ -.23+ -.28+ -.24+ -.31+ .45* .51* .22* .33* .43* .37* .39* .38* .32* .41* .47* .42* .36+  664 
CIDI-SF -.31+ -.26+ -.29+ -.26+ -.31+ -.28+ -.35+ .35* .42* .16* .22* .37* .26* .26* .26* .24* .29* .39* .33* .29+  1068 
 
Abbreviations: Aget1, Age at baseline; Aget2, Age at re-contact; BRS, Individual items from the Brief Resilience Scale; Resilience, Total score from the Brief Resilience Scale; EPQ, 
Individual items from the Eysenck Personality Questionnaire Short-Form; Neuroticism, Total score from the Eysenck Personality Questionnaire Short-Form; SCID, Structured Clinical 
Interview for DSM-IV Axis I Disorders representing clinical MDD; CIDI-SF, Composite International Diagnostic Interview – Short Form representing self-reported MDD.  
N.B. All p-values significant at p < 0.01 
EPQ items represent the number and percentage of ‗Yes‘ responses. SCID and CIDI-SF represent the number of individuals meeting criteria for clinical and self-reported MDD, 
respectively 
All coefficients represent Pearson correlations except those denoted by * which represent tetrachoric correlations – resultant from both variables being binary, and those denoted by + 
which represent point biserial correlations – resultant from binary and continuous variables 
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Descriptive Statistics for Clinical and Self-reported MDD 
 
Clinical MDD 
Based on Structured Clinical Interview for DSM-IV Axis I Disorders (SCID; First et al., 1997) at baseline 
assessment (2006-2011), clinically diagnosed MDD cases were predominately female (73%) and younger than 
non-MDD cases (61% female, M = 49.13, SD = 11.39 and M = 50.49, SD = 12.50, respectively); (t(990.30) = 
2.78, p < 0.001, Cohen‘s d = .11). Clinical MDD cases were found to have significantly higher neuroticism 
scores (M = 6.31, SD = 3.28) than did non-MDD cases (M = 3.20, SD = 2.90); (t(869.91) = 22.75, p < 0.001, 
Cohen‘s d = 1.00). Clinically diagnosed MDD cases were found to score significantly lower in resilience (M = 
2.94, SD = 0.85) in comparison to non-MDD cases (M = 3.63, SD = 0.76); (t(879.19) = 19.48, p < 0.001, 
Cohen‘s d = .08). 
 
Self-reported MDD 
Using the Composite International Diagnostic Interview – Short Form (CIDI-SF; Kessler et al., 1998) at re-
contact (2014-2017), a larger proportion of females met criteria for self-reported depression (75%) in 
comparison to non-MDD cases (59%). Self-reported MDD cases were younger (M = 54.40, SD = 12.28) in 
comparison to non-MDD cases (M = 56.56, SD = 12.27) at re-contact; (t(1852.70) = 4.96, p < 0.001, Cohen‘s d 
= .18). Individuals self-reporting MDD scored higher in neuroticism than did non-MDD cases (M = 5.26, SD = 
3.45 and M = 3.16, SD = 2.88, respectively); (t(1608) = 17.80, p < 0.001, Cohen‘s d = .66). Significant group 
differences were found between self-reported MDD cases (M = 3.03, SD = 0.86) and non-MDD cases (M = 
3.69, SD = 0.73) in resilience; (t(1617.60) = 22.33, p < 0.001, Cohen‘s d = .83), whereby self-reported MDD 
cases scored lower on psychological resilience.  
 
Overlap between clinical and self-reported MDD 
The two measures of MDD were taken at two separate time-points using two different methods, approximately 
six years apart. Below is a table detailing the overlap between these two measures in our sample of 4,166 
individuals. 
 
Table B4. The overlap of individuals meeting criteria for clinical and self-reported MDD in the current sample 
(n = 4,166) 
  Self-reported MDD (CIDI-SF) 
  Met criteria Did not meet criteria 
Clinical MDD (SCID) Met criteria 411 253 Did not meet criteria 6157 2,845 
Abbreviations: SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, representing clinical MDD; 
CIDI-SF, Composite International Diagnostic Interview – Short Form, representing self-reported MDD; MDD, 
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Moderation models for clinical MDD 
 
Table B5. Results of a generalised linear model predicting odds ratios for clinical MDD status, p value, upper 
and lower 95% confidence intervals and the Akaike Information Criterion  
MDD 




95%  CIs p value AIC 
SCID Aget1 0.99 0.99 1.00 0.031 3607.60 
 Sex (F) 1.71 1.42 2.07 1.53x10-8  
 PRS 1.20 1.11 1.31 1.87x10-5  
 C1 2.92 0.00 7.89x1024 0.969  
 C2 0.01 0.00 8.63x1026 0.886  
 C3 0.00 0.00 1.05 0.127  
 C4 1.83x104 0.01 2.07x1010 0.169  
SCID Aget1 0.99 0.99 1.00 0.026 3155.90 
 Sex (F) 1.33 1.09 1.63 0.005  
 PRS 1.16 1.05 1.29 0.004  
 Neuroticism 2.49 2.28 2.72 < 2.00x10ˉ16  
 PRS * Neuroticism 0.92 0.84 1.00 0.062  
 C1 1.60x103 0.00 2.18x1029 0.805  
 C2 0.00 0.00 2.05x1026 0.431  
 C3 0.01 0.00 8.08x102 0.516  
 C4 134.63 0.00 3.43x108 0.062  
SCID Aget1 0.99 0.99 1.00 0.030 3251.90 
 Sex (F) 1.53 1.26 1.86 1.97x10ˉ⁵  
 PRS 1.17 1.06 1.30 0.002  
 Resilience 0.44 0.40 0.48 < 2.00x10ˉ16  
 PRS * Resilience 1.06 0.97 1.16 0.211  
 C1 0.00 0.00 1.58x1022 0.753  
 C2 0.00 0.00 8.81x1022 0.629  
 C3 0.00 0.00 2.42x102 0.323  
 C4 1.03x1048 0.04 2.44x1011 0.124  
Abbreviations: SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, representing clinical MDD; 
MDD, Major Depressive Disorder; AIC, Akaike Information Criterion; PRS, Polygenic Risk Score; Aget1, Age 
at the time of baseline; C1-4, the principal components which control for population stratification 
N.B. Neuroticism has been controlled for Aget1 and these residuals used within the model. Resilience has been 
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Moderation models for self-reported MDD 
 
Table B6. Results of a generalised linear model predicting odds ratios for self-reported MDD status, p value, 
upper and lower 95% confidence intervals and the Akaike Information Criterion 
MDD 




95%  CIs p value AIC 
CIDI-SF Aget2 0.99 0.98 0.99 1.88x10-5 4632.80 
 Sex (F) 1.94 1.66 2.28 < 2.00x10-16  
 PRS 1.18 1.10 1.27 6.01x10-6  
 C1 5.87x1018 0.01 2.18x1040 0.082  
 C2 0.63 0.00 3.17x1024 0.987  
 C3 0.00 0.00 1.85 0.068  
 C4 5.41x102 0.00 7.40x107 0.298  
CIDI-SF Aget2 0.99 0.98 0.99 4.48x10-6 4366.40 
 Sex (F) 1.66 1.41 1.95 1.03x10-9  
 PRS 1.13 1.05 1.22 0.002  
 Neuroticism 1.81 1.68 1.95 < 2.00x10-16  
 PRS * Neuroticism 0.97 0.90 1.04 0.416  
 C1 1.81x1021 0.54 4.30x1043 0.058  
 C2 0.07 0.00 3.19x1024 0.931  
 C3 0.00 0.00 20.120 0.187  
 C4 19.49 0.00 3.89x106 0.634  
CIDI-SF Aget2 0.99 0.98 0.99 4.15x10-6 4156.80 
 Sex (F) 1.80 1.52 2.12 4.38x10-12  
 PRS 1.14 1.06 1.24 0.001  
 Resilience 0.43 0.40 0.47 < 2.00x10-16  
 PRS * Resilience 1.07 0.99 1.17 0.080  
 C1 3.75x1017 0.00 1.06x1041 0.134  
 C2 0.00 0.00 4.61x1021 0.733  
 C3 0.00 0.00 16.60 0.168  
 C4 1.28x103 0.00 1.17 0.266  
Abbreviations: CIDI-SF, Composite International Diagnostic Interview – Short Form, representing self-reported 
MDD; MDD, Major Depressive Disorder; AIC, Akaike Information Criterion; PRS, Polygenic Risk Score; 
Aget2, Age at the time of re-contact; C1-4, the principal components which control for population stratification 
N.B. Neuroticism has been controlled for Aget1 and these residuals used within the model. Resilience has been 





















Figure B1. Path diagram of Model 1A, which includes a direct path between PRS and clinical MDD status, and 
indirect path through neuroticism, modelled as a latent variable. Values are standardised path coefficients. All 
endogenous variables have been adjusted for population stratification, sex and the age at which the variable was 
measured. 
Abbreviations: PRS, Polygenic Risk Score; SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, 
representing clinical MDD; MDD, Major Depressive Disorder 
 
 
Table B7. Results of all standardised path coefficients and factor loadings from Model 1A examining the 
mediation of Neuroticism through PRS to clinical MDD status 
Model description ß S.E p value 
SCID ~ PRS 0.044 0.025 0.077 
SCID ~ Neuroticism 0.874 0.114 < 0.001 
SCID ~ Sex 0.191 0.054 < 0 .001 
SCID ~ Aget1 0.003 0.027 0.900 
SCID ~ C1 0.004 0.024 0.856 
SCID ~ C2 -0.004 0.025 0.868 
SCID ~ C3 -0.020 0.025 0.429 
SCID ~ C4 0.013 0.025 0.605 
Neuroticism ~ PRS 0.066 0.010 < 0 .001 
Neuroticism ~ Sex 0.116 0.019 < 0 .001 
Neuroticism ~ Aget1 -0.063 0.010 < 0 .001 
Neuroticism ~ C1 -0.004 0.005 0.514 
Neuroticism ~ C2 0.001 0.005 0.828 
Neuroticism ~ C3 -0.020 0.006 0 .001 
Neuroticism ~ C4 0.022 0.006 < 0 .001 
Neuroticism =~ EPQ1 1.000   
Neuroticism =~ EPQ3 1.012 0.139 < 0 .001 
Neuroticism =~ EPQ5 0.631 0.090 < 0 .001 
Neuroticism =~ EPQ7 0.695 0.120 < 0 .001 
Neuroticism =~ EPQ9 0.967 0.141 < 0 .001 
Neuroticism =~ EPQ11 0.853 0.125 < 0 .001 
Neuroticism =~ EPQ13 0.803 0.170 < 0 .001 
Neuroticism =~ EPQ15 0.829 0.117 < 0 .001 
Neuroticism =~ EPQ17 0.808 0.147 < 0 .001 
Neuroticism =~ EPQ19 0.859 0.119 < 0 .001 
Neuroticism =~ EPQ21 0.803 0.108 < 0 .001 
Neuroticism =~ EPQ23 0.916 0.127 < 0 .001 
Abbreviations: SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, representing clinical MDD; 
PRS, Polygenic Risk Score; Aget1, Age at baseline; C1-4, the principal components which control for population 




0.044, p = 0.077
 









Figure B2. Path diagram of Model 2A, which includes a direct path between PRS and self-reported MDD 
status, and indirect path through neuroticism, modelled as a latent variable. Values are standardised path 
coefficients. All endogenous variables have been adjusted for population stratification, sex and the age at which 
the variable was measured 
Abbreviations: PRS, Polygenic Risk Score; CIDI-SF, Composite International Diagnostic Interview – Short 
Form, representing self-reported MDD; MDD, Major Depressive Disorder 
 
 
Table B8. Results of all standardised path coefficients and factor loadings from Model 2A examining the 
mediation of Neuroticism through PRS to self-reported MDD status 
Model description ß S.E p value 
CIDI-SF ~ PRS 0.055 0.022 0.013 
CIDI-SF ~ Neuroticism 0.647 0.087 < 0.001 
CIDI-SF ~ Sex 0.312 0.047 < 0.001 
CIDI-SF ~ Aget1 -0.030 0.188 0.874 
CIDI-SF ~ C1 0.045 0.024 0.065 
CIDI-SF ~ C2 -0.002 0.022 0.931 
CIDI-SF ~ C3 -0.028 0.022 0.203 
CIDI-SF ~ C4 0.008 0.022 0.705 
Neuroticism ~ PRS 0.064 0.010 < 0.001 
Neuroticism ~ Sex 0.119 0.020 < 0.001 
Neuroticism ~ Aget1 -0.249 0.055 < 0.001 
Neuroticism ~ C1 -0.003 0.005 0.540 
Neuroticism ~ C2 0.002 0.005 0.719 
Neuroticism ~ C3 -0.020 0.006 0.001 
Neuroticism ~ C4 0.021 0.006 0.001 
Neuroticism =~ EPQ1 1.000   
Neuroticism =~ EPQ3 1.024 0.143 < 0.001 
Neuroticism =~ EPQ5 0.626 0.091 < 0.001 
Neuroticism =~ EPQ7 0.758 0.128 < 0.001 
Neuroticism =~ EPQ9 0.957 0.143 < 0.001 
Neuroticism =~ EPQ11 0.858 0.128 < 0.001 
Neuroticism =~ EPQ13 0.845 0.128 < 0.001 
Neuroticism =~ EPQ15 0.845 0.179 < 0.001 
Neuroticism =~ EPQ17 0.852 0.122 < 0.001 
Neuroticism =~ EPQ19 0.790 0.150 < 0.001 
Neuroticism =~ EPQ21 0.893 0.121 < 0.001 
Neuroticism =~ EPQ23 1.000 0.140 < 0.001 
Abbreviations: CIDI-SF, Composite International Diagnostic Interview – Short Form, representing self-reported 
MDD; PRS, Polygenic Risk Score; Aget1, Age at baseline; C1-4, the principal components which control for 




0.055, p = 0.013
 









Figure B3. Path diagram of Model 1B, which includes a direct path between PRS and clinical MDD status, and 
indirect path through resilience, modelled as a latent variable. Values are standardised path coefficients. All 
endogenous variables have been adjusted for population stratification, sex and the age at which the variable was 
measured 
Abbreviations: PRS, Polygenic Risk Score; SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, 
representing clinical MDD; MDD, Major Depressive Disorder 
 
 
Table B9. Results of all standardised path coefficients and factor loadings from Model 1B examining the 
mediation of Resilience through PRS to clinical MDD status 
Model description ß S.E p value 
SCID ~ PRS 0.064 0.024 0.008 
SCID ~ Resilience -0.577 0.018 < 0.001 
SCID ~ Sex 0.197 0.052 < 0.001 
SCID ~ Aget1 -0.452 0.201 0.024 
SCID ~ C1 -0.008 0.024 0.741 
SCID ~ C2 -0.010 0.025 0.697 
SCID ~ C3 -0.028 0.025 0.271 
SCID ~ C4 0.030 0.025 0.228 
Resilience ~ PRS -0.577 0.018 < 0.001 
Resilience ~ Sex -0.165 0.014 < 0.001 
Resilience ~ Aget2 0.010 0.056 0.860 
Resilience ~ C1 -0.015 0.007 0.021 
Resilience ~ C2 -0.014 0.007 0.040 
Resilience ~ C3 0.018 0.007 0.006 
Resilience ~ C4 -0.004 0.007 0.531 
Resilience =~ BRS1 1.00  < 0.001 
Resilience =~ BRS2 0.879 0.022 < 0.001 
Resilience =~ BRS3 0.947 0.023 < 0.001 
Resilience =~ BRS4 0.974 0.024 < 0.001 
Resilience =~ BRS5 0.975 0.024 < 0.001 
Resilience =~ BRS6 1.024 0.025 < 0.001 
Abbreviations: SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, representing clinical MDD; 
PRS, Polygenic Risk Score; Aget1, Age at baseline; Aget2, Age at re-contact; C1-4, the principal components 







0.064, p = 0.008
 










Figure B4. Path diagram of Model 2B, which includes a direct path between PRS and self-reported MDD 
status, and indirect path through resilience, modelled as a latent variable. Values are standardised path 
coefficients. All endogenous variables have been adjusted for population stratification, sex and the age at which 
the variable was measured 
Abbreviations: PRS, Polygenic Risk Score; CIDI-SF, Composite International Diagnostic Interview – Short 
Form, representing self-reported MDD; MDD, Major Depressive Disorder 
 
 
Table B10. Results of all standardised path coefficients and factor loadings from Model 2B examining the 
mediation of Resilience through PRS to self-reported MDD status 
Model description ß S.E p value 
CIDI-SF ~ PRS 0.058 0.022 0.008 
CIDI-SF ~ Resilience -0.597 0.018 < 0.001 
CIDI-SF ~ Sex 0.290 0.047 < 0.001 
CIDI-SF ~ Aget1 -0.070 0.022 0.001 
CIDI-SF ~ C1 0.033 0.024 0.171 
CIDI-SF ~ C2 -0.009 0.022 0.683 
CIDI-SF ~ C3 -0.030 0.022 0.177 
CIDI-SF ~ C4 0.019 0.022 0.383 
Resilience ~ PRS -0.065 0.007 < 0.001 
Resilience ~ Sex -0.165 0.014 < 0.001 
Resilience ~ Aget2 0.037 0.006 < 0.001 
Resilience ~ C1 -0.015 0.007 0.021 
Resilience ~ C2 -0.014 0.007 0.040 
Resilience ~ C3 0.018 0.007 0.006 
Resilience ~ C4 -0.004 0.007 0.531 
Resilience =~ BRS1 1.000  < 0.001 
Resilience =~ BRS2 0.879 0.022 < 0.001 
Resilience =~ BRS3 0.950 0.023 < 0.001 
Resilience =~ BRS4 0.972 0.024 < 0.001 
Resilience =~ BRS5 0.973 0.023 < 0.001 
Resilience =~ BRS6 1.022 0.025 < 0.001 
Abbreviations: CIDI-SF, Composite International Diagnostic Interview – Short Form; PRS, Polygenic Risk 
Score; Aget1, Age at baseline; Aget2, Age at re-contact; C1-4, the principal components which control for 







0.058, p = 0.008
 














Figure B5. Path diagram of Model 1C, which includes a direct bath between PRS and clinical MDD status, an 
indirect path through neuroticism and an indirect path through resilience, both modelled as latent variables. 
Values are standardised path coefficients. All endogenous variables have been adjusted for population 
stratification, sex and the age at which the variable was measured 
Abbreviations: PRS, Polygenic Risk Score; SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, 
representing clinical MDD;MDD, Major Depressive Disorder 
 
 
Table B11.Results of all standardised path coefficients and factor loadings from Model 1C examining the 
separate mediation of Neuroticism and Resilience through PRS to clinical MDD status 
Model description ß S.E p value 
SCID ~ PRS 0.039 0.024 0.108 
SCID ~ Neuroticism 0.680 0.105 < 0.001 
SCID ~ Resilience -0.295 0.044 < 0.001 
SCID ~ Sex 0.164 0.053 0.002 
SCID ~ Aget1 -0.283 0.205 0.166 
SCID ~ C1 -0.001 0.024 0.962 
SCID ~ C2 -0.007 0.025 0.784 
SCID ~ C3 -0.019 0.025 0.440 
SCID ~ C4 0.017 0.025 0.499 
Neuroticism ~ PRS 0.064 0.008 < 0.001 
Neuroticism ~ Sex 0.116 0.017 < 0.001 
Neuroticism ~ Aget1 -0.249 0.052 < 0.001 
Neuroticism ~ C1 -0.003 0.005 0.511 
Neuroticism ~ C2 0.001 0.005 0.782 
Neuroticism ~ C3 -0.020 0.006 < 0.001 
Neuroticism ~ C4 0.021 0.006 < 0.001 
Neuroticism =~ EPQ1 1.00  < 0.001 
Neuroticism =~ EPQ3 1.038 0.102 < 0.001 
Neuroticism =~ EPQ5 0.591 0.060 < 0.001 
Neuroticism =~ EPQ7 0.801 0.097 < 0.001 
Neuroticism =~ EPQ9 1.012 0.107 < 0.001 
Neuroticism =~ EPQ11 0.910 0.093 < 0.001 
Neuroticism =~ EPQ13 0.899 0.154 < 0.001 
Neuroticism =~ EPQ15 0.842 0.082 < 0.001 
Neuroticism =~ EPQ17 0.805 0.113 < 0.001 
Neuroticism =~ EPQ19 0.886 0.086 < 0.001 




.039,  p = .108
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Neuroticism =~ EPQ23 0.910 0.088 < 0.001 
Resilience ~ PRS -0.066 0.007 < 0.001 
Resilience ~ Sex -0.165 0.014 < 0.001 
Resilience ~ Aget2 0.019 0.057 0.733 
Resilience ~ C1 -0.016 0.007 0.021 
Resilience ~ C2 -0.014 0.007 0.040 
Resilience ~ C3 0.018 0.007 0.006 
Resilience ~ C4 -0.004 0.007 0.530 
Resilience =~ BRS1 1.000   
Resilience =~ BRS2 0.880 0.021 < 0.001 
Resilience =~ BRS3 0.947 0.022 < 0.001 
Resilience =~ BRS4 0.968 0.023 < 0.001 
Resilience =~ BRS5 0.974 0.023 < 0.001 
Resilience =~ BRS6 1.014 0.024 < 0.001 
Abbreviations: SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, representing clinical MDD; 
PRS, Polygenic Risk Score; Aget1, Age at baseline; Aget2, Age at re-contact; C1-4, the principal components 























Figure B6. Path diagram of Model 2C, which includes a direct bath between PRS and self-reported MDD 
status, an indirect path through neuroticism and an indirect path through resilience, both measured as latent 
variables. Values are standardised path coefficients. All endogenous variables have been adjusted for population 
stratification, sex and the age at which the variable was measured 
Abbreviations: PRS, Polygenic Risk Score; CIDI-SF, Composite International Diagnostic Interview – Short 
Form, representing self-reported MDD;MDD, Major Depressive Disorder 
 
 
Table B12.Results of all standardised path coefficients and factor loadings from Model 2C examining the 
separate mediation of Neuroticism and Resilience through PRS to self-reported MDD status 
Model description ß S.E p value 
CIDI-SF ~ PRS 0.047 0.022 0.033 
CIDI-SF ~ Neuroticism 0.295 0.070 < 0.001 
CIDI-SF ~ Resilience -0.473 0.035 < 0.001 
CIDI-SF ~ Sex 0.276 0.047 < 0.001 
CIDI-SF ~ Aget1 -0.016 0.190 0.933 




0.047,  p = .033
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CIDI-SF ~ C2 -0.008 0.022 0.730 
CIDI-SF ~ C3 -0.027 0.022 0.231 
CIDI-SF ~ C4 0.013 0.022 0.537 
Neuroticism ~ PRS 0.064 0.008 < 0.001 
Neuroticism ~ Sex 0.116 0.017 < 0.001 
Neuroticism ~ Aget1 -0.249 0.052 < 0.001 
Neuroticism ~ C1 -0.003 0.005 0.513 
Neuroticism ~ C2 0.001 0.005 0.783 
Neuroticism ~ C3 -0.020 0.006 < 0.001 
Neuroticism ~ C4 0.021 0.006 < 0.001 
Neuroticism =~ EPQ1 1.000  < 0.001 
Neuroticism =~ EPQ3 1.039 0.102 < 0.001 
Neuroticism =~ EPQ5 0.589 0.060 < 0.001 
Neuroticism =~ EPQ7 0.782 0.096 < 0.001 
Neuroticism =~ EPQ9 1.020 0.108 < 0.001 
Neuroticism =~ EPQ11 0.899 0.922 < 0.001 
Neuroticism =~ EPQ13 0.888 0.152 < 0.001 
Neuroticism =~ EPQ15 0.834 0.082 < 0.001 
Neuroticism =~ EPQ17 0.800 0.112 < 0.001 
Neuroticism =~ EPQ19 0.881 0.086 < 0.001 
Neuroticism =~ EPQ21 0.809 0.076 < 0.001 
Neuroticism =~ EPQ23 0.912 0.088 < 0.001 
Resilience ~ PRS -0.066 0.007 < 0.001 
Resilience ~ Sex -0.166 0.014 < 0.001 
Resilience ~ Aget2 0.029 0.057 0.608 
Resilience ~ C1 -0.016 0.007 0.021 
Resilience ~ C2 -0.014 0.007 0.040 
Resilience ~ C3 0.018 0.007 0.006 
Resilience ~ C4 -0.004 0.007 0.530 
Resilience =~ BRS1 1.000   
Resilience =~ BRS2 0.880 0.021 < 0.001 
Resilience =~ BRS3 0.949 0.022 < 0.001 
Resilience =~ BRS4 0.967 0.023 < 0.001 
Resilience =~ BRS5 0.973 0.022 < 0.001 
Resilience =~ BRS6 1.013 0.023 < 0.001 
Abbreviations: SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, representing clinical MDD; 
PRS, Polygenic Risk Score; Aget1, Age at baseline; Aget2, Age at re-contact; C1-4, the principal components 






















Figure B7. Path diagram of Model 1D, which includes a direct path between PRS and clinical MDD status, and 
an indirect path through the latent variable (Neuroticism+Resilience). Values are standardised path coefficients. 
All endogenous variables have been adjusted for population stratification, sex and the age at which the variable 
was measured 
Abbreviations: PRS, Polygenic Risk Score; SCID, Structured Clinical Interview for DSM-IV Axis I Disorders, 
representing clinical MDD;MDD, Major Depressive Disorder; Neuroticism+Resilience, a latent factor 
comprised of the individual items from the Eysenck Personality Questionnaire Short Form-Revised and the 
individual items from the Brief Resilience Scale 
 
Table B13. Results of all standardised path coefficients and factor loadings from Model 1D examining the mediation 
of a latent variable Neuroticism+Resilience through PRS to clinical MDD status 
Model description ß S.E p value 
SCID ~ PRS 0.055 0.024 0.023 
SCID ~ Neuroticism+Resilience 1.187 0.108 < 0.001 
SCID ~ Sex 0.184 0.052 < 0.001 
SCID ~ Aget1 -0.371 0.203 0.067 
SCID ~ C1 -0.004 0.024 0.856 
SCID ~ C2 -0.008 0.025 0.748 
SCID ~ C3 -0.024 0.025 0.341 
SCID ~ C4 0.023 0.024 0.351 
Neuroticism+Resilience ~ PRS 0.040 0.005 < 0.001 
Neuroticism+Resilience ~ Sex 0.091 0.010 < 0.001 
Neuroticism+Resilience ~ Aget1 -0.068 0.026 0.008 
Neuroticism+Resilience ~ Aget2 0.042 0.025 0.093 
Neuroticism+Resilience ~ C1 0.005 0.003 0.120 
Neuroticism+Resilience ~ C2 0.005 0.003 0.073 
Neuroticism+Resilience ~ C3 -0.012 0.003 < 0.001 
Neuroticism+Resilience ~ C4 0.008 0.003 0.009 
Neuroticism+Resilience =~ EPQ1 1.000   
Neuroticism+Resilience =~ EPQ3 1.030 0.108 < 0.001 
Neuroticism+Resilience =~ EPQ5 0.537 0.059 < 0.001 
Neuroticism+Resilience =~ EPQ7 0.838 0.110 0.002 
Neuroticism+Resilience =~ EPQ9 1.042 0.118 < 0.001 
Neuroticism+Resilience =~ EPQ11 0.902 0.098 < 0.001 
Neuroticism+Resilience =~ EPQ13 1.208 0.218 < 0.001 
Neuroticism+Resilience =~ EPQ15 0.776 0.218 < 0.001 
Neuroticism+Resilience =~ EPQ17 0.860 0.130 < 0.001 
Neuroticism+Resilience =~ EPQ19 0.852 0.089 < 0.001 
Neuroticism+Resilience =~ EPQ21 0.731 0.073 < 0.001 
Neuroticism+Resilience =~ EPQ23 0.834 0.086 < 0.001 
Neuroticism+Resilience =~ BRS1 -1.939 0.173 < 0.001 
Neuroticism+Resilience =~ BRS2 -1.707 0.152 < 0.001 




0.055, p = 0.023
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Neuroticism+Resilience =~ BRS4 -1.868 0.167 < 0.001 
Neuroticism+Resilience =~ BRS5 -1.886 0.168 < 0.001 
Neuroticism+Resilience =~ BRS6 -1.956 0.174 < 0.001 
Abbreviations:  Structured Clinical Interview for DSM-IV Axis I Disorders, representing clinical MDD ; PRS, 
Polygenic Risk Score;  Aget1, Age at baseline; Aget2, Age at re-contact; C1-4, the principal components which control 
for population stratification;  Neuroticism+Resilience, a latent factor comprised of the individual items from the 










Figure B8. Path diagram of Model 2D, which includes a direct path between PRS and self-reported MDD 
status, and an indirect path through the latent variable (Neuroticism+Resilience). Values are standardised path 
coefficients. All endogenous variables have been adjusted for population stratification, sex and the age at which 
the variable was measured 
Abbreviations: PRS, Polygenic Risk Score; Composite International Diagnostic Interview – Short Form, 
representing self-reported MDD;MDD, Major Depressive Disorder; Neuroticism+Resilience, a latent factor 
comprised of the individual items from the Eysenck Personality Questionnaire Short Form-Revised and the 
individual items from the Brief Resilience Scale 
 
Table B14.Results of all standardised path coefficients and factor loadings from Model 2D examining the mediation 
of a latent variable Neuroticism+Resilience through PRS to self-reported MDD status 
Model description ß S.E p value 
CIDI-SF ~ PRS 0.049 0.022 0.025 
CIDI-SF ~ Neuroticism+Resilience 1.207 0.109 < 0.001 
CIDI-SF ~ Sex 0.280 0.047 < 0.001 
CIDI-SF ~ Aget2 -0.071 0.190 0.708 
CIDI-SF ~ C1 0.037 0.024 0.126 
CIDI-SF ~ C2 -0.007 0.022 0.752 
CIDI-SF ~ C3 -0.027 0.022 0.230 
CIDI-SF ~ C4 0.012 0.022 0.569 
Neuroticism+Resilience ~ PRS 0.040 0.005 < 0.001 
Neuroticism+Resilience ~ Sex 0.090 0.010 < 0.001 
Neuroticism+Resilience ~ Aget1 -0.067 0.025 0.009 
Neuroticism+Resilience ~ Aget2 0.034 0.025 0.167 
Neuroticism+Resilience ~ C1 0.005 0.003 0.116 
Neuroticism+Resilience ~ C2 0.005 0.003 0.071 
Neuroticism+Resilience ~ C3 -0.012 0.003 < 0.001 
Neuroticism+Resilience ~ C4 0.008 0.003 0.010 
Neuroticism+Resilience =~ EPQ1 1.000   
Neuroticism+Resilience =~ EPQ3 1.032 0.108 < 0.001 
Neuroticism+Resilience =~ EPQ5 0.531 0.059 < 0.001 




0.049, p = 0.025
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Neuroticism+Resilience =~ EPQ9 1.045 0.119 < 0.001 
Neuroticism+Resilience =~ EPQ11 0.888 0.097 < 0.001 
Neuroticism+Resilience =~ EPQ13 1.187 0.216 < 0.001 
Neuroticism+Resilience =~ EPQ15 0.766 0.080 < 0.001 
Neuroticism+Resilience =~ EPQ17 0.851 0.128 < 0.001 
Neuroticism+Resilience =~ EPQ19 0.846 0.088 < 0.001 
Neuroticism+Resilience =~ EPQ21 0.733 0.074 < 0.001 
Neuroticism+Resilience =~ EPQ23 0.834 0.086 < 0.001 
Neuroticism+Resilience =~ BRS1 -1.959 0.174 < 0.001 
Neuroticism+Resilience =~ BRS2 -1.724 0.154 < 0.001 
Neuroticism+Resilience =~ BRS3 -1.858 0.166 < 0.001 
Neuroticism+Resilience =~ BRS4 -1.887 0.168 < 0.001 
Neuroticism+Resilience =~ BRS5 -1.904 0.170 < 0.001 
Neuroticism+Resilience =~ BRS6 -1.975 0.176 < 0.001 
Abbreviations:  Composite International Diagnostic Interview – Short Form, representing self-reported MDD; PRS, 
Polygenic Risk Score; Aget1, Age at baseline; Aget2, Age at re-contact; C1-4, the principal components which control 
for population stratification; Neuroticism+Resilience, a latent factor comprised of the individual items from the 
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Appendix C 
Supplementary material from Chapter 6 
 
 
Table C1 Descriptive data from the individuals in this sample 
 
Table C2 Age-, sex-, and population stratification-adjusted univariate GCTA estimates of narrow-sense 
heritability 
 
Table C3 Number of non-zero off diagonal entries in the lower triangular part of all variance component 
matrices 
 
Table C4 Age-, sex-, and population stratification-adjusted variance component analysis results for 
Resilience, ToC, EoC, and AoC 
 





Descriptive statistics of the current cohort 
Table C1. Descriptive data from the individuals in this sample (n = 8,734) 
Variable n Mean (SD) n (%) Median Range 
Age 8734  56.36 (13.15)  59 22 – 100 
Sex (Female) 8734  5,403 (62)   
Resilience 8557 3.56 (0.80)  3.67 1- 5 
ToC 8172 54.38 (12.21)  56 16 – 80 
EoC 8308 37.62 (12.55)  37 16 – 80 
AoC 8250 39.43 (10.49)  40 16 – 80 
Neuroticism 8004 3.55 (3.11)  3 0 – 12 
Abbreviations: ToC, Task-oriented coping; EoC, Emotion- oriented coping; AoC, Avoidance-oriented coping 
 
 
Narrow-sense heritability estimates for the four traits examined 
Table C2. Age-, sex-, and population stratificationa-adjusted univariate GCTA estimates of narrow-sense heritability 
 n VG VK Ve Vp VG/VP VK/VP 𝑕𝑛2  
Resilience 8555 0.05 (0.03) 0.04 (0.03) 0.54 (0.02) 0.63 (0.01) 0.08 (0.04) 0.06 (0.05) 0.14 (0.09) 
ToC 8170 17.26 (6.74) 18.56 (8.32) 112.27 (5.21) 148.08 (2.34) 0.12 (0.05) 0.13 (0.06) 0.24 (0.10) 
EoC 8306 19.84 (6.46) 14.41 (7.98) 110.45 (5.04) 144.69 (2.26) 0.14 (0.04) 0.10 (0.06) 0.24 (0.10) 
AoC 8248 12.91 (4.26) 8.57 (5.31) 73.75 (3.33) 94.75 (1.49) 0.14 (0.04) 0.09 (0.06) 0.23 (0.10) 
a first four principal components 
Abbreviations: ToC, Task-oriented Coping; EoC, Emotion-oriented Coping; AoC, Avoidance-oriented coping; VG, variance 
associated with additive genetic effect from common variants, VK, variance associated with the pedigree; Ve, residual variance, 
Vp, phenotypic variance, VG/VP, ratio of additive genetic effect from common variants to phenotypic variance; VK/VP, ratio of 
pedigree variances to phenotypic variance; 𝑕𝑛2 , narrow-sense heritability 
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Construction of Genetic Relationship Matrices (GRMs) 
 
Two GRMs were fitted using the method created by Zaitlen et al (2013). The first GRM comprised of pairwise 
relationship coefficients of all individuals in the sample. The second GRM included off-diagonal elements of 
pairs of individuals who has a relationship coefficient < 0.05 set to 0. Assuming inbreeding had not taken place, 
the second GRM excluded pairs of individuals with a most recent common ancestor of approximately four 
generations distant. This method has been found to account for potential upward biases due to excessive 
relationships which allows for the inclusion of closely and distantly related individuals in genetic analyses  
 
Constructing variation-covariance matrices representing different source of variation 
 
G: Genomic relationship matrix: The genetic relationships between individuals were calculated in GCTA 







Yang et al. (2011) 
 
in which i represents a SNP, x is the allele count of the minor allele for individual j or k at i. pi is the minor allele 
frequency of SNP i , and N is the total number of SNPs. This matrix was created in GCTA. 
 
K: Kinship relationship matrix: K was calculated by the modification of the G matrix. Relationship co-
efficient values less than or equal to 0.05 in the G matrix were set to 0, as this threshold separates closely and 
distantly related individuals (Zaitlen et al, 2013).  
 
F,S,C: Environmental relationship matrices: To represent different shared environmental effects, familial 
relationship matrices were designed. Each was created by making an N x N matrix in which all entries were set 
to 0 and all diagonal entries set to 1. Off-diagonal entries, too, were set to 1 if two families shared the 
environment of interest. A total of three environmental relationship matrices were created; F represents the 
shared environment of a nuclear family living within the same household, S represents the sibling environment, 
and C represents the couple environment. 
 
Estimating the phenotypic variance explained by different source of variation. 
 
The genomic and environment relationship matrices described above were selectively jointly fitted in a Linear 
Mixed Model (LMM) implemented in GCTA. The models analyzed included all fixed effects and subsets of 
random effects in the full model: 
 
Y = Xb + gg + gkin+ ef+ es+ ec+ ε 
 
In which Y is a phenotype vector, b is a vector of covariates fitted as fixed effects (age, sex, and four principal 
components derived from the genome-wide genomic relationship matrix). gg and gkinare random genetic effects 
from SNPs and the extra random genetic effect from the pedigree, respectively. ef, es, ec represent random 
environmental effects shared by nuclear family members, full-siblings and couples, respectively. For simplicity, 
the following codes were used to represent the matrices fitted: for example, ‗GKFSC‘ was the full model fitting 
all five matrices as random effects simultaneously, whereas ‗GFC‘ represents a model in which the genomic 
relationship matrix, nuclear family and couple environment matrices were simultaneously fitted. The proportion 
of variance explained by individual component was estimated using REML and tested using Log-likelihood 
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Number of non-zero off diagonal entries for each trait 
 
 
Table C3. Number of non-zero off diagonal entries in the lower triangular part of all variance component 
matrices 
 
Matrix Number of non-zero off diagonal entries 
 Full sample Resilience ToC EoC AoC 
 
K - pedigree associated genetics 6,015 5,810 5,314 5,501 5,439 
F – nuclear family 4,508 4,340 3,982 4,115 4,057 
C – couple 655 633 574 588 1,753 
S –sibling 1,925 1,863 1,733 1,774 574 
 
Abbreviations: ToC; Task-oriented Coping; EoC, Emotion-oriented Coping; AoC, Avoidance-oriented Coping 




Variance component analysis 
 
Table C4. Age-, sex-, and population stratificationa-adjusted variance component analysis results for Resilience, 
ToC, EoC, and AoC 
Variable n Model 𝑕𝑔 2 (SE) 𝑕𝑘2(SE) 𝑒𝑓
2(SE) 𝑒𝑠2(SE) 𝑒𝑐2 (SE) 
 
Resilience 8,555 
GK 0.08 (0.04) 0.06 (0.05)    
GKFSC 0.06 (0.04) 0.00 (0.12) 0.05 (0.06) 0.00 (0.03) 0.01 (0.07) 
GFSC 0.07 (0.04)  0.05 (0.03) 0.00 (0.03) 0.02 (0.05) 
GFC 0.07 (0.04)  0.04 (0.03)  0.04 (0.05) 
GF 0.06 (0.04)  0.05 (0.02)   
ToC 8,170 
GK 0.12 (0.05) 0.13 (0.06)    
GKFSC 0.11 (0.05) 0.02 (0.13) 0.03 (0.06) 0.08 (0.04) 0.16 (0.07) 
GFSC 0.12 (0.04)  0.03 (0.03) 0.08 (0.04) 0.15 (0.05) 
GSC 0.14 (0.03)   0.10 (0.03) 0.18 (0.04) 
EoC 8,306 
GK 0.14 (0.04) 0.10 (0.06)    
GKFSC 0.14 (0.04) 0.03 (0.12) 0.04 (0.06) 0.00 (0.03) 0.14 (0.07) 
GFSC 0.14 (0.04)  0.06 (0.03) 0.00 (0.03) 0.13 (0.05) 
GFC 0.15 (0.04)  0.05 (0.03)  0.14 (0.05) 
AoC 8,248 
GK 0.14 (0.04) 0.09 (0.06)    
GKFSC 0.12 (0.04) 0.00 (0.13) 0.03 (0.06) 0.05 (0.03) 0.14 (0.07) 
GFSC 0.13 (.04)  0.03 (0.03) 0.06 (0.03) 0.15 (0.05) 
GSC 0.15 (0.03)   0.07 (0.03) 0.18 (0.04) 
a first four principal components 
Abbreviations: ToC; Task-oriented Coping; EoC, Emotion-oriented Coping; AoC, Avoidance-oriented Coping; 𝑕𝑔2 , 
common variants -associated genetic effect; 𝑕𝑘2 , pedigree associated genetic effect; 𝑒𝑓2, nuclear family environmental 
effect; 𝑒𝑠2, full sibling environmental effect; 𝑒𝑐2, couple environmental effect 
N.B. Backward stepwise selection was used to select the most parsimonious model for each trait 







- 131 -  
 
Appendix D 





Navrady, LB., Zeng, Y., Clarke, T-K., Adams, MJ., Howard, DM., Deary, IJ., McIntosh, AMM. Genetic and  
environmental contributions to psychological resilience and coping. Accepted by Wellcome Open 
Research (awaiting review). 
 
Navrady, LB., Adams, MJ., Chan, SWY., Major Depressive Disorder Working Group of the  
Psychiatric Genomics Consortium, Ritchie, SJ., McIntosh, AM. (2017). Genetic risk of Major 
Depressive Disorder: the moderating and mediating effects of neuroticism and psychological resilience 
on clinical and self-reported depression. Psychological Medicine, doi: 10.1017/S0033291717003415. 
 
Navrady, LB., Wolters, MK., MacIntyre, DJ., Clarke, T-K., Campbell, AI., Murray, AD., Evans,  
KL., Seckl, J., Haley, C., Milburn, KK., Wardlaw, JM., Porteous, DJ., Deary, IJ., McIntosh, AM. 
(2017). Cohort Profile: Stratifying Resilience and Depression Longitudinally (STRADL): A 
questionnaire follow-up of the Generation Scotland: Scottish Family Health Study (GS:SFHS). 
International Journal of Epidemiology: dyx115.  
 
 Navrady, LB., Ritchie, SJ., Chan, SWY., Kerr, D., Adams, MJ., Hawkins, E., Porteous, D., Deary,  
IJ., Gale, CR., Batty, GD., McIntosh, AM. (2017). Intelligence and neuroticism in relation to 
depression and psychological distress: Evidence from two large population cohorts. European 






Wigmore EM, Navrady LB, Hafferty JF, Clarke T-K, Campbell A, Thomson PA, Porteous DJ,  
Nicodemus KK, Deary IJ, McIntosh AM. Antidepressant treatment resistance and the impact  
of neuroticism, psychological resilience and coping style. In submission.  
 
Wigmore EM, Hafferty JD, Hall LS, Howard DM, Clarke T-K, Fabbri C, Lewis CM, Uher R,  
Navrady LB, Adams MJ, Zeng Y, Campbell A, Gibson J, Thomson PA, Hayward C, Smith BH, 
Hocking DJ, Mors O, Mattheisen M, Nicodemus KK, McIntosh AM. Genome-wide association study 
of antidepressant treatment resistance in a population-based cohort using health service prescription 
data and metaanalysis with GENDEP. In submission. 
 
Clarke T-K, Zeng Y, Navrady LB, Xia C, Haley C, Campbell A, Navarro P, Amador C, Adams MJ,  
Howard DM, Hayward C, Thomson PA, Soler AA, Smith BH, Padmanabhan S, Hocking LJ,  
Hall LS, Porteous DJ, Deary IJ, McIntosh AM. Genetic and environmental determinants of stressful 
life events and their overlap with depression and neuroticism. Accepted by Wellcome Open Research 
(awaiting review).  
 
Hafferty JD, Campbell AI, Navrady LB, Adams MJ, MacIntyre D, Lawrie SM, Nicodemus K,  
Porteous DJ, McIntosh AM. (2017). Validation of Self-Reported Medication Use Through Record 
Linkage To National Prescribing Data. Journal of Clinical Epidemiology, doi: 
10.1016/j.jclinepi.2017.10.013. 
 
Schweizer S, Navrady L, Breakwell L, Howard R, Golden A-M, Werner-Seidler A, Dalgleish T. (2017).  
Affective Enhancement of Working Memory is Maintained in Depression. Emotion, doi: 
10.1037/emo0000306. 
 
FeldmanHall O, Dalgleish T, Evans D, Navrady L, Tedeschi E, Mobbs D. (2016). Moral Chivalry: The  
 
- 132 -  
 
interactive effect of gender and moral orientation on altruistic choice. Social Psychology and 
Personality Science, 7, 542-551.  
 
Dalgleish T, Navrady L, Bird E, Dunn BD, Golden A-M. (2013). Method-of-loci as a mnemonic device to  
facilitate access to self-affirming personal memories for individuals with depression. Clinical 
Psychological Science, 1, 156-162.  
 
FeldmanHall O, Mobbs D, Evans D, Hiscox L, Navrady L, Dalgleish. (2012). What we say and what we do:  
The relationship between real and hypothetical moral choices. Cognition, 123, 434-441.
 
 
 
 
  
 
 
